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Resumen 
 
El presente trabajo “Development of hybrid chitosan hydrogels. A combined 
application in magnetic hyperthermia and drug delivery”, tiene como objetivo el 
desarrollo de hidrogeles híbridos a base de quitosano con el propósito de adquirir 
nuevos conocimientos y explorar aplicaciones potenciales de estos hidrogeles 
poliméricos en hipertermia magnética y liberación controlada de fármacos. Para el 
desarrollo de hidrogeles poliméricos con respuesta al pH se ha seleccionado un 
polímero de origen natural como es el quitosano, debido a sus propiedades intrínsecas 
de biodegradabilidad y biocompatibilidad. Con el fin de ampliar las aplicaciones de los 
hidrogeles de quitosano, se han preparado y caracterizado hidrogeles compuestos de 
quitosano/agarosa, como sistemas duales con respuesta al pH y a la temperatura para 
aplicaciones en liberación controlada de fármacos. Para aplicaciones en Hipertermia 
Magnética (MH), se han sintetizado hidrogeles de quitosano con partículas magnéticas 
encapsuladas. Con el fin de diversificar el campo de aplicación de los hidrogeles de 
quitosano, se ha llevado a cabo el desarrollo de geles a escala micro y nanométrica.  Los 
microgeles de quitosano se han preparado mediante la técnica de microfluídica que ha 
permitido la obtención de microgeles monodispersos. Los nanogeles de quitosano se 
han preparado mediante un proceso de nanoprecipitación mediante el cual se han podido 
encapsular nanopartículas magnéticas y 5-Fluorouracil, fármaco modelo empleado en 
quimioterapia. De esta forma, se han desarrollado nano-transportadores para 
aplicaciones combinadas de hipertermia magnética y liberación de fármacos en terapias 
contra el cáncer. Por último, se ha realizado un estudio de las propiedades viscoelásticas 
de los macro y nanogeles mediante el cual se ha podido determinar la organización 
estructural de estos sistemas mediante la aplicación de modelos de escala.  
Esta memoria describe en siete capítulos los objetivos parciales necesarios para 
conseguir el objetivo final. A continuación se describe el objetivo establecido para cada 
uno de ellos junto con las conclusiones derivadas del trabajo experimental realizado:  
En el primer capítulo, “Introdución general y objetivos” se enmarca el trabajo de 
tesis doctoral dentro de las líneas de investigación del grupo donde se ha llevado a cabo 
y se describe el objetivo general de la tesis así como cada uno de los objetivos parciales 
y la metodología empleada para su consecución.  
El segundo capítulo, “Estado del arte”, resume el estudio bibliográfico llevado a 
cabo sobre los principales temas relacionados con el presente trabajo doctoral, en el cual 
se destaca: i) Las características principales del quitosano y su importancia como 
polímero natural para la obtención de materiales para aplicaciones biomédicas, ii) 
Hidrogeles a base de quitosano, macro y nanogeles y su caracterización reológica, iii) 
Sistemas de quitosano como nano-transportadores en terapias combinadas de 
hipertermia magnética y liberación de fármacos iv) la técnica de microfluídica como 
técnica avanzada de preparación de microgeles poliméricos. 
El tercer capítulo, “Macrogeles de quitosano. Estudio de sus propiedades” 
describe la preparación y caracterización de diferentes geles físicos de quitosano: 
macrogeles de quitosano, macrogeles compuestos de quitosano/agarosa y macrogeles 
cargados con nanopartículas magnéticas. Los macrogeles de quitosano se obtienen por 
medio de la adicción de una disolución coagulante. Este mismo método es empleado 
para la síntesis de ferrogeles de quitosano mediante el cual se lleva a cabo la 
gelificación del quitosano y la preparación in situ de nanopartículas de óxido de hierro 
de forma simultánea. Los macrogeles compuestos de quitosano/agarosa se obtienen por 
gelificación de la agarosa en presencia de una disolución de quitosano y son evaluados 
como materiales para liberación controlada de fármacos. Estos macrogeles compuestos 
son cargados con diferentes concentraciones de ferrofluido y son evaluados como 
materiales para hipertermia magnética. 
De acuerdo a los estudios realizados para todos los macrogeles, se observó que: 
i) los macrogeles de quitosano preparados por adicción de una disolución coagulante, 
deben su formación al establecimiento de enlaces de hidrógeno e interacciones 
hidrofóbicas y presentaron un comportamiento de tipo gel de acuerdo a su 
comportamiento reológico ii) mediante la síntesis in situ de nanopartículas de óxido de 
hierro en macrogeles de quitosano se obtuvieron ferrogeles de quitosano con mayor 
módulo elástico y estabilidad térmica que los macrogeles de quitosano, iii) con respecto 
a los macrogeles compuestos de quitosano/agarosa, la incorporación de quitosano dió 
lugar a materiales con módulos elásticos mayores y  mayor estabilidad temporal (menor 
pérdida de peso con el tiempo) que los geles simples de agarosa, asimismo, iv) la 
incorporación de ferrofluido a los macrogeles compuestos de quitosano/agarosa mejoró 
la estabilidad térmica de los macrogeles resultantes aunque dio lugar a una disminución 
de sus propiedades mecánicas, finalmente, v) los macrogeles quitosano/agarosa se 
evaluaron como materiales para aplicaciones en hipertermia magnética y liberación 
controlada de 5-Fluorouracil. 
El cuarto capítulo, “Microgeles de quitosano preparados a través de 
microfluídica”, está enfocado a la preparación de diferentes tipos de microgeles de 
quitosano a través de la técnica de microfluídica. Se incluye la fabricación de diferentes 
dispositivos y la influencia de diferentes parámetros experimentales tales como 
velocidad de flujo y concentración de las fases orgánica y acuosa en el proceso de 
emulsificación del quitosano y en la formación final de microgeles.  
Del estudio de estos sistemas se puede concluir que: i) se ha logrado la 
emulsificación en gotas de disoluciones de quitosano en los dos dispositivos empleados, 
“T-junction” y “flow-focusing”, ii) se ha logrado el entrecruzamiento de las gotas de 
quitosano dentro del dispositivo de microfluidos empleando el tripolifosfato de sodio 
(TPP) como agente entrecruzante, iii) se han preparado microgeles compuestos de 
quitosano/agarosa por la técnica de microfluídica, iv) de acuerdo a los diferentes 
experimentos, la concentración de agarosa y la velocidad de flujo tuvieron un efecto 
directo sobre los tamaños de los microgeles, por último, v) se ha podido encapsular un 
ferrofluido en microgeles compuestos de quitosano/agarosa utilizando microfluídica. 
El quinto capítulo, “Nanopartículas de quitosano cargadas con ferrofluido” da 
inicio al desarrollo de nanopartículas de quitosano obtenidas por medio de 
entrecruzamiento físico del quitosano con el tripolifosfato de sodio (TPP). Este método 
de preparación ha permitido además la obtención de nanopartículas de quitosano 
cargadas con ferrofluido que han sido evaluadas para aplicaciones en hipertermia 
magnética. 
Los resultados obtenidos han permitido establecer las siguientes conclusiones: i) 
la reacción de entrecruzamiento entre el quitosano y el TPP depende de la concentración 
de quitosano y de TPP y de la proporción en volumen de quitosano/TPP, ii) las 
nanopartículas cargadas con ferrofluido presentaron una morfología tipo capa-núcleo 
(`core-shell´), un tamaño entre los 192-259 nm y todas las muestras presentaron carga 
superficial positiva, iii) La aplicación de teorías de escala y el análisis fractal obtenido a 
partir de los resultados reológicos ha permitido entender el tipo de uniones que suceden 
en la dispersión de los nanogeles de quitosano en función de la concentración de dichas 
dispersiones, iv) se evaluó la citotoxicidad de los materiales sintetizados sobre células 
de tipo fibroblasto observándose que la viabilidad celular depende de la concentración 
de nanopartículas empleada y que además, disminuye en función del contenido de 
ferrofluido, y finalmente v) las nanopartículas de quitosano cargadas con ferrofluido 
pueden ser empleadas como agentes de hipertermia por su capacidad para calentarse al 
ser sometidas a un campo magnético. 
En el sexto capítulo, “Estudio in vitro de nanopartículas magnéticas de 
quitosano cargadas con 5-fluorouracil para aplicaciones en hipertermia magnética”, 
se describe la preparación y caracterización de nanopartículas de quitosano cargadas 
con un fármaco empleado en quimioterapia, 5- Fluorouracilo (5-FU) y con un  
ferrofluido. Además  se han  evaluado sus propiedades para ser utilizadas como nano-
transportadores en terapias combinadas de hipertermia magnética y liberación 
controlada.  
De los estudios realizados se puede extraer que: i) 5-FU y ferrofluido fueron 
encapsulados exitosamente dentro de las nanopartículas de quitosano, ii) los tamaños 
nanométricos (140-200 nm) obtenidos para dichas nanopartículas, fueron adecuados 
para su internalización en células tipo fibroblasto y células cancerígenas (A-172), iii) el 
perfil de liberación de 5-FU puede ser modulado en función del pH y del contenido en 
ferrofluido de los nanogeles de quitosano, iv) los estudios de citotoxicidad permitieron 
determinar una menor viabilidad celular para células cancerígenas con respecto a 
células de tipo fibroblasto y v) los estudios  de Hipertermia Magnética llevados a cabo 
en un equipo diseñado por el laboratorio (INA, Universidad de Zaragoza) permitieron 
determinar daños celulares, cambios morfológicos en las células y una reducción en la 
viabilidad celular tras la aplicación de un ciclo de hipertermia magnética, sin embargo, 
vi) no se observaron diferencias significativas sobre la viabilidad celular trás un 
segundo tratamiento de hipertermia magnética, por último, viii) las células cancerígenas 
(A-172) fueron más sensibles al tratamiento de hipertermia magnética que las células de 
tipo fibroblasto.  
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The present work “Development of hybrid chitosan hydrogels. A combined 
application in magnetic hyperthermia and drug delivery”, aims to bring new insights 
in the framework of the research line “polymer gels”, in which the group 
`Nanostructured Polymers and gels´ has been working for the last years, by searching 
new objectives. As a continuation of the significant efforts put on this topic, we 
proposed to develop a general study about hybrid hydrogels based on chitosan with the 
aim of getting deep knowledge and exploring potential applications of these polymer 
hydrogels. In order to accomplish this aim, the following strategy has been adopted: 
Chitosan has been selected as a biopolymer obtained from natural resources 
with intrinsic properties of biodegradability and biocompatibility for the development of 
pH responsive polymer hydrogels for biomedical applications. In order to broaden the 
applications of chitosan hydrogels, chitosan/agarose composite hydrogels have also 
been investigated as materials with dual pH and temperature response to be employed in 
controlled drug delivery. In addition, to achieve chitosan hydrogels for magnetic 
hyperthermia applications, magnetic nanoparticles loaded chitosan hydrogels have 
been investigated. In order to diversify the range of applications of the chitosan gels, 
two other size scales have been studied, micro and nanogels. In relation to chitosan 
microgels, microfluidics methods have been applied to obtain monodisperse microgels. 
This technique was not settled up in our laboratory, neither in any other laboratories of 
CSIC or Spanish Universities, so a new collaboration was established with the team of 
Prof. E. Kumacheva (U. Toronto), pioneer in the field of microfluidics. On the other 
hand, chitosan nanogels have been prepared and characterized as nano-carriers for 
magnetic nanoparticles and a model chemotherapy drug, 5-Fluorouracil for combined 
hyperthermia treatment and drug delivery in cancer treatment. For these materials, in 
addition to the determination of the cytotoxicity, a thorough in vitro study of the effect 
of the application of magnetic field on fibroblasts and cancer cells loaded with the 
prepared materials is presented. Finally, the traditional rheological characterization 
strategy followed in other PhD thesis developed in our group has been applied to the 
study of the rheological behaviour of all the materials prepared. In this way a 
relationship between the rheological behaviour and the structural organization of 
polymer hydrogels and aqueous dispersions of polymer nanogels can be established 
which allows for the development of their applications.   
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In order to accomplish the general objective of this thesis “Development of 
hybrid chitosan hydrogels. A combined application in magnetic hyperthermia and 
drug delivery” the thesis is structured in seven chapters, each of them corresponding to 
selected targets as described below:   
 
 The first chapter
 
, “General Introduction and objectives”, is intended to establish 
the scientific framework in which the present work is carried out.  
 The second chapter,
 
 “Brief state of the art”, summarizes the results found in 
literature about specific features related to the aims of this thesis. It includes, i) the main 
characteristics of chitosan macro, micro and nanogels; ii) a general description of the 
microfluidics as innovative technique for the preparation of microgels; iii) a description 
of the rheological characterization of gels and aqueous colloidal polymer dispersions as 
a tool to establish  the structure/properties relationship for these materials; iv) finally, 
the role of chitosan as nanocarriers for biomedical applications is studied, specifically 
for drug delivery and magnetic hyperthermia 
  The third chapter,
  
 “Chitosan macrogels. Study of their properties” includes the 
preparation of different types of chitosan macrogels: chitosan, chitosan/agarose and 
magnetically loaded chitosan macrogels and the characterization of their morphological, 
chemical and crystalline structure. Moreover, the temporal stability of the gels measured 
as the mass loss as a function of weight and the rheological properties are determined. 
Finally, the viability of chitosan hydrogels as precursors of biomedical applications in 
magnetic hyperthermia and controlled drug delivery is described.  
 The fourth chapter,
 
 “Chitosan microgels prepared through microfluidics”, gives 
a detailed description of the fabrication of microfluidic devices and the obtention of 
chitosan microparticles. The results are discussed on the basis of different device 
geometries, number of inlets and flow rates and concentrations of the continuous and 
the dispersed phases. It includes results and discussion about the effect of the different 
experimental parameters on the droplet size and the final particle size obtained.  
The fifth chapter, entitled “Ferrofluid loaded chitosan nanoparticles” is aimed 
to the preparation and characterization of magnetic ferrofluid loaded chitosan 
General introduction and objectives 
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nanoparticles and evaluation for hyperthermia applications. It includes the optimization 
of the experimental parameters employed for the preparation of the chitosan 
nanoparticles by ionic crosslinking with sodium tripolyphosphate (TPP). Then, chitosan 
nanoparticles loaded with ferrofluid were prepared by simultaneous crosslinking and 
encapsulation of the ferrofluid and characterized by morphological studies, structural 
analysis, thermal stability, rheological studies, and cytotoxicity. Finally, chitosan 
nanoparticles loaded with ferrofluid were evaluated for hyperthermia applications 
through the evaluation of their heating in response to an alternating magnetic field.   
 
 The sixth chapter “In vitro study of magnetic chitosan nanoparticles loaded with 
5-fluorouracil for magnetic hyperthermia applications” describes the preparation of 
chitosan nanoparticles loaded with ferrofluid and a model chemotherapeutic drug, 5-
fluorouracil and their evaluation as materials for cancer therapy. The drug release 
profile of 5-fluorouracil was determined as a function of pH and ferrofluid content. All 
magnetic chitosan nanoparticles prepared have been assessed for in vitro magnetic 
hyperthermia applications following two different protocols designed in this thesis. 
Finally, cellular damage was analyzed though crystal violet staining and acridine orange 
and propidium iodide (AO/PI).  
 
 In the seventh chapter, the manuscript ends with a summary of the most general 
conclusions and future perspectives. 
 
 The manuscript includes a large number of references (more than 250), 
distributed among the different chapters which report the most relevant and updated 
results related to chitosan hydrogels, rheology models, microfluidics methods, and 
biomedical (hyperthermia and drug delivery) chitosan applications.  
 
 Finally, during the realization of this PhD work and related to this, new 
challenges have been set up (opened) in our group, which made us undertake new 
specific projects in the same line of research, carried out in parallel. For instance, we are 
involved in several projects regarding the employment of chitosan and additional 
natural polymers such as alginate, poly (lactic acid) and nanocellulose for the 
preparation of biodegradable polymer nanoparticles for the controlled release of active 
agents. As a continuation of the development of applications of polymer hydrogels in 
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magnetic hyperthermia, we are currently focused on the preparation of polymer 
hydrogels based on natural polymers employing a `layer-by-layer´ technique as a means 
to obtain nanostructured materials in which the magnetic response of the resulting 
materials can be controlled.  
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The present chapter summarizes the results found in literature about specific features 
related to the aims of this thesis. It includes, i) the main characteristics of chitosan 
macro and nanogels; ii) a description of the rheological characterization of gels and 
dispersions of polymer micro and nanogels as a tool to establish  the structure/properties 
relationship for these materials; iii) the role of chitosan nanogels as nanocarriers for 
biomedical applications is studied, specifically for drug delivery and magnetic 
hyperthermia; iv) finally, a general description of  microfluidics as innovative technique 
for the preparation of microgels is provided 
 
2.1 CHITOSAN: A NATURAL POLYMER 
   
Chitosan is the most important derivative of chitin, which is the second most 
abundant polysaccharide in nature after cellulose. Chitin was first isolated from fungi by 
Braconnot in 1811, but the name chitin which means tunic or cover was given by Odier, 
who in 1923 isolated it from the elytrum of the cockchafer beetle by treatment with hot 
alkaline solutions.[1] This is considered the beginning of modern carbohydrate 
polymers science. Chitin is generally represented as a linear polysaccharide composed 
of β (1 → 4) linked units of N -acetyl-2- amino-2-deoxy- d -glucose and it acts as 
structural support and defense materials in living organisms[1, 2]. The chemical 
structure of chitin is represented in Figure 2.1. Chitin is the most abundant organic 
component of the skeletal structure of many classes comprising the group of 
invertebrates, such as arthropods, mollusks and annelids. It is also found as a major 
polymeric constituent of the cell wall of fungi and algae. Therefore, chitin constitutes an 
important material obtained from a renewable natural resource.[2]  
Chitosan is obtained by partial deacetylation of chitin in the solid state under 
alkaline conditions (concentrated NaOH) or by enzymatic hydrolysis in the presence of 
chitin deacetylase[2]. It is a copolymer of β (1 → 4) linked 2-aceta-mido-2-deoxy-D-
glucopyranose and 2-amino-2-deoxy-D-glucopyranose[3]. The chemical structure of 
chitosan is represented in Figure 2.1.[4] The physicochemical properties of chitosan are 
defined mainly by the degree of acetylation (or deacetylation) and the molecular mass 
[3, 4]. Both parameters vary with the biological source of the raw material and the 
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preparation method. They also dictate the physicochemical, functional and biological 
properties of chitosan, essential to fit an application or end product. Solubility, pK, 
viscosity, gelling capacity, among other properties, are all dependent on these 
parameters. The molecular weight and its distribution affect the physical, chemical and 
biological properties of chitosan, such as (i) the mechanical properties of hydrogels, (ii) 
the pore size of membranes, scaffolds and microcapsules, (iii) the particle size and drug 
release properties of nanoparticles, (iv) the effect of chitosan on the permeability of 
epithelial cells and (v) its antimicrobial activity. Therefore, degree of acetylation and the 
molecular mass affects directly the performance of chitosan in biotechnology, food, 
pharmaceutical, biomedical and biological applications.[4] 
 
 
 
 
 
 
 
Figure 2.1. Chemical structure of chitin (blue) and chitosan (red) 
 
The great variety of applications of chitosan in the field of biomaterials is due to 
its biocompatibility, biodegradability and low toxicity [5, 6]. Also, it presents excellent 
properties when interacting with the human body such as bioactivity, antimicrobial 
activity, immunostimulation, chemotactic action, enzymatic biodegradability, 
mucoadhesion and epithelial permeability which support the adhesion and proliferation 
of different cell types. Chitosan has the advantage that can be biodegraded by a number 
of enzymes, such as lysozyme, di-N-acetylchitobiase, N-acetyl-beta-D-glucosaminidase 
and chitiotriosidase, which are present in human mucosas and other physiological 
fluids. [7]. Current chitosan is used as a generally regarded as safe (GRAS) material [1, 
7]. 
Nowadays, chitosan can be found it in a verity of different forms such as gels [8-
10], membranes [11, 12], nanofibers[13, 14], beads[15-17], microparticles[18, 19], 
nanoparticles[20-22], scaffolds [2, 23, 24]. The above forms provide a wide variety of 
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biomedical applications in tissue engineering, wound dressing, cancer drug delivery, 
targeting and preventing bacterial adhesion [2, 4].  
 
2.2 CHITOSAN HYDROGELS. 
 
Hydrogels are defined as three-dimensional crosslinked, hydrophilic, polymeric 
networks capable to retain large amounts of water, or biological fluids [25]. In the 
swollen state, these gel networks are characterized by a soft and rubbery consistence, 
being thus similar with living tissues[26]. Specifically, chitosan hydrogels are 
extensively employed for biomedical applications since they are inherently 
biodegradable and biocompatible and also they provide response to pH due to the fact 
that its amine group is protonated under acidic conditions which confer positive 
charges. The pKa value always lies between 6.3 and 6.7. In this section it is presented 
the current knowledge about the development of chitosan macrogels and nanogels 
employed in biomedical applications. The preparation and characteristics of chitosan 
microgels prepared through microfluidics tecniques will be detailed in a separate section 
of this chapter.  
 
2.2.1 Chitosan macrogels 
 
Chitosan macrogels can be divided in many ways, but in this work, they are 
divided into two classes depending on the nature of the crosslinking, namely covalently 
crosslinked networks (irreversible covalent links) and networks formed by physical 
interactions (reversible links).   
Chitosan chemical macrogels (Figure 2.2-a) are formed by irreversible covalent 
links. Some crosslinkers agents, as for example glutaraldehyde, present high toxicity 
and therefore it is a necessary a purification step, being a drawback for biomedical 
applications and therefore, the development of alternative types of hydrogels is 
desirable.  
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Figure 2.2. Types of hydrogels networks, ab) chemical crosslinked and b) physical crosslinked.  
 
Chitosan physical macrogels (Figure 2.2-b) can be formed thanks to the 
polycationic nature of the chitosan in acidic medium by interaction with polyanions, 
leads to the formation of chitosan hydrogels via electrostatic interactions [6]. The ionic 
interactions can be divided into three groups depending on the type of crosslinker used, 
anions, anionic molecules or polymers with negative charge, commonly known it as 
polyelectrolyte complexes (PEC) [6]. According to the literature, the most common 
crosslinkers employed are: Mo(VI) or Pt(II) as ionic crosslinkers, among anionic 
molecules, phosphate-bearing groups, such as β-glycerophosphate and particularly 
tripolyphosphate salts and for PEC the alginate, pectin, xanthan and some proteins, such 
as collagen[3]. It is also possible to obtain chitosan physical macrogels without any 
crosslinking agent just by solubilisation of chitosan in an acidic aqueous medium and 
subsequent neutralization of –NH2 groups. In this way, the repulsion between chitosan 
chains is blocked thus resulting in the formation of hydrogels through hydrophobic 
interactions, chitosan crystallinity and hydrogen bonding [6]. 
 The method of preparation of physical chitosan macrogels is usually simple and 
these materials present several advantages such as a high pH-response due to 
modification of the global charge densities of chitosan, which can be useful for pH-
controlled drug delivery.[3] Nevertheless, physical gels can be disintegrated by changes 
in the environment conditions such as ionic strength, pH, and temperature.[25] 
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It is well known that single-network hydrogels have weak mechanical properties 
and slow response at swelling.[25] To enhance the mechanical strength and/or 
properties such as swelling/deswelling response, multicomponent hydrogels have been 
designed.  
From a biomedical perspective chitosan macrogels can be used for tissue 
engineering [27-29], drug delivery [30-33], and template for magnetic hyperthermia 
applications[34].  
 
2.2.2 Chitosan nanogels 
 
The preparation of chitosan nanogels can be accomplished with chemical or 
physical crosslinking methods as in the case of chitosan macrogels. The processes 
employed are emulsification, coacervation (nanoprecipitation) and shear break-up. One 
of the most well-known methods for the preparation of chitosan nanogels is crosslinking 
through the addition of an ionic crosslinker.  [35]. Chitosan nanogels by ionic 
crosslinking can be assigned some key advantages: (i) they form under very mild 
conditions; (iii) they can stabilize encapsulated proteins against denaturation; (iv) their 
salt- and pH-sensitive ionic groups make them responsive to external stimuli; and (v) 
their properties can easily be enhanced by either coating their surface with polymers, 
nanoparticles and proteins, or covalently conjugating active molecules to their 
functional groups.[35] 
Among the ionic crosslinkers, sodium tripolyphosphate (TPP) is generally 
employed for the preparation of chitosan nanogels for biomedical applications, because 
it is non-toxic, a quick gelling ability[36] and it is categorized as being GRAS 
(generally recognized as safe) by the FDA.[31] Chitosan nanoparticles crosslinked with 
TPP are formed mainly through the electrostatic interaction between positively charged 
amine from chitosan in acidic medium and negatively charged TPP molecules.[37] 
Chitosan nanogels provide interesting opportunities as nanocarriers for drug 
delivery applications due to the fact they can protect the encapsulated molecule while 
facilitating its transport to the different sites [38]. Also, it can act in a controlled manner 
while preserving the ability to interact with mucosal surfaces, in summary chitosan 
nanocarriers can improve the pharmacological and therapeutic effects in terms of 
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reducing their toxic side effects. That is why chitosan nanocarriers have been broadly 
studied for a variety of biomedical applications, such as drug delivery [39-41], gene 
therapy [42], and carriers for magnetic nanoparticles for applications in magnetic 
hyperthermia [43-45]. The employment of chitosan nanocarriers for cancer therapy 
based on magnetic hyperthermia will be described in a separate section of this chapter.  
  
2.2.3. Rheological studies of polymer macrogels and dispersions of 
nanogels 
 
One important topic in this work is the study of the rheological properties of 
chitosan macrogels and dispersions of chitosan nanogels in order to determine the 
structure-properties relationship for these materials in order to develop the proposed 
final applications of these materials. The determination of the viscoelastic properties of 
these materials allows for the determination of their structural organization by means of 
fractal models applied to the rheological results. 
 
i. Fundamentals of Rheology. 
Rheology has been defined as a branch of physics which concerns itself with the 
mechanism of deformable bodies and flow of matter. However, rheological experiments 
do not merely reveal information about flow behavior of liquids but also about 
deformation behavior of solids. The connection here is that a large deformation 
produced by shear forces causes many materials to flow. All kinds of shear behavior, 
which can be described rheologically in a scientific way, can be viewed as being in 
between two extremes: flow of ideally viscous liquids on the one hand and deformation 
of ideally elastic solids on the other.[46] Behavior of all real materials is based on the 
combination of both a viscous and an elastic portion and therefore, they are considered 
as viscoelastic.  
Nowadays, modern rheometers allow the precise measurement of a complex 
material’s response to an applied force (stress) or deformation (strain). Linear 
oscillatory rheology subjects the material to a small oscillatory strain (or stress) of the 
form: 
γ = Asin(ωt) Equation 2.1 
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where γ is the strain, A is the amplitude of the oscillation and ω is the frequency of 
oscillation. The resulting response of the material is measured. For a purely elastic 
solid, the stress required to impose the deformation is proportional to the strain whereas 
for a viscous liquid, the stress is proportional to the strain rate  
 
γ = Aω cos(ω t) 
 
Viscoelastic solids such as gels will have a response that is somewhere between 
the two extremes. The complex shear modulus G* can be separated into the fraction that 
is in-phase with the deformation and the part that is out-of-phase with the deformation. 
These are generally represented in terms of the elastic G’ and viscous G” shear moduli: 
 
 
 
The phase angle δ shows the relative importance of the liquid-like viscous 
modulus G” with respect  to the solid-like elastic modulus G’.  
Oscillatory rheology is a powerful characterization tool in polymer science 
because by varying the amplitude and frequency of the applied strain, a wide range of 
timescales and behaviors can be studied and that allows the characterization of the 
viscoelastic behavior of polymer materials. In the case of polymers gels, oscillatory 
experiments are carried out within the linear viscoelastic regime which allows an 
investigation of the gel response without disruption of the gel structure. In addition, the 
determination of the viscoelatic behaviour of polymer gels allows the study of their 
structural organization. In fact, the structures of gels are highly disordered, but there is 
much experimental evidence that in certain length scales they are often self-similar and 
can be described in terms of fractal geometry employing models based on scaling laws 
[47].  
 
 
 
 
Equation 2.2 
Equation 2.3 
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ii. Fractal analysis of gels. 
 
The viscoelastic properties of gels can be analyzed using the theoretical model 
based on the scaling approach which relates modulus to concentration following the 
relation described in Equation 2.4. [48, 49]: 
 
where C is the polymer concentration and n is an exponent which depends upon the 
conformation of the chain linking junction points. The exponent n is related to the 
fractal dimension, ν-1. There are several theoretical models for the determination of n.  
For a monodisperse solution of polymer with dimension ν-1 gives a viscoelastic 
exponent n defined in the next equation:  
 
 
However, for not entanglement system, n is given by: 
 
 
where r is scaling exponent that describes the size distribution. Muthukamar proposed 
other theoretical model and n values is given by: 
 
 
 According the equation 2.7, all n values (0<n<1) are possible with a fractal 
dimension of 1<ν-1<3. 
 
iii. Fractal analysis of aqueous dispersions of polymer nanogels 
 
Aqueous dispersions of polymer nano or microgels are very similar to polymer 
macrogels in that they both behave as viscoelastic materials. Aqueous dispersions os 
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polymer nano or microgels aggregate given rise to colloidal gels whereas polymer 
macrogels are formed by polymerization and/ or crosslinking, both of which are 
aggregation process. Taking into account this fact, scaling theories are developed to 
account for the elastic properties of colloidal gels by applying the scaling concepts 
which have been proved to be successful with polymer macrogels. Figure 2.3 shows a 
schematic representation of possible intra or inter interaction among microgels in 
dispersion.       
 
Figure 2.3 A) Schematic representation of microgels dispersions agglomerated, B) Formation of 
agglomerates composed of fractal microgels. Adapted from the Coro Echeverria Zabala thesis. 
 
Several theories have been developed for studying the structure of a gel from 
rheological measurements, however, nowadays there are two main theories that will be 
explained ahead, Shi et al[50] and Wu and Morbidelli[47].  
 
- Shi et al model   
First, it is important to remark that for these scaling theories by assuming a 
certain structure for colloidal gels, simple but systematic scaling theory for both the 
elastic constant and the limit of linearity of colloidal gels that are well above the 
gelation threshold can be derived. The scaling of the elastic properties of colloidal gels 
under such conditions is dominated by the fractal nature of the flocs.     
In this model, Shi and coworkers have developed a scaling model by defining 
two separate regimes: the strong-link regime and weak-link regime. The strong-link 
regime may be achieved by allowing the individual flocs to grow very big is that each 
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flocs is very weak spring, therefore it is presents at low particle concentrations. In this 
regime the links among flocs (interfloc links) have a higher elastic constant that those of 
the flocs, consequently the breaking of bonds occurs within a floc[50]. On the other 
hand, weak-link regime is presents at high particle concentrations, consequently with 
very small flocs. These small flocs are stronger springs compared to large flocs.  
  In this model, it is assumed that the structure of gels is constituted by fractal 
flocs, which during gelation aggregate with each other. The elastic properties of a flocs 
are dominated by its effective backbone, which can be approximated as a linear chain of 
springs. In the strong-link regime, where the interfloc links are stronger than the 
intrafloc links, the macroscopic elasticity of the gel is given by that of intralinks. In this 
case, it is possible to derive two relationships relating the fractal dimension of the flocs 
(df) and the fractal dimension of the backbones (x) to the storage modulus (G´) and the 
limit of linearity (γ0): 
 
G´  φA  
 
γ0   φ
B
 
 
where φ is the volume fraction and the exponents, A and B, have the form 
 
A = (d + x)/(d - df) 
B = - (1 + x)/(d - df) 
 
where d is the Euclidean dimension of the system. 
 
On the other hand, the weak-link regime is defined where the flocs are more 
rigid than the interfloc links, the elasticity of the interfloc links determines the elasticity 
of the gel. For this regime are employed the same equations for G´ and γ0 previously 
described, but with different expressions for the exponents: 
 
A = B = 1/(d - df) 
Equation 2.8 
Equation 2.9 
Equation 2.10 
Equation 2.11 
Equation 2.12 
 Brief state of the art  
  
19 
 
 
Therefore with this model only to regimes are considered and the transition from 
one to the other with the change in particle concentration must be continuous, leading to 
intermediate situations where both inter- and intrafloc links contribute to the gel’s 
overall elasticity. Therefore, Wu and Morbidelli includes a new regime as it will be 
explained below. 
 
- Wu and Mobidelli model 
Wu and Mobidelli proposed a modification of the scaling model of Shi et al. that 
relates the structure parameters of the gel to its elastic properties and is valid not only 
for the strong- and the weak-link regimes but also for the intermediate regimes. In this 
model the structure of a colloidal gel (network) is considered as a collection of flocs. 
The flocs are fractal objects with average size ξ and fractal dimension df. It is well 
known that the size of the flocs that constitute a gel is in the range from one to hundreds 
of microns. Thus the flocs can be considered as microscopic elements that built the 
macroscopic gel.  
Moreover, a macroscopic gel system is divided into two levels of structure: 
intramicrostructure characterizing structure within a floc and intermicrostructure 
characterizing the collection of flocs. Thus, the macroscopic elasticity of a gel must be 
related to both intra- and intermicroscopic elasticity.  
Briefly, the relation between the macroscopic elastic constant and the particle 
volume fraction in terms of the microstructure parameters is given by 
 
K φA   
 
where 
 
A = β /(d - df) 
and  
β = (d - 2) + (2 + x)(1 -α) 
 
Equation 2.13 
Equation 2.15 
Equation 2.14 
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where α is a constant in the range [0, 1], which depends on the given range of Kξ/Kl. 
Moreover, x represents the backbone fractal dimension or tortuosity of the network, 
whose value for a colloidal gel is in the range of 1-1.3. Therefore, β is a constant, which 
for a three-dimensional system (d = 3) ranges between 1, for α = 1, and 3 + x, for α = 0. 
 On the other hand, Wu and Morbidelli extends the approach above to derive a 
scaling model for the limit of linearity, γ0, following an approach originally proposed by 
Shih et al. The limit of linearity (γ0) is defined as the situation where the weakest bonds 
break and the linear elastic behavior vanishes. These are generally the singly connected 
bonds and is given by  
 
where 
B = (d - β - 1)/(d - df) 
 
Thus, from the experimental values of γ0 as a function of the particle volume 
fraction φ, one can estimate the exponent B, which together with the value of A in 
equation X allows us to determine the values of both β and df.  
  
2.3 CHITOSAN NANOGELS AS NANOCARRIERS FOR 
CANCER THERAPY BASED ON MAGNETIC 
HYPERTHERMIA.   
 
In recent years much attention has been focused on development of polymer 
nanogels and nanoparticles that can respond to external stimuli and act as drug nano-
carrier, as well[51] for their employment in cancer therapy. [51]. In this way, their 
synergistic effect will improve the cancer therapy, resulting in less dose for the same 
therapeutic effects or the same dose with much higher therapeutic effects and less side 
effects.  
 
 
Equation 2.16 
Equation 2.17 
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2.3.1 Magnetic Hyperthermia. 
Hyperthermia is defined as a kind of heat therapy which makes body tissue 
exposed to high temperatures. This treatment can be applied local, regional and whole 
body hyperthermia depending on the location of disease[52]. According to the degree of 
temperature raise, hyperthermia treatment can be classified into different types. In 
thermo ablation, a tumor is subjected to high temperatures of heat >46 °C (up to 56 °C) 
causing cells to undergo direct tissue necrosis, coagulation or carbonization. Moderate 
hyperthermia (41 °C < T < 46 °C) has various effects both at the cellular and tissue 
levels. The latter kind usually is named as hyperthermia treatment. This kind of 
hyperthermia can damage and kill cancer cells, while cause minimal injury to normal 
tissues. [51] After a hyperthermia treatment, cells can present a serial of changes and/or 
damages as: activation and/or initiation of many intra and extracellular degradation 
mechanisms like protein denaturation, protein folding, aggregation and DNA cross 
linking, induction and regulation of apoptosis, signal transduction, multidrug resistance 
and heat shock protein (HSP) expression.[52] Some recent studies are reported that 
cancer cells may present thermotolerance due to the existence of a class of heat-shock 
proteins (HSPs). Hyperthermia treatment would increases the expression of HSPs in 
cancer cells, which leads to higher resistance to hyperthermia therapy.[51] 
Magnetic materials for hyperthermia applications have been broadly employed, 
because have the possibility to convert dissipated magnetic energy into thermal energy, 
the application of magnetic materials for hyperthermia treatment of cancer was first 
proposed in 1957[52]. Magnetic nanoparticles (MNPs) include metallic, bimetallic, and 
superparamagnetic iron oxide nanoparticles, which have reactive surface that can be 
coated with biocompatible polymers and loaded with therapeutic agents. [53] However, 
iron oxides are often used as hyperthermia agent because of their high biocompatibility 
and their heat response to the applied magnetic field.[51] 
Specifically, for iron oxides when they are submitted to an alternating magnetic 
field at a specified frequency, they can produce enough heat for cancer treatment due to 
its high specific absorption rate (SAR) or specific loss power (SLP) [51]. This term is 
used to define the absorption efficiency of any material to generate heat due to 
AMF.[54] The heat generation mechanism can be attributed to two different 
phenomena: relaxation and hysteresis loss. The former mechanism (relaxation) is of two 
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types: Néel and Brownian relaxations. Heat generation through Néel relaxation is due to 
rapidly occurring changes in the direction of magnetic moments relative to crystal 
lattice (internal dynamics). In the case of Brownian relaxation is due to physical rotation 
of particles within a medium in which they are placed (external dynamics) and is 
hindered by the viscosity that tend to counter the movement of particles in the 
medium.[54] Usually, SPA values depend on parameters such as MNPs structure (size, 
shape and crystal structure), magnetic properties (magnetic anisotropy and temperature 
dependence of magnetizations) and amplitude (H) and frequency (f) of AMF, 
polydispersity of MNPs, and the surrounding environment, that means for those 
particles internalized within the cells.[54] 
Magnetic nanoparticles (MNPs) based hyperthermia treatment has a number of 
advantages compared to conventional hyperthermia treatment, as example: i) cancer 
cells absorb MNPs thereby increasing the effectiveness of hyperthermia by delivering 
therapeutic heat directly to them, ii) MNPs can be targeted through cancer specific 
binding agents making the treatment much more selective and effective, iii) MNPs can 
also effectively cross blood-brain barrier (BBB) and hence can be used for treating brain 
tumors, iv) effective and externally stimulated heating can be delivered at cellular levels 
through alternating magnetic field (AMF), v) MNPs used for hyperthermia are only few 
tens of nanometer in size and therefore, allows easy passage into several tumors whose 
pore sizes are in 380–780 nm range, vi) MNP-based hyperthermia can also be utilized 
for controlled delivery of drugs. 
Chitosan has the capacity to form complexes with metal ions, particularly with 
transition and post-transition metal ions. This fact is explained by the presence of the 
amino groups in the structural unit of chitosan, it is definitely the main cause of its 
complexing capacity, but the binding mechanism of metal ions to chitosan is not yet 
completely understood. Various processes such as adsorption, ion exchange and 
chelation have been considered as the mechanisms responsible for complex formation 
between chitosan and metal ions. The type of the interaction prevailing depends on the 
metal ion, its chemistry and the pH. [4] Chitosan has attracted intense attention as an 
important biopolymer to effectively stabilize colloidal dispersions of superparamagnetic 
iron oxide nanoparticles, conferring them an increased biocompatibility and chemical 
functionality and giving rise to materials for applications in magnetic hyperthermia [55, 
56].  
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2.3.2 Combined treatments for cancer therapy 
 
One of the trends employed in cancer therapy is the combination of two or more 
treatments with the aim to diminish the side effects of conventional treatments that are 
actually employed such as chemotherapy. The drug delivery for cancer therapy includes 
a huge number of drugs that are used for different kind of cancers. The most commonly 
employed drugs for chemotherapy reported in the literature are Doxorubician 
(DOX)[53], Placlitaxel[57, 58] and 5-Fluorouracil[43, 59, 60].  To this end, 
hyperthermia therapy, may be combined with well-developed therapeutics such as 
chemotherapy, irradiation, surgery, gene therapy, and immunotherapy in order to 
enhance its efficacy [52].  
The use of nanoparticles loaded with anti-cancer drug have the advantages that 
are able to penetrate tumors due to their small size and the leaky nature of tumor 
microvasculature[53], therefore the efficacy of the treatment would improve the quality 
of life of cancer patients, particularly those who are end-staged and too weak to 
withstand harsh therapy. It is well known that tumor cells present low pH values, such 
as pH 5.5, that fact is generated by the anaerobic glucose metabolism. After targeting of 
nanoparticles to the tumor site drug release starts at the acidic microenvironment of the 
tumor tissue [53]. pH responsive chitosan nanoparticles would be expected to have an 
effective drug release in the tumor microenvironment since the drug release rate can be 
suddenly accelerated with lower pH. 
 
2.4 CHITOSAN MICROGELS BY MICROFLUIDICS. 
 
Microfluidics techniques arise as a powerful potential technique for the 
preparation of microgels with controlled dimensions. It is considered a promising 
strategy for the generation of microgels via rapid, high-throughput production of highly 
monodisperse droplets, which can be subsequently gelled to form microgels with 
tunable compositions and mechanical properties[61]. Moreover, microfluidic strategies 
offer a control over the shapes, morphologies, and size distribution of polymer colloids 
[62, 63]. It is worth pointing the importance of particle size and particle size distribution 
on pharmaceutical uses such as drug encapsulation [64] and controlled drug delivery 
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[65]. MF platforms can also provide precise control of mixing of reagents, residence 
time and reaction temperature of the diverse methods of synthesis of microparticles 
[66].  
 
2.4.1 Fundamentals of MF. 
 
Microfluidics technique is related to a set of technologies for the manipulation of 
small fluid volumes in the range of mL, µL, nL, pL, within artificially fabricated 
microsystems. Microfluidic systems enable generic and consistent miniaturization, 
integration, automation and parallelization of different chemical processes. [67]. In 
polymer science, the control over the dimensions of microfluidic channels in 
microfluidic devices allows for the generation of polymer microgels of controlled 
particle size.  
The synthesis of microgels by MF can be explained in two main steps. The first 
step consists in the emulsification of polymer solutions, an oligomer or monomers in an 
immiscible non-polar liquid. The second step is based on the gelation of the precursor 
droplets.  
The emulsification in MF devices can occur via different mechanisms as 
previously reported by E. Kumacheva et. al.[62], which depend on the geometry of the 
MF device, the macroscopic properties of the liquids, the flow rates of the liquids, 
viscosity ratio, gas pressure, and channel wettability. [68] With regard to the geometry, 
different routes to microfluidic emulsification have been reported in order to generate 
polymer particles[62]. As can be observe in Figure 2.4, there are several geometries that 
and currently employed for the generation of droplets. Most of the geometries employed 
for the generation of polymer microgels are limited to T-junction and flow-focusing 
geometries fabricated into a poly(dimethylsiloxane) (PDMS) slab, because they are the 
most frequently exploited to produce droplets with narrow size distribution.  
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Figure 2.4. Schematic drawings of various types of microfluidic droplet generators the (a) flowfocusing, 
(b) T-junction, (c) terrace-like, and (d) and co-flowing stream geometries. The droplet and the disperse 
phases are labeled as A and B, respectively. Adapted from the Ethan Tumarkin thesis. 
 
In the flow-focusing droplet generator (Figure 2.4-a), an aqueous phase and a 
nonpolar liquid (labeled as A and B, respectively) are introduced to the central and side 
channels, respectively. A stream of the aqueous droplet phase is focused in the narrow 
orifice by the shear force imposed by the stream of the continuous phase. A highly 
periodic break-up of the thread of the disperse phase yields droplets with narrow size 
distribution. In this kind of geometry the size of the droplets is controlled by the ratio of 
the flow rates of the continuous to droplets phases, that is, the diameters of the droplets 
decrease with the increase in the ratio of the flow rates [69]. On the other hand, in the T-
junction droplet generator (Figure 2.4-b) the droplet phase flows into the junction, the 
continuous phase forms a thin film layer between the disperse phase and the walls of the 
device, causing an increase in pressure which ‘‘squeezes’’ the disperse phase to form a 
droplet.[62] In this case, the droplets are usually considering as plugs that are droplets 
that span over the entire width of the channel, as it is shown in Figure 2.4-b. The size of 
the plugs is controlled by the ratio of flow rates of the continuous to droplets phases: 
with increasing flow rates ratio, the droplets become smaller.  
The dimensions of microgels, their morphologies and shapes are determined by 
the corresponding properties of the precursor droplets. These final microgels can be 
obtained by on-chip or off-chip gelation of the precursor droplets. It is important to 
define that on-chip gelation, means that the gelation process occurs in the droplets 
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during their residence in the microchannels. [62] Off-chip gelation referes to gelation 
occurring  outside of the microfluidic device.  
 Despite the advantages previously mentioned, the generation of microgels by 
MF technique has important challenges as for example the control of the viscosity of the 
precursor solutions once they are gelled. In fact, the small dimensions of MF reactors 
require fast gelation, so that the microgels emerging from the reactor should be 
sufficiently strong to keep their integrity, especially upon their transfer into an aqueous 
phase and to avoid collisions of gelling droplets in the microchannels.[62]  
 The transformations of precursor droplets into polymer particles is achieved by 
either chemical or physical mechanisms, such as crosslinking polymerization , 
thermally induced gelation, self-assembly, evaporation of the solvent from the droplets, 
or phase separation. [61]   
 
2.4.2 Chitosan microgels by microfluidics and applications. 
 
The use of biopolymers for the preparation of microgels by MF lies at the 
forefront because they are inherently scalable for bulk production and possess low 
environmental impact, providing new options for more distributed networks and utility 
for such systems in environmental and human health applications. [70] Also, microgels 
from biopolymers obtained by MF such as agarose[71, 72], collagen[73], alginate[74] 
and chitosan[75], presented several advantages related with the intrinsic properties of 
the biomaterial such as their stimuli responsive nature, the ease with which their 
surfaces can be functionalized, and their capacity to encapsulate and release functional 
species. [76].  
Specifically for chitosan microgels, different methods have been reported for 
their preparation with MF employing different geometries and crosslinking processes. 
Xu et al [77] have prepared chitosan microgels employing T-junction geometry and by 
off-chip crosslinking with glutaraldehyde. These microgels are applied in the field of 
protein drug controlled release and immobilization lipases. Also, chitosan microgels 
have been synthesized using a double T-junction channel geometry on a microfluidic 
chip to generate droplets and separate satellite droplets from parent droplets and then 
microgels were off-chip crosslinking with sodium tripolyphosphate. [75] Some studies 
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are reported in the literature employing flow-focusing devices. Yan et al[78] used MF 
for generating TPP-chitosan microparticles using a cross-flow microfluidic chip coupled 
with external crosslinking reaction for pharmaceutical applications.  
Very few studies are reported based on the gelation of chitosan solutions without 
the use of crosslinkers by MF. Chen et al[63] reported the preparation of 
chitosan/cytosine-phosphodiester-guanine oligodeoxynucleotide (CpG ODN) 
nanoparticles as potential immunostimulatory adjuvants, yielding a decrease in particle 
size and size range, an increase in loading efficiency with regard to bulk synthesis. 
Zhang et al [79] reported the synthesis of microgels from a triple interpenetrating 
network (3XN), based on partially oxidized dextran (Odex), Teleostean, and N-
carboxyethyl chitosan (CEC). In this case, a chitosan derivative is employed.  
The MF technique has also been employed for the encapsulation of bio-
molecules or cells and functional nanoparticles. Jiang et al [80] prepared chitosan 
droplets obtained by T-junction MF device that are interfacially crosslinked with 
glutaraldehyde. These microparticles were loaded with various payloads, such as 
magnetic nanoparticles and/or fluorescent dyes and then semiflexible chains were 
prepared. Such microparticles could find applications as microfluidic mixers, delivery 
vehicles, microscale sensors, or miniature biomimetic robots. Xi Lu et al [81] 
synthesized soft dimer capsules based on chitosan, that are like Janus particles. They 
prepared dimmers wherein one lobe encapsulates paramagnetic Fe2O3 nanoparticles and 
the other is composed by chitosan.  
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In this chapter chitosan macrogels were prepared through two different methods. 
The first one consists in the preparation of alkali chitosan macrogels by adding 
coagulant solution. This method allows for the in situ synthesis of iron oxide 
nanoparticles. Another route is based on the preparation of composite chitosan/agarose, 
where the gelation process is achieved by the feature of agarose to gel at low 
temperatures (8–17 ºC). This method enables the encapsulation of ferrofluid. The 
preparation, characterization and development of biomedical application, Magnetic 
Hyperthermia and drug release, are detailed in the following sections. 
 
3.1. INTRODUCTION   
 
Hydrogels are defined as three-dimensional polymer networks that are able to 
retain a large amount of water in their swollen state[1]. Specifically, hydrogels obtained 
from natural polymers are currently the focus of considerable scientific research for the 
development of biomedical applications due to their inherent biocompatibility, 
biodegradability and also they are susceptible to enzymatic degradation [2, 3][4]. As 
stated in the introduction, an example of natural polymers commonly employed for the 
preparation of hydrogels is chitosan. Chitosan is soluble in certain acidic aqueous 
solutions, owing to the protonation of the primary amine groups. Due to the pH-
responsiveness and inherent biocompatibility, chitosan gels are attractive for biomedical 
applications [5-7] and specially, as materials for controlled drug delivery [8-11].  
Chitosan hydrogels are accomplished either by physical associations, such as 
secondary forces (hydrogen, ionic, or hydrophobic bonding) and physical entanglements 
and by covalent crosslinkages [2]. It is known that chitosan aqueous solution can to 
become a gel in alkaline solution without any chemical crosslinkers. This kind of gel is 
achieved when the pH of chitosan solution is high and consequently the positive charges 
of chitosan molecules are neutralized and under goes coacervation-phase inversion, and 
chitosan gels [12]. This material can be used for controlled release not only in acidic but 
also in basic media, for rapid release by dissolution and as thermogelling systems[13].  
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Another route for the preparation of chitosan hydrogels consists in ionic 
crosslinking, which is a simple and mild method for preparing chitosan hydrogels. This 
kind of hydrogel is obtained thanks to the cationic amino groups of chitosan that can 
interact with negatively charged molecules, anions and polyelectrolytes, such as 
polysaccharides, proteins and synthetic polymers.[2] This method presents advantages 
for biomedical applications because it is not necessary the use of organic precursors, 
catalysts, or reactive agents.  
In order to broaden the applications of chitosan hydrogels, researchers have 
developed composite hydrogels, where chitosan is blended with others biopolymers e.g. 
collagen[14], gelatin[15] and agarose[16]. In particular, agarose, an alternating 
copolymer found in some seaweeds consisting of 1, 4-linked 3, 6-anhydro-α-l-galactose 
and 1, 3-linked β-d-galactose derivatives is a neutral polysaccharide that forms 
thermoreversible gels upon cooling agarose aqueous solutions. The mechanical and 
thermal properties of agarose hydrogels depend on polymer concentration, pH and 
solvent type [17-19]. The biocompatibility of agarose and the mild conditions of its 
gelation make agarose suitable for applications in tissue engineering [20], however, 
agarose hydrogels exhibit  low cell adhesiveness [21] and slow degradation rate [22]. To 
overcome these disadvantages, agarose can be chemically functionalized [23] or  
blended  with others biopolymers such as gelatin [24, 25]. In particular, the combination 
of chitosan and agarose in composite gels has improved the mechanical and cell-
adhesive properties of agarose [26, 27].  
The complex formation of chitosan with transition metal ions is another method 
to obtain ionic crosslinked chitosan. This process has been widely studied and the 
existence of intra- or intermolecular complexes has been reported depending on 
parameters such as the nature of the ion, pH and relative chitosan/ion concentration [28-
30]. Specifically, the ferric ion has been shown to coordinate with two chitosan residues, 
three molecules of water and one chloride ion [31]. Iron oxide particles such as 
magnetite, Fe3O4, have been in situ synthesized into a chitosan matrix to obtain 
magnetic chitosan materials. Another method to preparer magnetic chitosan hydrogels 
consist in the encapsulation of magnetic nanoparticles into chitosan matrix. These 
materials present the advantage that they can be employed in biomedical applications 
involving magnetic fields. 
 Chitosan macrogels 
39 
 
Therefore, in this chapter two different chitosan macrogels were prepared. On 
the one hand, alkali chitosan macrogels were prepared by the addition of coagulant 
solution (alkali solution). Then, in situ iron oxide nanoparticles were prepared into 
chitosan matrix and they were fully characterized trough FT-IR, thermal analysis, XRD 
and viscoelastic properties. On the other hand, composite chitosan/agarose macrogels 
were prepared taking into account the capacity of agarose of forming gels a low 
temperature. Their final viscoelastic properties and temporal stability were evaluated. 
Composite chitosan/agarose macrogels loaded with ferrofluid were synthesized and 
evaluated by heating performance, when macrogels are submitted to an alternating 
magnetic field. There are few studies that report a combination of hydrogels with micro- 
and/or nanomagnetic particles (e.g., γ-Fe2O3, Fe3O4, CoFe2O4) have been implemented 
as materials able to heat up target tumors remotely through an external magnetic field 
[32, 33]. In addition composite chitosan/agarose macrogels were loaded with drug 
model chemotherapy, 5-Fluorouracil (5-FU), and their drug release profile were 
evaluated as a function of pH and temperature. 5-Fluorouracil  is one of the most widely 
used agents for the treatment of cancer and presented a broad activity against many 
cancer, for example, breast, head and neck, adrenal, pancreatic, gastric, colon, rectal, 
esophageal, liver and G-U (bladder, penile, vulva, prostate), as well as skin cancers 
(basal cell and keratosis) by topical application[34]. According to the literature, there 
are few systems reported based on composite chitosan/agarose as drug delivery 
carrier[35] or hyperthermia applications.  
 
3.2. EXPERIMENTAL PART  
 
3.2.1 Materials 
 
Chitosan employed in this work was isolated from shrimp's shell (Heterocarpus 
vicarious) and supplied by Polymers Laboratory, National University, Costa Rica. 
Chitosan has a deacetylation degree of 65% as determined by potentiometric titration 
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and a molecular weight of 362 KDa as determined by viscosity method (ASTM D 
2857). Ultra-low gelling temperature agarose (gelling temperature in the range of 8–17 
ºC and melting point in the range of 40-50 ºC) was purchased from SeaPrep (Lonza, 
Switzerland, www.lonza.com). Oleic-acid-coated iron oxide nanoparticles dispersed in 
water as a ferrofluid (density =1.08 g/mL), NGAP FeO-05#4, were provided by 
Nanogap Subnmparticles, Spain. 
Phosphate buffer saline (PBS, pH=7.4) (Gibco-BRL, Rockville, MD), acetate 
buffer (pH 5.2), 5-Fluorouracil (5-FU), acetic acid, ferrous chloride (FeCl2·4H2O), ferric 
chloride (FeCl3·6H2O), sodium hydroxide, methanol 80% were purchased from Sigma 
Company (Sigma Company, St. Louis, MO, USA) and used as received. The deionised 
water was obtained from the Millipore Milli-Q water purification system.  
 
 
3.2.2 Preparation of alkali chitosan macrogels 
 
i. Alkali chitosan macrogels 
Chitosan solutions (1.5-4.0% w/v) were prepared by dissolving chitosan powder 
in 100 ml of acetic acid solution at 1% (v/v) (pH=3.8). Chitosan solutions were cast on 
teflon moulds and alkali chitosan macrogels were prepared by adding coagulant solution 
(H2O:MeOH: NaOH) (4:5:1w/w)[36] to the chitosan solutions at room temperature. 
  
ii. Chitosan ferrogels (in situ synthesis of iron oxide nanoparticles)  
An aqueous solution (20 mL) of iron ions was prepared by mixing 0.21g of 
FeCl2·4H2O and 0.58 g of FeCl3· 6H2O under constant N2 bubbling with ultrasonication. 
After 30 minutes, the aqueous solution of iron ions was added under vigorous stirring to 
a chitosan solution (4% w/v) in a N2 atmosphere to obtain a final chitosan concentration 
of 3% and 2% w/v. 
Finally, each solution was cast on a teflon mould and carefully immersed in a 1 
M sodium hydroxide solution in a N2 atmosphere. The immersion time was varied from 
30 minutes to 2 hours.   
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3.2.3 Preparation of composite chitosan/agarose macrogels 
   
Macrogels based on composite chitosan/agarose macrogels were prepared at a 
fixed concentration of chitosan and three different concentrations of agarose. Their 
preparation is described below: 
 
i. Composite chitosan/agarose macrogels. 
For the preparation of composite chitosan/agarose macrogels, different amounts 
of agarose were dissolved at 60 °C in 0.5% (w/v) aqueous chitosan solutions containing 
1% (v/v) of acetic acid. The concentration of agarose in the mixed solution was 1.0, 1.5 
and 2.0% (w/v). The samples were designated as chitosan/agarose-1, chitosan/agarose-
1.5 and chitosan/agarose-2. The chitosan-free sample was used as a control, for this 
sample agarose was dissolved in acetic acid 1% (v/v) and was labeled as agarose-1.5 
(Table 3.1).  
 
Table 3.1. Concentrations of agarose and chitosan in precursor solutions. 
Sample Agarose (% w/v) Chitosan (% w/v) 
Agarose-1.5 1.5 0 
Chitosan/agarose-1 1 0.5 
Chitosan/agarose-1.5 1.5 0.5 
Chitosan/agarose-2 2 0.5 
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Mixed solutions were poured in Teflon moulds and maintained overnight at 4 ºC 
to allow the mixtures to gel. Teflon moulds with two different diameters (∼4 and 8 mm) 
and ∼5 mm in height were employed. 
  
ii. Composite chitosan macrogels loaded with ferrofluid. 
Composite chitosan/agarose macrogels and agarose macrogels were loaded with 
two different concentrations of ferrofluid in water (2% and 5% w/v). The concentrations 
of agarose and chitosan solutions were the same as reported in Table 3.1.  The ferrofluid 
solutions were mixed under vortex agitation with the corresponding chitosan/agarose 
solutions in a volume ratio of 6:1, until getting homogeneous samples. Then, mixed 
solutions were poured in Teflon moulds and maintained overnight at 4 ºC to allow the 
mixtures to gel. As an example, samples were designed as chitosan/agarose-1+FeX, 
where X corresponds to the ferrofluid concentration, 2% or 5% (w/v).   
 
iii. Composite chitosan/agarose macrogels loaded with 5-Fluorouracil. 
Composite chitosan/agarose-1.5 macrogels and agarose-1.5 macrogels were 
loaded with a model anticancer drug 5-Fluorouracil (5-FU) at a concentration 0.5% 
(w/v). 5-FU was dissolved directly in chitosan/agarose solution and stirred at 60 ºC. The 
procedure of the preparation of 5-FU loaded chitosan/agarose macrogel was identical to 
that used for the preparation of 5-FU free composite macrogels. Final mixed solutions 
were poured in Teflon moulds and maintained overnight at 4 ºC to allow the mixtures to 
gel. Composite chitosan/agarose-1.5 loaded with 5-FU was designated as 
chitosan/agarose-1.5+FU. The chitosan-free sample was used as a control and was 
named as agarose-1.5+FU.  
 
3.2.4 Characterization of macrogels. 
 
i. Morphological studies.  
- Transmission Electron Microscopy (TEM) 
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Samples were dried to form films and the morphology of thin films prepared by 
ultra-microtome was observed by transmission electron microscope (TEM, 200Kv 
Philips Tecnai). Thin films were cut perpendicular to the surface direction and laid on a 
copper grid. 
 
- Scanning Electron Microscopy (SEM). 
The surface and cross section of all macroscopic gel samples was examined 
using an SEM (XL30 ESEM, Philips). All the gels under study were freeze-dried. 
Subsequently the dried sample was coated with an ultrathin coating of gold deposited on 
the sample by high-vacuum metallization. Analysis of the pore structure was done using 
Image Pro 5.0 (media Cybernetics, USA) software. 
 
 
ii. Study of the chemical structure by Attenuated Total Reflection Fourier 
Transformed Infra-Red Spectroscopy (ATR-FTIR) 
Attenuated Total Reflection Fourier Transformed Infra Red Spectroscopy (ATR-
FTIR) experiments were carried out on freeze-dried samples using a Perkin Elmer 
spectrometer.  The spectra were acquired in the wave number range of 600-4000 cm−1 at 
a 4 cm−1 resolution.  
 
iii. Temporal stability (mass loss).  
To examine temporal stability (mass loss as a function of time) of the composite 
chitosan/agarose macrogels, the samples were immersed at 37 ºC in buffer solutions at 
pH 7.4 or 5.2 for various time intervals. Mass loss was determined as (mt-mo)/mo, where 
mt is the mass of the sample after a given time interval and mo the mass of the `as 
prepared´ gel. Before weighing, the gel samples were quickly dried with a filter paper to 
remove excess water from the surface.  
 
iv. Thermal stability by thermogravimetric analysis (TGA).  
Dried alkali chitosan macrogels and composite chitosan/agarose macrogels were 
evaluated by thermogravimetric analysis (TGA) performed on a Q500 TA Instruments 
TGA, using a nitrogen stream as purge gas, at a heating rate of 10 ºC/min. Specifically 
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for chitosan macrogels the range of temperature employed was 40-950 ºC and for 
composite chitosan/agarose macrogels was 25–700 ºC 
 
v. Determination of crystallinity by X-ray diffraction measurements (XRD).  
X-ray diffraction measurements were performed on powdered samples in a 
Bruker Advance D8 equipment by using CuKα radiation (λ=1.5418Å) in the range 
2θ=5-65º. 
 
vi. Rheological properties by dynamic oscillatory measurements. 
The viscoelastic properties of alkali chitosan macrogels, composite 
chitosan/agarose macrogels and composite chitosan/agarose macrogels loaded with 
ferrofluid were carried out in an AR-G2 rheometer (TA Instruments, USA) using the 20 
mm-diameter steel parallel plates. Two different experiments were performed:   
frequency sweeps between 0.1 and 10 Hz at 20 ºC and the temperature sweeps were 
performed from 5 to 80 ºC at 10 ºC/min and at 1 Hz frequency. All the experiments 
were carried out at a fixed torque in the linear viscoelastic regime. The linear 
viscoelastic region was located with the aid of a torque sweep. All the viscoelastic 
measurements were performed on hydrogels swelled to equilibrium. 
 
3.2.5 Composite chitosan macrogels as precursors for biomedical 
applications. 
 
i. Determination of Magnetic Remote Heating. 
The specific power absorption (SPA) of the ferrofluid loaded chitosan/agarose-
1.5 macrogels with two concentration of ferrofluid (2% and 5% w/v) were measured 
with a commercial AC field applicator (DM100 by nB nanoscale Biomagnetics, Spain) 
working at ƒ=580 kHz and 24 kA/m (≈300 Oe). Figure 3.1 shows a scheme of the 
hyperthermia experiments. Experiments were carried out within a thermally-insulated 
working space of about 1 cm3, using a closed container of 1.0 mL volume. All gels were 
prepared directly in the vial. This experiment was carried out in the Universidade Nova 
de Lisboa, FCT-UNL, Caparica, Portugal.  
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Figure 3.1. a) Schematic representation of hyperthermia experiments. 
 
ii. Evaluation of in vitro drug release. 
To study the in vitro release of 5-FU loaded from chitosan/agarose-1.5 
macrogels at different pH values, the following procedure was used. Macroscopic gel 
samples were placed in vials containing 10 mL of buffer at pH of 5.0 (acetate buffer) or 
7.4 (PBS buffer), both at 37 ºC, and stirred. An aliquot of 1 mL of the solution was 
periodically withdrawn to determine the concentration of 5-FU using UV/Vis 
spectrometry (Perkin Elmer Instrument Lambda 35 UV/VIS spectrometer, wavelength 
of 265 nm). The solution medium was replaced with the same volume of fresh medium. 
 
3.3 RESULTS AND DISCUSSION 
 
Two kinds of chitosan macrogels have been prepared. The first one consists in 
alkali chitosan macrogels. Then, iron oxide nanoparticles have been successfully 
synthesized in the presence of chitosan using an in situ coprecipitation method. This 
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method allows obtaining chitosan ferrogels. Secondly, composite chitosan/agarose 
macrogels were elaborated, taking into account the capacity of agarose to gel at low 
temperatures. Then, it has been developed composite chitosan/agarose macrogels loaded 
with ferrofluid. Finally, both system loaded with magnetic particles were evaluated for 
magnetic hyperthermia. Therefore, chitosan/agarose macrogels were loaded with a 
model anticancer drug 5-Fluorouracil and its release profile was analyzed as a function 
of pH and temperature. Next, it is described all the results obtained for both chitosan 
macrogels prepared. 
 
3.3.1 Chitosan macrogels 
 
i. Preparation of alkali chitosan macrogels. 
In the process of formation of physical chitosan macrogels due to a pH increase 
by the addition of the coagulant solution, there is a balance between hydrogen bonding 
and hydrophobic interactions responsible for the formation of physical junctions. Alkali 
chitosan macrogel is shown in Figure 3.2. For degrees of acetylation lower than 40 %, 
the physical junctions are mainly composed of hydrogen bonding counterbalancing the 
low amount of acetyl groups in favour of hydrophobic interactions[37]. The formation 
of hydrogen bonds requires the deprotonation of the amine sites achieved by dissolving 
the raw chitosan in acetic acid.  
 
 
Figure 3.2. Visual appearance of chitosan ferrogels: (a) alkali chitosan hydrogel (2% w/v). 
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The direct addition of NaOH to a chitosan solution would result in the local 
precipitation of chitosan[38]. To avoid this, MeOH  is added to the coagulating solution 
in order to participate in the formation of hydrophobic junctions between polymer chain 
segments and therefore favour the formation of the gel[39].   
 
ii. Preparation of chitosan ferrogels: in situ synthesis of iron oxide 
nanoparticles. 
The synthesis of iron oxide nanoparticles inside chitosan macrogels involves two 
steps. As a first step, the chitosan is dissolved in an acid solution containing Fe2+ and 
Fe3+, it has been reported that each iron ion is chelated with two moles of amino groups 
and four moles of oxygen[40, 41]. As a second step, the solutions are carefully 
immersed in a NaOH solution to simultaneously gel the chitosan solution and oxidize 
the iron cations to yield iron oxide nanoparticles. A schematic representation of the 
procedure is shown in Figure 3.3.  
 
 
Figure 3.3. Schematic representation of the synthesis of iron oxide in the presence of a chitosan solution: 
(a) neat chitosan; (b) formation of a complex Fe–chitosan and (c) chitosan ferrogel (black dots represent 
iron oxide nanoparticles). 
 
Due to the fact that chitosan dissolves in acidic mediums such as the one 
provided by the aqueous Fe3+/Fe2+ solutions, it was not possible to repeat the number of 
oxidation cycles to increase the amount the iron oxide nanoparticles [42, 43]. Instead, 
the immersion time in NaOH solution was varied.  
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The formation of iron oxide nanoparticles is highly dependent on the chitosan 
concentration. Figure 3.4 shows that ferrogels obtained from a 2% (w/v) chitosan 
solution present a dark brown colour after 1 hour immersion time in NaOH which is 
characteristic of magnetite. Furthermore they are responsive to a 1T magnetic field. 
Interestingly, attempts to prepare a magnetite polymer gel hybrid by in situ oxidation of 
3% (w/v) chitosan solutions were unsuccessful. Rather than the development of the 
black coloration characteristic of magnetite, the gel turned red/orange in colour possibly 
due to the formation of iron(III) oxyhydroxides [44]. One possible explanation for the 
absence of magnetite is that the higher viscosity of the 3% (w/v) chitosan solution with 
respect to the 2% (w/v) chitosan solution restricts the extent of oxidation by hindering 
the diffusion of NaOH. In fact it has been reported that, in the formation of iron oxide 
by coprecipitation of iron chlorides with bases, the slow addition of the base may lead 
to the formation of a brown nonmagnetic precipitate, probably hydroxides[45].  
 
 
Figure 3.4. Visual appearance of chitosan ferrogels: a) chitosan ferrogel subjected to 1 h immersion time 
in NaOH (3% w/v) and b) chitosan ferrogel subjected to 1 h immersion time in NaOH (2% w/v). 
 
iii. Morphological study. 
Figure 3.5 shows the TEM images corresponding to alkali chitosan macrogels 
prepared with two concentration of chitosan: 2% and 3 (w/v). A good dispersion of 
spherical iron oxide nanoparticles was observed in the 2% (w/v) chitosan matrix with an 
average size of 10 nm. This result confirmed the successful in situ formation of iron 
oxide nanoparticles. Meanwhile the nanoparticles synthesized inside the 3% (w/v) 
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chitosan gel presented a very fine needle like morphology which is typical of 
hydroxides[46].  
 
 
Figure 3.5. Transmission electron microscopy corresponding to: (a) 2% (w/v) chitosan ferrogel and (b) 3 
% (w/v) chitosan ferrogel subjected to 30 min immersion time in NaOH (bar = 500 nm). Inset shows iron 
oxide nanoparticles at a higher magnification (bar = 10 nm). 
 
iv. Determination of crystallinity by X-ray diffraction measurements (XRD) 
The crystalline phase of the iron oxides was confirmed through XRD and the 
results are presented in Figure 3.6. Pure chitosan (Figure 3.6-a) exhibits two 
characteristic peaks at 2θ=9.7º (020) and 19.9º (110 and 040) [28]. 
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Figure 3.6. Wide angle X-ray diffractograms of: (a) pure chitosan; (b) 2% (w/v) chitosan ferrogel 
immersed in NaOH for 1 h and (c) 3% (w/v) chitosan ferrogel immersed in NaOH for 1 h. 
 
The diffractogram corresponding to the 2% (w/v) chitosan ferrogel immersed for 
1 hour in a NaOH solution (Figure 3.6-b) present six characteristic peaks at 30.1º (220), 
35.5º (311), 43.1º (400), 53.4º (422), 57.0º (511) and 62.6º (440), which are consistent 
with standard diffraction data for magnetite[29]. Only the peak located at 2θ=19.9º 
corresponding to pure chitosan is slightly visible in this diffractogram which indicates 
almost complete disruption of the chitosan crystalline domains. The diffractogram 
corresponding to the 3% (w/v) chitosan ferrogel (Figure 3.6-c) does not present 
appreciable peaks corresponding to magnetite which corroborates the absence of 
magnetic, crystalline, iron oxide species in this sample. Furthermore, in this sample, the 
peak located at 2θ=19.9 º indicates only slight disruption of the chitosan crystalline 
domain. 
 
v. Analysis of the chemical structure.  
The interaction of the chitosan matrix and the iron oxide nanoparticles was 
elucidated through FT-IR experiments presented in Figure 3.7.  
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Raw chitosan (Figure 3.7-a) presents two strong vibrations located at 1650 cm-1 
that has previously been assigned to the amide I and at 1584 cm-1 attributed to the amine 
groups bending vibration overlapped with the amide II vibration respectively [31, 47]. 
Nitrogen atoms corresponding to the amine group hold a free electron doublet that is 
responsible for the uptake of metal ions by a chelation mechanism [48, 49].  However 
the overlapping of the bands assigned to the amide II and the amine groups prevent the 
observation of the interaction of the amine groups with the iron ions. Instead, the 
presence of amino complexes is corroborated by the appearance of a new band located 
at 800 cm-1 attributed to νNH2 and ρNH2. This band has been observed in chitosan metal 
complexes with Cu2+, Mn2+ and Zn2+[30, 50]. 
 
 
Figure 3.7. FT-IR spectra of: (a) raw chitosan; (b) 2% (w/v) chitosan ferrogel and (c) 3% (w/v) chitosan 
ferrogel after 2 h immersion time in NaOH. The inset image shows the structure of partially acetylated 
chitosan constituted by (m) glucosamine units and (n) N-acetylglucosamine units. 
 
The acetyl groups remaining from chitin may also participate in the interaction 
with iron nanoparticles as denoted by the shift to lower frequency numbers of the 1650 
cm-1 band corresponding to the amide I vibrations observed for the spectra containing 
iron oxide.  
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The absorption bands in the region of 1000-1100 cm-1 in the raw chitosan 
spectrum owe their origin to C-O stretching vibrations primarily in the alcohol 
groups[51]. Specifically, the band at 1095 cm-1 assigned to the C3-O stretching in the 
spectrum corresponding to raw chitosan shifts to 1080 cm-1 in the spectra corresponding 
to the samples containing iron oxide nanoparticles (Figures 3.7-b and 3.7-c) whereas the 
peak located at 1020 cm-1 assigned to the C6-O in Figure 3.7-a does not move in the 
samples containing iron oxide nanoparticles which indicates the existence of 
interactions involving the C3 hydroxyl groups in agreement with theoretical studies[52]. 
It is worth of remark that even if the formation of magnetite nanoparticles is not 
achieved in the case of the 3% (w/v) chitosan ferrogels as shown by TEM images 
(Figure 3.5) and XRD (Figure 3.6), the FT-IR spectrum corresponding to this sample 
immersed for 2 hours in NaOH (Figure 3.7-c) presents the same features as the 
spectrum corresponding to the 2% (w/v) chitosan samples subjected to the same 
treatment (Figure 3.7-b). This indicates that the coordination of the iron cations to the 
chitosan matrix does take place for 3% (w/v) chitosan ferrogels and that it is the slow 
diffusion of the OH- species in the viscous medium provided by the 3% (w/v) chitosan 
what hinders the formation of the magnetite nanoparticles. These results will be further 
corroborated by rheological measurements. 
 
vi. Analysis of the thermal degradation of the samples under study. 
The iron oxide content in 2% (w/v) chitosan ferrogels was determined through 
TGA experiments and the results are shown in Figure 3.8.  
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Figure 3.8. (a) Thermogravimetric analysis and (b) differential thermogravimetric curves of 2% (w/v) 
chitosan ferrogels subjected to different inmersion times. (black) Neat chitosan; (red) 30 min; (green) 1 
h; (blue) 2 h.  
 
The peak degradation temperatures obtained from the DTG curves and the 
residue at 950 ºC are given in Table 3.2.  
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Table 3.2. Temperature of the maximum weight loss rate, Tp and associated weight loss 
for neat chitosan and 2% (w/v) chitosan ferrogels.  
 
 
For neat chitosan, the first degradation stage ranges between 90 and 200 ºC and 
shows about 14.7% loss in weight. This may correspond to the loss of adsorbed and 
bound water. The second stage of weight loss starts at 200 ºC and continues up to 575 
ºC and it is due to dehydration, depolymerisation and decomposition of the acetylated 
and deacetylated units of the chitosan[53]. This stage left about 30 % (w/w) solid 
residue in the neat chitosan.  
The TGA of the iron-containing chitosan showed three degradation steps instead 
of the two observed for the starting chitosan. The amount of adsorbed water occurring 
during the first degradation range decreases to 8 % (w/w) for the three samples. The 
peak degradation corresponding to the second degradation range shifts to higher 
temperatures which indicate an increase of the thermal stability associated to the 
samples containing iron oxide. A third degradation range is observed in the samples 
containing iron oxide at temperatures 575-785 ºC. This may imply the attachment of the 
iron particles to the hydrogel networks [54, 55]. In addition, leakage of iron oxide 
nanoparticles from the swollen hydrogels in water was not observed at room 
temperatures for periods up to three months. This is a further indication of the 
attachment of the iron particles to the polymer network.  
The iron oxide content was calculated assuming that the ratio between the 
weight of the residue at 950 ºC and the weight loss in the interval of 200-575 ºC for 
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pure chitosan is the same for chitosan in the ferrogels [56]. Therefore, the weight 
percentage of magnetite, M, in the ferrogels can be calculated as follows: 
 
 
where Rq is the residue (% w/w) at 950 ºC of the starting chitosan; ΔWq and ΔWm are 
the weight loss percentages in the interval of 200-575 ºC for starting chitosan and 
chitosan ferrogels respectively and R is the residue at 950 ºC for the chitosan ferrogels.  
In Table 3.2, it can be seen that the iron oxide concentration is independent from 
the immersion time in NaOH. The results are in agreement with reports in which it was 
determined that the chitosan-induced synthesis of iron oxide nanoparticles hardly 
depended on the iron ion concentration [57].  
 
vii. Viscoelastic properties of alkali chitosan macrogels. 
Before of analysis the viscoelastic properties of the samples, first it has been 
determined the Linear Viscoelastic Regions (LVR), defined as the region in which the 
elastic modulus and loss modulus are independent of the applied deformation. As an 
example, Figure 3.9 shows a strain sweep of alkali chitosan macrogels. From the 
experiments a value of 1% strain was employed for the rest of the rheological 
experiments.  
 RMW
W
Rq
m
q
=+∆×
∆
Equation 3.1 
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Figure 3.9. Strain sweep for the determination of the Linear Viscoelastic Region (LVR) of 
chitosan/agarose-2.(■) Elastic modulus (G´) and (●) loss modulus (G´´). 
    
We have examined the rheological behaviour of chitosan gels precipitated in an 
alkali coagulating solution (H2O:MeOH:NaOH: 4:5:1, w/w)[36]. 
Figure 3.10 shows a representative plot of the frequency dependence of G´ and 
G´´ for a 2% (w/v) chitosan hydrogel formed by neutralizing an acidic solution of 
chitosan with an alkali coagulating solution.  
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Figure 3.10 . (■) Elastic modulus (G´) and (●) loss modulus (G´´) as a function of frequency for 2% (w/v) 
alkali chitosan hydrogels. 
 
As can be observed, G´ is much higher than G´´ over the entire frequency range 
and both modules are essentially frequency independent, a behaviour that is typical of 
hydrogels [58, 59]. The same conclusions are reached for other chitosan hydrogels 
obtained by raising the pH [60, 61].  
The storage modulus as a function of frequency for chitosan hydrogels of 
varying chitosan concentrations are presented in Figure 3.11. All the samples present a 
typical gel behaviour in which the dynamic elastic modulus (G´) is relatively 
independent of the frequency of deformation. Moreover the elastic modulus increases 
with the chitosan concentration. Similar results have been reported for chitosan 
hydrogels obtained by treating chitosan solutions with gaseous NH3. The increase of the 
elastic modulus with the chitosan concentration has been attributed to the presence of 
more polymer chains responsible for more entangled junctions[37]. 
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Figure 3.11. Elastic modulus (G´) as a function of frequency for alkali chitosan hydrogels  (■) 1.5% 
(w/v); (●) 2% (w/v); (▲) 3% (w/v); (▼) 4% (w/v) (inset: double logarithmic plot of storage modulus 
versus polymer concentration). 
 
The viscoelastic results have been analyzed using the theoretical model based on 
the scaling approach which relates modulus to concentration following the relation 
described in Equation 3.2. [62, 63]: 
 
where C is the polymer concentration and n is an exponent which depends upon the 
conformation of the chain linking junction points.   
The double logarithmic plot of G´ versus concentration is shown in the inset of 
Figure 3.11. From this figure and making use of equation 3.2 a value of the exponent of 
3 is obtained. The exponent n is related to the fractal dimension, ν-1, of the object 
between the junctions as: 
 
 
Therefore, the fractal dimension, ν-1, obtained from the exponent n is 2, which is 
characteristic of flexible systems with elasticity predominantly of entropic origin. This 
result indicates that these gels present a structure more similar to chemical gels than to 
  nCG ≈
  )13/(3 −≈ ννCG
Equation 3.2 
Equation 3.3 
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physical gels in the sense that they are constituted of flexible chains linked each other 
either through the formation of cooperative hydrogen bonds or by chemical 
crosslinking.  
 
- Influence of iron oxide nanoparticles over viscoelastic properties of alkali 
chitosan macrogels. 
It was evaluated the influence of the formation in situ of iron oxide nanoparticles 
in the rheological behaviour of chitosan hydrogels. Figure 3.12-a shows the evolution of 
the storage modulus as a function of frequency for 2% (w/v) chitosan ferrogels 
subjected to different immersion times. The in situ synthesis of iron oxide nanoparticles 
results in an increase of the elastic modulus of the chitosan ferrogels with respect to the 
neat alkali chitosan hydrogels, however, the increase of the NaOH immersion time does 
not entail an increase in the elastic modulus. On the contrary, the storage modulus 
corresponding to the gels immersed for 1 and 2h in NaOH are lower with respect to the 
gels after 30 minutes immersion time. This is more clearly seen in Figure 3.12-b where 
the storage modulus, G´ at 1 Hz is represented as a function of the immersion time in 
NaOH. To explain these results two factors have to be taken into account, on the one 
hand, the incorporation of metal nanoparticles onto polymer hydrogels will generally 
improve the mechanical properties of the systems[64]. According to this, an increase in 
the magnetite content would result in an increase of the storage modulus. Therefore, at 
immersion times longer than 1 h, the storage modulus, G´ becomes independent from 
the immersion time may be explained by the fact that the magnetite content remains 
constant as determined by TGA experiments (Figure 3.8) and thus an increase of the 
NaOH immersion time does not entail a reinforcement of the network.  
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Figure 3.12. (a) Log of the elastic modulus (G´) as a function of frequency for 2% (w/v) chitosan 
ferrogels subjected to different immersion times in NaOH. (■) 0; (●) 30 min; (▲) 1 h; (○) 2 h. (b) Elastic 
modulus, G´, at 1 Hz as a function of immersion time in NaOH. 
 
On the other hand, the interaction of the iron cations with the amine groups and 
the hydroxyl groups in the chitosan matrix demonstrated through FT-IR (Figure 3.7) 
prevents the establishment of hydrogen bonding involving these groups. At the same 
time, the acetyl groups responsible for the establishment of hydrophobic interactions 
also interact with the iron cations and thus it is reasonable to assume that the 
effectiveness of these interactions are also reduced.  
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Figure 3.13-a shows the storage modulus as a function of frequency for 3% 
(w/v) chitosan hydrogels. For these samples, the immersion time in NaOH does not 
result in an increase of the modulus with respect to the neat chitosan hydrogels. In fact, 
as can be observed in Figure 3.13-b, the storage modulus remains unchanged for NaOH 
immersion times equal or shorter than 1 hour with respect to the neat chitosan.  
 
Figure 3.13. Log of the elastic modulus (G0) as a function of frequency for 3% (w/v) chitosan ferrogels 
subjected to different immersion times in NaOH. (■) 0; (●) 30 min; (▲) 1 h; (○) 2 h (b) Elastic modulus, 
G´, at 1 Hz as a function of immersion time in NaOH. 
 
These results are in good agreement with the fact that magnetite nanoparticles 
are not formed in this case; instead the formation of hydroxides takes place which does 
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not induce the reinforcement of the network. At immersion times longer than 1 hour the 
storage modulus is lower than the corresponding to neat chitosan due to the fact that the 
interaction between iron cations and the polymer matrix prevent the formation of 
interactions between the polymer groups responsible for the formation of chitosan 
hydrogels. 
 
3.3.2 Composite chitosan/agarose macrogels. 
 
i. Preparation of composite chitosan/agarose macrogels.  
Chitosan/agarose macrogels were prepared changing agarose content in the 
precursor chitosan/agarose solutions with three different concentrations. Figure 3.14-a 
shows a schematic representation of composite chitosan/agarose macrogels. The control 
agarose-1.5 looks transparent, as can be observed in Figure 3.14-b. The composite 
chitosan/agarose macrogels retained a transparency in the hydrated state, which 
suggested uniform distribution of chitosan in the host agarose matrix, without 
noticeable phase separation, as shown in Figure 3.14.  
 
 
Figure 3.14. (a) Schematic representation of chitosan/agarose macrogels. Photographs of b) agarose-
1.5, c) chitosan/agarose-1 d) chitosan/agarose-1.5 and e) chitosan/agarose-2 macrogels. 
 
ii. Morphological study 
The microstructure of the agarose-1.5 and composite chitosan/agarose macrogels 
was examined using scanning electron microscopy (SEM) after lyophilization of the 
samples. The structure of the surface and cross-section of the agarose-1.5 and 
chitosan/agarose macrogels are shown in Figure 3.15-a and 3.15-b respectively. Both 
 Chitosan macrogels 
63 
 
types of macrogels had a similar a sponge-like structure and porosity. Representative 
images of the pore size corresponding to agarose-1.5 and chitosan/agarose-2 gels 
determined from SEM images taken on the cross section (Figure 3.15-b) was 73±16 µm 
and 102±39 µm respectively. The individual agarose and chitosan domains were not 
distinguishable in the composite macrogels.   
 
 
Figure 3.15. (a) SEM images corresponding to the surface of agarose-1.5 and composite 
chitosan/agarose macroscopic gels. (b) Cross sections of agarose-1.5 and chitosan/agarose-2. 
 
iii. Analysis of the chemical structure.  
The presence of interactions between chitosan and agarose in the composite gels 
was examined by ATR-FTIR spectroscopy experiments.  The ATR-FTIR spectrum of 
agarose-1.5 (Figure 3.16-a) shows the peak at 1046 cm–1 for C-O (characteristic of axial 
deformation), 1371 cm-1 ascribed to C-C bending, 890 cm–1 attributed to C-H angular 
deformation of anomeric carbon, and 931 cm-1 assigned to 3,6-anhydrogalactose [22]. 
The chitosan spectrum exhibited the band at 1579 cm-1 corresponding to the N-H 
bending vibration overlapping the amide II vibration and the band at 1649 cm-1 that 
corresponds to the amide I vibration (Figure 3.16-b). Absorption bands at 1153 cm-1 
(antisymmetric stretching C-O-C bridge), 1089 cm-1 and 1033 cm-1 (skeletal vibrations 
involving the C-O stretching) were characteristic of the CS saccharide structure [65].  
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Figure 3.16. ATR-FTIR spectra of (a) agarose-1.5, (b) chitosan, (c) chitosan/agarose-1.5  
 
The ATR-FTIR spectrum corresponding to the sample chitosan/agarose-1.5 
(Figure 3.16-c) showed the characteristic bands of each polymer, however, the band 
located at 1579 cm-1 in  chitosan (Figure 3.16-b) shifted to 1568 cm-1 (Figure 3.16-c), 
suggesting intermolecular hydrogen bonding between the chitosan amino groups and 
agarose hydroxyl groups. In addition, band broadening indicated interaction between 
the polymers.   
 
iv. Temporal stability  
In vitro stability of the composite chitosan/agarose macrogels was measured as 
their temporal mass loss at physiological temperature and pH 7.4 (Figure 3.17). The 
study was extended to pH=5.2, in order to simulate acidic tumor environment [66] and a 
45 ºC, to analyze the effect of the temperature. First, the comparison among agarose-1.5 
and chitosan/agarose-1.5 was analyzed, with the objective to study the addition of 
chitosan into the macrogel. Then, it will be reported the stability as function of agarose 
concentration, specifically for chitosan/agarose-2.  
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At physiological temperature of 37 ºC and pH 7.4, composite chitosan/agarose-
macrogels have a significantly weaker mass loss than agarose-1.5 gels (Figure 3.17-a). 
This fact could be explained by two factors: the addition of chitosan to the system and 
the medium employed for the preparation of agarose solution. Agarose gels are known 
to be stable at physiological temperature and pH. Generally, they are prepared by 
dissolving agarose in water or PBS buffer and subsequently gelling the solution under 
reduced temperatures. In this work, agarose-1.5 gel was prepared by dissolving agarose 
in an aqueous 1% (v/v) acetic acid solution (pH=3.5), which could promote the light 
hydrolysis of 1-4 glucosidic links and decrease the stability of agarose gels. At pH=5.2 
the increase in stability in chitosan/agarose gels, in comparison with agarose samples 
was evident (Figure 3.17-b). Therefore, the hydrolysis of agarose polymer was hindered 
in the presence of chitosan which led to an enhanced stability of the composite gels.  
 
 
Figure 3.17. Kinetics of stability of chitosan/agarose-2 macrogels (■), chitosan/agarose-1.5 macrogels 
(▲) and agarose-1.5 macrogel (●) at T=37 ºC and pH 7.4 (a) and at pH 5.2(b) and at T=45 ºC at pH 7.4 
(c) and pH 5.2 (d).  
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It is important to recall that agarose can gel below 17 ºC and melts in the range 
of 40-50 ºC. These transitions depend on the degree of hydroxyethylation of agarose 
component of the hydrogel. In order to determine the effect of chitosan on stability of 
the composite gels above agarose melting temperature, it is determined mass loss at 45 
ºC at pH 7.4 and at pH 5.2. After 24 h, at pH 7.4 the mass loss was ~28% and ~41% for 
both composite chitosan/agarose gels and agarose-1.5 gel, respectively (Figure 3.17-c). 
Whilst, at pH 5.2 it is observed an important diminishing of the mass loss for all the 
samples under study, where composite chitosan/agarose macrogels were more stable 
than agarose gels. Thus, it can be concluded that at T=45 oC, the stability of the gels 
was lower than at T=37 ºC as a consequence of partial melting of the agarose gel, yet, it 
was higher in the presence of chitosan.   
In general, to compare the influence of agarose concentration in composite 
chitosan/agarose macrogels, it is possible to conclude that macrogels with higher 
agarose concentration were more stable at both pHs and temperatures. This results 
suggest that chitosan/agarose-2 presented a higher melting point than chitosan/agarose-
1.5, for this reason there was no an important difference on function of temperature. The 
improvement of stability can be related with more hydrogen bonding among polymers, 
this fact was confirmed trough ATR-FTIR spectroscopy. Considering this hypothesis, 
composite chitosan/agarose-2 is less sensitive to pH and their degradation as it was 
mentioned before can be controlled on functions of agarose concentration, as well. 
As Figure 3.18 shows, despite of the better stability of composite macrogels, an 
evident change on its appearance was observed. This fact may suggest a slow hydrolysis 
process of agarose, because samples turned white at pH 5.2 and after 24 h. It is 
important to highlight that this effect was the same for agarose-1.5 with the difference 
that this was observed a shorter times and finally the gel was broken in small pieces.  
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Figure 3.18. Representative photograph of chitosan/agarose-1.5, a) before the experiment and b) 24 h 
latter at pH 5.2. 
 
v. Viscoelastic properties of composite chitosan/agarose macrogels. 
The variation in the elastic modulus of the composite chitosan/agarose 
macrogels as a function of temperature is shown in Figure 3.19. No variation in the 
elastic modulus G'e was observed below the melting temperature of the gel, Tm. Above 
Tm, the value of G'e dramatically decreased and ultimately reached the second plateau at 
~70 oC, above which the agarose network completely melted down. The value of Tm 
increased with agarose concentration from 57±1 oC (chitosan/agarose-1) to 62±1 oC 
(chitosan/agarose-2). The elastic modulus of the composite gels increased with agarose 
concentration, reaching the value of 1 kPa at 20 oC for chitosan/agarose-2. In addition, 
composite gels had a higher elastic modulus than agarose gels (G' = 824 ±10 Pa for the 
sample chitosan/agarose-1.5 and G´ = 540±44 Pa for agarose-1.5). 
 
The dependence of the elastic modulus on agarose concentration in the 
chitosan/agarose macrogels was analyzed using the scaling approach [67]. For that, it 
was employed the equation 3.2. Individual agarose chains are intrinsically rigid and, on 
cooling, they form bundles (nanofibrils), which assemble in a gel [68]. Jones and 
Marques theory [69] relates the exponent n to the longitudinal fractal dimensions of the 
fibrils as [70]   
 
                                           G'~ C (3υ+1)/ (3υ-1)                                                                Equation 3.4 
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where the constant υ is the inverse of the fractal dimension. 
 
 
Figure 3.19. Variation in elastic modulus, G ,` plotted as a function of temperature, for agarose-1.5 (■), 
chitosan/agarose-1 (●), chitosan/agarose-1.5 (▲) macrogel and chitosan/agarose-2 (▼) macrogels. 
Dashed lines show the determination of the melting point, Tm, of the gel. Insert shows the variation in G' 
as a function of agarose concentration. The black dashed line corresponds to the linear fit of the data.  
 
 
The double logarithmic dependence of G'e vs. agarose concentration for the 
composite gels is shown in the inset of Figure 3.19. The elastic modulus of the 
composite gel increased with agarose concentration, in agreement with the reported 
changes for agarose gel[17, 71]. The linear fitting of the data plotted in the inset of 
Figure 3.19 yielded a slope of ~2. A relation of G'~C2 and the fractal dimension 1/ υ ~1 
obtained for the chitosan/agarose macrogels indicated that agarose gels with embedded 
chitosan chains were composed of rigid nanofibrils identical to those in pure agarose 
gels. [70, 72] This result was in agreement with the earlier measurements of the elastic 
modulus of agarose gels, which gave a power law dependence of G' corresponding to a 
longitudinal fractal dimension 1/υ ≈1.1  [73, 74]. From these results, it is possible to 
infer a close similarity between the structural organization of agarose fibrils in the 
chitosan-free and chitosan/agarose macrogels. 
The increase in the elastic modulus of the composite chitosan/agarose gels with 
respect to agarose gels could be caused by the hydrogen bonding between the chitosan 
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chains and the agarose network, as it was reported for agarose mixed with collagen [75, 
76], κ-carrageenan, [77] or xylans [78]. 
 
3.3.3 Composite chitosan/agarose macrogels loaded with ferrofluid. 
 
i. Preparation of composite chitosan/agarose macrogels loaded with 
ferrofluid. 
In this section, composite chitosan/agarose macrogels were loaded with two 
concentrations of ferrofluid, 2% and 5% (w/v) and after an extended characterization 
were evaluated for hyperthermia applications. Figure 3.20, shows photograph 
corresponding to composite chitosan/agarose-1.5 and their respective ferrofluid loaded 
macrogels and a schematic representation of the materials obtained. As can be observed 
the encapsulation of ferrofluid was successful for both concentrations employed.   
 
 
Figure 3.20. Photographs of a) chitosan/agarose-1.5,b) chitosan/agarose-1.5+Fe2%, c) 
chitosan/agarose-1.5+Fe5% and d) schematic representation of chitosan/agarose macrogels loaded 
with ferrofluid. 
 
ii. Morphological study 
Figure 3.21 shows the SEM images corresponding to the surface morphology (a) 
and cross section (b) of agarose-1.5 and chitosan/agarose-1.5, both loaded with 
ferrofluid at 2% and 5% (w/v). The SEM photographs of all surfaces presented 
roughness and their respective cross section corroborated the porous microstructure of 
all the samples. 
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Figure 3.21. SEM images corresponding to the a) surface and b) cross sections of agarose-1.5and 
chitosan/agarose-1.5, both loaded with ferrofluid at 2% and 5% (w/v).   
 
iii. Study of the chemical structure. 
Figure 3.22 shows ATR-FTIR spectra of chitosan/agarose-1.5 and 
chitosan/agarose-1.5+Fe5%. Previously, it was described the spectra of 
chitosan/agarose-1.5 (Figure 3.16-c) where it was remarked the band of N-H bending 
vibration at 1568 cm-1 and also it was observed the band corresponding to C=O located 
at 1648 cm-1. In this ATR-FTIR study, it was analyzed the shifts of the main bands of 
chitosan/agarose-1.5+Fe5% to regard at chitosan/agarose-1.5 without ferrofluid.   
Chitosan/agarose-1.5+Fe5% spectrum (Figure 3.22-b) presents the band of N-H 
bending and C=O at 1557 cm-1 and 1635 cm-1. Both bands are shifted a lower frequency 
with regard to chitosan/agarose-1.5 (Figure 3.22-a) that appears at 1568 cm-1 and 1648 
cm-1, respectively. These results suggest intermolecular hydrogen bonding between the 
chitosan and ferrofluid.  
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Figure 3.22. ATR-FTIR spectra of (a) chitosan/agarose-1.5 and b) chitosan/agarose-1.5+Fe5%. 
 
No changes were observed as a function of ferrofluid content. Chitosan/agarose-
1.5+Fe2% presented the same spectra as chitosan/agarose-1.5+Fe5% (results not 
shown). 
 
iv. Thermal stability by TGA. 
Thermal stability of chitosan/agarose-2 macrogels loaded with ferrofluid at 2% 
and 5% (w/v) was studied through thermogravimetric analysis. The results are shown in 
Figure 3.23.  
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Figure 3.23. a) Thermal degradation and b) differential thermogravimetric curves of (a) 
chitosan/agarose-2 and b) chitosan/agarose-2+Fe2% and c) chitosan/agarose-2+Fe5%. 
 
All samples presented a first weight loss between 25-80 ºC, which is attributed 
to the evaporation of superficial water, the weight loss (%) for chitosan/agarose-2, 
chitosan/agarose-2+Fe2% and chitosan/agarose-2+Fe5% were 8%, 10% and 8%, 
respectively.  
Then, the second weight loss stage in the range of 150-500 ºC is due to the 
decomposition of the organic chains of polymers, chitosan[53] and agarose[22]. 
According to the derivative of TGA (Figure 3.23-b), the degradation temperature for 
chitosan/agarose-2, chitosan/agarose-2+Fe2% and chitosan/agarose-2+Fe5% were 294, 
307 and 308 ºC, with weight loss 79%, 74% and 75%, respectively. The thermal 
stability increases with the ferrofluid content. This fact can be attributed to the 
 Chitosan macrogels 
73 
 
establishment of interactions among polymer matrix and the ferrofluid as determined 
through ATR-FTIR analysis.  
The residue obtained for chitosan/agarose-2, chitosan/agarose-2+Fe2% and 
chitosan/agarose-2+Fe5% at 600 ºC were 12%, 15% and 16%, respectively. Taking into 
account these values, the residue obtained increases with the encapsulation of the 
ferrofluid content.  
 
v. Viscoelastic properties of composite chitosan/agarose macrogels loaded with 
ferrofluid.  
Figure 3.24 shows the variation in elastic modulus, G` with the temperature of 
chitosan/agarose macrogels loaded with ferrofluid at 5% (w/v) for different 
concentrations of agarose. As can be observing, the elastic modulus increases as a 
function on agarose content, keeping the same tendency as chitosan/agarose macrogels. 
With respect to melting temperature (Tm) was determined as shown in Figure 3.24. The 
Tm of macrogels loaded with ferrofluid is in the range of 48-50 ºC, which increased 
slightly as a function of agarose content. These Tm values were lower than composite 
chitosan/agarose macrogels, which can be explained by their low degree of crosslinking 
and therefore samples melts at lower temperatures.  
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Figure 3.24. Variation in elastic modulus, G ,` plotted as a function of temperature, for chitosan/agarose-
1+Fe5%  (●), chitosan/agarose-1.5+Fe5%  (▲) and chitosan/agarose-2+Fe5%  (▼) macrogels. Dashed 
lines show the determination of the melting temperature, Tm, of the gel. Inset image corresponds to the 
variation in G' as a function of agarose concentration for macrogels loaded with both concentrations of 
ferrofluid (2% and 5% w/v).   
 
Comparing the G` values obtained in this experiment with chitosan/agarose 
macrogels without ferrofluid, it is observed that elastic modulus G´ were lower than 
chitosan/agarose macrogels, reaching the value of 1150 Pa at 20 oC for 
chitosan/agarose-2+Fe5%. This fact can be related with the new interactions among 
polymers-ferrofluid, which reduce the interactions of the network components, chitosan 
and agarose. Therefore, there is a low degree of crosslinking and consequently their 
mechanical properties diminish. However, ferrofluid loaded chitosan/agarose macrogels 
had a higher elastic modulus than ferrofluid loaded agarose macrogels, keeping the 
same tendency as chitosan/agarose macrogels (G' ~600 Pa for the sample 
chitosan/agarose-1.5+Fe5% and G´ ~300 Pa for agarose-1.5+Fe5%). 
The inset image of Figure 3.24 exhibits the variation in G' as a function of 
agarose concentration for macrogels loaded with two concentrations of ferrofluid (2% 
and 5% w/v). Taking into account this result, there was not significant contribution of 
ferrofluid over the viscoelastic properties of chitosan/agarose macrogels loaded with 
ferrofluid.  
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3.3.4 Composite chitosan/agarose macrogels as precursors for biomedical 
applications. 
 
Composite chitosan/agarose macrogels were assessed as precursors for two 
biomedical applications, hyperthermia applications and drug delivery. The results 
obtained are describes below. 
 
i. Application  in Magnetic Hyperthermia. 
Figure 3.25 shows the results obtained for chitosan/agarose-1.5 loaded with two 
concentrations of ferrofluid (2% and 5% w/v). There was an evident increase of 
temperature as a function of ferrofluid content. Macrogels loaded with 5% (w/v) of 
ferrofluid presented a higher temperature change than macrogels loaded with 2% (w/v). 
Chitosan/agarose-1.5+Fe2% and chitosan/agarose-1.5+Fe5% presented an increase of 
the temperature (ΔT) of 2.5 and 1.5, respectively at 300 s. 
 
 
 
Figure 3.25. Time dependence of the temperature of chitosan/agarose-1.5 macrogel loaded with 
ferrofluid at 2% (w/v) (black line) and 5% (w/v) (red line) for at ƒ=580 kHz and 24 kA/m. 
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The capacity on heat generation of chitosan/agarose macrogels loaded with 
ferrofluid when are submitted to an alternating magnetic field were assessed. Specific 
power absorption (SPA) was determined from the initial slope of the temperature vs 
time curves (Figure 3.25). The temperature increase (ΔT) of a given mass of ferrofluid 
diluted in the system during the time interval (Δt) of the experiment. SPA was 
calculated by the following equation[79] 
 
              
where cLIQ and cNPs are the specific heat capacities of the liquid carrier, whereas we can 
approximate +     and write Eq. 3.6 as 
  
 
The SPA values listed in Table 3.3 show the variation of SPA as a function of 
ferrofluid content, specifically for the two samples under study. 
 
Table 3.3. Specific power absorption of the samples under study. 
Samples ΔT/Δt SPA (W/g) 
chitosan/agarose-1.5+Fe2% 0.007 1.5 
chitosan/agarose-1.5+Fe5% 0.009 0.8 
 
  
 
 
Equation 3.5 
Equation 3.6 
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ii. Controlled release of 5-FU from composite chitosan/agarose macrogels. 
 
- Preparation of composite chitosan/agarose macrogels loaded with 5-
Fluorouracil. 
 
Composite chitosan/agarose-1.5 macrogels and agarose-1.5 loaded with 5-
Fluorouracil (5-FU) were prepared as matrixes for drug delivery. The gel formation was 
successful, even in presence of 5-FU. As can be observed in Figure 3.26, agarose-
1.5+5-FU and chitosan/agarose-1.5+5-FU, looks transparent as 5-FU-free composite 
chitosan/agarose macrogels. 
 
 
Figure 3.26. (a) Photographs of a) agarose-1.5+5-FU, b) chitosan/agarose-1.5+5-FU.  
 
 
- Study of drug-polymer matrix interactions by ATR-FTIR spectroscopy. 
 
The loading of 5-Fluorouracil in the agarose and chitosan/agarose macrogels 
was confirmed in ATR-FTIR experiments. The inset image in Figure 3.27 shows, the 
characteristic absorption bands of 5-Fluorouracil located at 1651 cm-1, corresponding to 
C=O stretching of the N-acetyl group (amide I band), 1501 cm-1 assigned to N-H amide 
II band, N-H stretching of amide at 1429 cm-1, 1244 cm-1 for C-F and 804 cm-1 for C-H 
out of plane deformation. 
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Figure 3.27. ATR-FTIR spectra of a) chitosan/agarose-1.5 and b) chitosan/agarose-1.5+5-FU. The insert 
image correspond to the ATR-FTIR spectra of 5-FU.   
 
After 5-Fluorouracil loading in chitosan/agarose macrogel, the absorption peak 
located at 1569 cm-1 and at 1648 cm-1 in the composite gel (Figure 3.27-a) shifted to 
1555 cm-1 and 1664 cm-1, respectively (Figure 3.27-b), which suggested hydrogen 
bonding between the polar functional groups in 5-Fluorouracil and NH2 groups of 
chitosan. Furthermore, the band located at 804 cm-1 and at 1244 cm-1 in 5-FU shifted to 
814 cm-1 and 1248 cm-1, when the drug was encapsulated in the composite 
chitosan/agarose gel (Figure 3.27-B) [80, 81], which suggested hydrogen bonding 
between the polar functional groups in 5-Fluorouracil and NH2 groups of chitosan. 
 
- Drug delivery of 5-FU from composite chitosan macrogels on function of pH. 
The drug release was evaluated for chitosan/agarose-1.5 and agarose-1.5 
macrogels in buffered solutions at pH 7.4 and 5.2 and at 37º C. For chitosan/agarose-
1.5+5-FU (Figure 3.28, full symbols), it can be observed that at pH=7.4, the cumulative 
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release of 5-Fluorouracil was ~50% within 96 h, whereas at pH=5.2 it was ~33%. In the 
initial period (~3 h) high release rates of 5-Fluorouracil were measured, due to the 
localization of the drug at or near the gel surface and a stronger relative mass loss of the 
gels after a short time interval, as shown in Figure 3.28. After 5 h, the drug release rate 
did not change with time. At pH of 7.4 and 5.2, part of the 5-Fluorouracil remained 
trapped in the hydrogel as a result of drug-polymer interactions, as demonstrated by 
ATR-FTIR spectra.  
 
 
Figure 3.28. In vitro release of 5-FU from the composite gel chitosan/agarose-1.5 at pH=7.4 (●) and 
pH=5.2 (▲) at 37 ºC.   
 
In principle, due to the ionic nature of 5-Fluorouracil, its electrostatic 
interactions with chitosan in chitosan/agarose composite gels could affect drug release, 
however the enolic hydroxyl groups of 5-Fluorouracil ionize at pK of 8.1,[82] and at pH 
values studied, 5-Fluorouracil remained uncharged. The main reason for the difference 
in release profiles at different pH values could result from the varying solubility of 5-
Fluorouracil: in alkaline media the solubility of 5-Fluorouracil is higher than that in 
acidic conditions [83]. According to the release profiles shown in Figure 3.28, 
chitosan/agarose1.5+5-FU gels allow a fast drug delivery of 5-FU in short time period, 
which is appropriate because 5-FU has a half-life of 10-20 min. On the other hand, for a 
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local application (cream or subcutaneous injection), chitosan/agarose gels would allow 
controlled 5-FU delivery in a single dose thus avoiding cycles of treatment and 
consequently side effects. Therefore, chitosan/agarose gels assure that 5-FU will be 
released along time under the conditions employed in this work.  
 
3.4. CONCLUSIONS 
 
After the preparation by two different methods and characterization of chitosan 
macrogels, the following conclusions can be drawn.  
Chitosan ferrogels can be prepared by simultaneous coprecipitation of iron ions 
in alkali media and chitosan gelation. As a first step, chitosan amine groups interact 
with iron ions and this step depends neither on the iron ions nor on the chitosan 
concentration. As a second step the simultaneous coprecipitation and chitosan gelation 
in alkali media is achieved. The iron oxide crystalline phase was seen to depend on the 
chitosan concentration. For the highest chitosan concentration (3% w/v), the formation 
of non magnetic iron hydroxides avoids the reinforcement of the chitosan hydrogel. The 
slow diffusion of OH-species through the polymer matrix was proposed as possible 
explanation for this behavior. For the lowest chitosan concentration (2% w/v), 
magnetite nanoparticles are formed that reinforces the chitosan hydrogels as viewed by 
the increase of the viscoelastic modulus. Nevertheless, this reinforcement effect is 
counterbalanced by the disruption of hydrogen bonding as a consequence of the 
coordination of iron ions with chitosan amine groups.  
A second method of preparation consisted of composite chitosan/agarose 
macrogels, which have presented good transparency and mechanical stability. 
Chitosan/agarose macrogels had a higher elastic modulus than agarose macrogels due to 
the reinforcement of the composite chitosan/agarose gels, in comparison with agarose 
gels. The introduction of chitosan in agarose gels reduced mass loss of the 
chitosan/agarose gels, in comparison with agarose gels, at 37 ºC and pH=7.2. The 
increase in the stability of the chitosan/agarose gels was more evident at pH=5.2. This 
result has an important implication for the utilization of these gels as drug delivery 
matrixes in areas where the pH is lower than the pH of the blood plasma (7.4) such as 
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the acidic stomach or tumoral tissues. Composite chitosan/agarose gels loaded with 
ferrofluid, presented a higher thermal stability, however, their mechanical properties 
decreased in presence of ferrofluid. Ferrofluid loaded chitosan/agarose gels, can be 
considered as agent for hyperthermia applications due to their response to an alternating 
magnetic field. The release of 5-Fluorouracil from chitosan/agarose macrogels at pH 7.4 
and 5.2 under physiological temperature demonstrated the feasibility of these hydrogels 
for drug delivery applications. Therefore composite chitosan/agarose gels can be useful 
for biomedical applications as cancer treatment. 
 
3. 5 REFERENCES 
 
[1] Buwalda SJ, Boere KWM, Dijkstra PJ, Feijen J, Vermonden T, Hennink WE. 
Hydrogels in a historical perspective: From simple networks to smart materials. Journal 
of Controlled Release. 2014;190:254-73. 
[2] Bhattarai N, Gunn J, Zhang M. Chitosan-based hydrogels for controlled, localized 
drug delivery. Advanced Drug Delivery Reviews.62:83-99. 
[3] Majedi FS, Hasani-Sadrabadi MM, Emami SH, Taghipoor M, Dashtimoghadam E, 
Bertsch A, et al. Microfluidic synthesis of chitosan-based nanoparticles for fuel cell 
applications. Chemical Communications. 2012;48:7744-6. 
[4] Dang JM, Leong KW. Natural polymers for gene delivery and tissue engineering. 
Advanced Drug Delivery Reviews. 2006;58:487-99. 
[5] Muzzarelli RAA, Boudrant J, Meyer D, Manno N, DeMarchis M, Paoletti MG. 
Current views on fungal chitin/chitosan, human chitinases, food preservation, glucans, 
pectins and inulin: A tribute to Henri Braconnot, precursor of the carbohydrate 
polymers science, on the chitin bicentennial. Carbohydrate Polymers. 2012;87:995-
1012. 
[6] Muzzarelli RAA, Muzzarelli C. Chitosan Chemistry: Relevance to the Biomedical 
Sciences. In: Heinze T, editor. Polysaccharides I: Springer Berlin Heidelberg; 2005. p. 
151-209. 
Chapter 3 
82 
 
[7] Dash M, Chiellini F, Ottenbrite RM, Chiellini E. Chitosan—A versatile semi-
synthetic polymer in biomedical applications. Progress in Polymer Science. 
2011;36:981-1014. 
[8] Park JH, Saravanakumar G, Kim K, Kwon IC. Targeted delivery of low molecular 
drugs using chitosan and its derivatives. Advanced Drug Delivery Reviews. 
2010;62:28-41. 
[9] Puga AM, Lima AC, Mano JF, Concheiro A, Alvarez-Lorenzo C. Pectin-coated 
chitosan microgels crosslinked on superhydrophobic surfaces for 5-fluorouracil 
encapsulation. Carbohydrate Polymers. 2013;98:331-40. 
[10] Zhang H, Mardyani S, Chan WCW, Kumacheva E. Design of Biocompatible 
Chitosan Microgels for Targeted pH-Mediated Intracellular Release of Cancer 
Therapeutics. Biomacromolecules. 2006;7:1568-72. 
[11] Wei L, Cai C, Lin J, Wang L, Zhang X. Degradation controllable biomaterials 
constructed from lysozyme-loaded Ca-alginate microparticle/chitosan composites. 
Polymer. 2011;52:5139-48. 
[12] Dobashi T, Tomita N, Maki Y, Chang CP, Yamamoto T. An analysis of anisotropic 
gel forming process of chitosan. Carbohydrate Polymers.In Press, Corrected Proof. 
[13] Berger J, Reist M, Mayer JM, Felt O, Peppas NA, Gurny R. Structure and 
interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical 
applications. European Journal of Pharmaceutics and Biopharmaceutics. 2004;57:19-34. 
[14] Wang L, Stegemann JP. Thermogelling chitosan and collagen composite hydrogels 
initiated with [beta]-glycerophosphate for bone tissue engineering. 
Biomaterials.31:3976-85. 
[15] Farshi Azhar F, Olad A, Salehi R. Fabrication and characterization of chitosan–
gelatin/nanohydroxyapatite–polyaniline composite with potential application in tissue 
engineering scaffolds. Designed Monomers and Polymers. 2014;17:654-67. 
[16] Miguel SP, Ribeiro MP, Brancal H, Coutinho P, Correia IJ. Thermoresponsive 
chitosan–agarose hydrogel for skin regeneration. Carbohydrate Polymers. 
2014;111:366-73. 
[17] Guenet JM. Thermoreversible Gelation of Polymers and Biopolymers. London: 
Academic Press; 1992. 
[18] Ramzi M, Rochas C, Guenet JM. Structure-properties relation for agarose 
thermoreversible gels in binary solvents. Macromolecules. 1998;31:6106-11. 
 Chitosan macrogels 
83 
 
[19] Fernández E, López D, Mijangos C, Duskova-Smrckova M, Ilavsky M, Dusek K. 
Rheological and thermal properties of agarose aqueous solutions and hydrogels. Journal 
of Polymer Science Part B: Polymer Physics. 2008;46:322-8. 
[20] Kong H, Dumitriu S. Polysaccharide-based hydrogels in tissue engineering 
Polysaccharides : Structural Diversity and Functional Versatility2004. 
[21] Lin P-W, Wu C-C, Chen C-H, Ho H-O, Chen Y-C, Sheu M-T. Characterization of 
cortical neuron outgrowth in two- and three-dimensional culture systems. Journal of 
Biomedical Materials Research Part B: Applied Biomaterials. 2005;75B:146-57. 
[22] Zhang LM, Wu CX, Huang JY, Peng XH, Chen P, Tang SQ. Synthesis and 
characterization of a degradable composite agarose/HA hydrogel. Carbohydrate 
Polymers. 2012;88:1445-52. 
[23] Luo Y, Shoichet MS. A photolabile hydrogel for guided three-dimensional cell 
growth and migration. Nature Materials. 2004;3:249-53. 
[24] Tripathi A, Kathuria N, Kumar A. Elastic and macroporous agarose–gelatin 
cryogels with isotropic and anisotropic porosity for tissue engineering. Journal of 
Biomedical Materials Research Part A. 2009;90A:680-94. 
[25] Imani R, Emami SH, Moshtagh PR, Baheiraei N, Sharifi AM. Preparation and 
characterization of agarose-gelatin blend hydrogels as a cell encapsulation matrix: An 
in-vitro study. Journal of Macromolecular Science, Part B: Physics. 2012;51:1606-16. 
[26] Cao Z, Gilbert RJ, He W. Simple Agarose−Chitosan Gel Composite System for 
Enhanced Neuronal Growth in Three Dimensions. Biomacromolecules. 2009;10:2954-
9. 
[27] Gómez-Mascaraque LG, Méndez JA, Fernández-Gutiérrez M, Vázquez B, San 
Román J. Oxidized dextrins as alternative crosslinking agents for polysaccharides: 
Application to hydrogels of agarose–chitosan. Acta Biomaterialia. 2014;10:798-811. 
[28] Guibal E. Heterogeneous catalysis on chitosan-based materials: a review. Progress 
in Polymer Science. 2005;30:71-109. 
[29] Ng JCY, Cheung WH, McKay G. Equilibrium Studies of the Sorption of Cu(II) 
Ions onto Chitosan. Journal of Colloid and Interface Science. 2002;255:64-74. 
[30] Varma AJ, Deshpande SV, Kennedy JF. Metal complexation by chitosan and its 
derivatives: a review. Carbohydrate Polymers. 2004;55:77-93. 
[31] Nieto JM, Peniche-Covas C, Del Bosque J. Preparation and characterization of a 
chitosan-Fe(III) complex. Carbohydrate Polymers. 1992;18:221-4. 
Chapter 3 
84 
 
[32] Hernandez R, Sacristan J, Nogales A, Fernandez M, Ezquerra TA, Mijangos C. 
Structure and viscoelastic properties of hybrid ferrogels with iron oxide nanoparticles 
synthesized in situ. Soft Matter. 2010;6:3910-7. 
[33] Li Y, Huang G, Zhang X, Li B, Chen Y, Lu T, et al. Magnetic Hydrogels and Their 
Potential Biomedical Applications. Advanced Functional Materials. 2013;23:660-72. 
[34] Tomoiaga AM, Cioroiu BI, Nica V, Vasile A. Investigations on nanoconfinement 
of low-molecular antineoplastic agents into biocompatible magnetic matrices for drug 
targeting. Colloids and Surfaces B: Biointerfaces. 2013;111:52-9. 
[35] Hu Z, Li S, Yang L. Preparation of berbamine loaded chitosan-agarose 
microspheres and in vitro release study. Polímeros. 2012;22:422-6. 
[36] Chatterjee S, Chatterjee S, Chatterjee BP, Das AR, Guha AK. Adsorption of a 
model anionic dye, eosin Y, from aqueous solution by chitosan hydrobeads. Journal of 
Colloid and Interface Science. 2005;288:30-5. 
[37] Montembault A, Viton C, Domard A. Rheometric Study of the Gelation of 
Chitosan in Aqueous Solution without Cross-Linking Agent. Biomacromolecules. 
2005;6:653-62. 
[38] Cairns P, Miles MJ, Morris VJ, Ridout MJ, Brownsey GJ, Winter WT. X-ray fibre 
diffraction studies of chitosan and chitosan gels. Carbohydrate Research. 1992;235:23-
8. 
[39] Montembault A, Viton C, Domard A. Physico-chemical studies of the gelation of 
chitosan in a hydroalcoholic medium. Biomaterials. 2005;26:933-43. 
[40] Bhatia SC, Ravi N. A Magnetic Study of an Fe&#x2212;Chitosan Complex and Its 
Relevance to Other Biomolecules. Biomacromolecules. 2000;1:413-7. 
[41] Bhatia SC, Ravi N. A M&ouml;ssbauer Study of the Interaction of Chitosan and d-
Glucosamine with Iron and Its Relevance to Other Metalloenzymes. 
Biomacromolecules. 2003;4:723-7. 
[42] Cendoya I, López D, Alegría A, Mijangos C. Dynamic mechanical and dielectrical 
properties of poly(vinyl alcohol) and poly(vinyl alcohol)-based nanocomposites. Journal 
of Polymer Science Part B: Polymer Physics. 2001;39:1968-75. 
[43] Hernández R, Mijangos C. In situ Synthesis of Magnetic Iron Oxide Nanoparticles 
in Thermally Responsive Alginate-Poly(<I>N</I>-isopropylacrylamide) Semi-
Interpenetrating Polymer Networks. Macromolecular Rapid Communications. 
2009;30:176-81. 
 Chitosan macrogels 
85 
 
[44] Montes Atenas G, Mielczarski E, Mielczarski JA. Composition and structure of 
iron oxidation surface layers produced in weak acidic solutions. Journal of Colloid and 
Interface Science. 2005;289:157-70. 
[45] Horák D, Babiccaron M, Macková H, Benescaron MJ. Preparation and properties 
of magnetic nano- and microsized particles for biological and environmental 
separations. Journal of Separation Science. 2007;30:1751-72. 
[46] Pattanayak J, Rao VS, Maiti HS. The hydrolysis product of ferric nitrate in sodium 
hydroxide. Journal of Materials Science. 1990;25:2245-8. 
[47] Lawrie G, Keen I, Drew B, Chandler-Temple A, Rintoul L, Fredericks P, et al. 
Interactions between Alginate and Chitosan Biopolymers Characterized Using FTIR 
and XPS. Biomacromolecules. 2007;8:2533-41. 
[48] Chang Y-C, Chen D-H. Adsorption Kinetics and Thermodynamics of Acid Dyes 
on a Carboxymethylated Chitosan-Conjugated Magnetic Nano-Adsorbent. 
Macromolecular Bioscience. 2005;5:254-61. 
[49] Bhattarai SR, Bahadur K.C R, Aryal S, Khil MS, Kim HY. N-Acylated chitosan 
stabilized iron oxide nanoparticles as a novel nano-matrix and ceramic modification. 
Carbohydrate Polymers. 2007;69:467-77. 
[50] Hernández RB, Yola OR, Mercê ALR. Chemical equilibrium in the complexation 
of first transition series divalent cations Cu2+, Mn2+ and Zn2+ with chitosan. Journal 
of the Brazilian Chemical Society. 2007;18:1388-96. 
[51] F. G. Pearson, Marchessault RH, Liang CY. Infrared spectra of crystalline 
polysaccharides. V. Chitin. Journal of Polymer Science. 1960;43:101-16. 
[52] Webster A, Halling MD, Grant DM. Metal complexation of chitosan and its 
glutaraldehyde cross-linked derivative. Carbohydrate Research. 2007;342:1189-201. 
[53] Peniche-Covas C, Argüelles-Monal W, San Román J. A kinetic study of the 
thermal degradation of chitosan and a mercaptan derivative of chitosan. Polymer 
Degradation and Stability. 1993;39:21-8. 
[54] Goiti E, Salinas MM, Arias G, Puglia D, Kenny JM, Mijangos C. Effect of 
magnetic nanoparticles on the thermal properties of some hydrogels. Polymer 
Degradation and Stability. 2007;92:2198-205. 
[55] Sahiner N. In situ metal particle preparation in cross-linked poly(2-acrylamido-2-
methyl-1-propansulfonic acid) hydrogel networks. Colloid & Polymer Science. 
2006;285:283-92. 
Chapter 3 
86 
 
[56] Peniche H, Osorio A, Acosta N, Campa A, Peniche C. Preparation and 
characterization of superparamagnetic chitosan microspheres: Application as a support 
for the immobilization of tyrosinase. Journal of Applied Polymer Science. 2005;98:651-
7. 
[57] Wang Y, Li B, Zhou Y, Jia D. Chitosan-induced synthesis of magnetite 
nanoparticles via iron ions assembly. Polymers for Advanced Technologies. 
2008;19:1256-61. 
[58] Nishinari K. Rheological and DSC study of sol–gel transition in aqueous 
dispersions of industrially important polymers and colloids. Colloid & Polymer Science. 
1997;275:1093-107. 
[59] Fernández E, López D, López-Cabarcos E, Mijangos C. Viscoelastic and swelling 
properties of glucose oxidase loaded polyacrylamide hydrogels and the evaluation of 
their properties as glucose sensors. Polymer. 2005;46:2211-7. 
[60] Chenite A, Buschmann M, Wang D, Chaput C, Kandani N. Rheological 
characterisation of thermogelling chitosan/glycerol-phosphate solutions. Carbohydrate 
Polymers. 2001;46:39-47. 
[61] Chenite A, Gori S, Shive M, Desrosiers E, Buschmann MD. Monolithic gelation of 
chitosan solutions via enzymatic hydrolysis of urea. Carbohydrate Polymers. 
2006;64:419-24. 
[62] Gennes PG. Scaling concepts in polymer physics. New York: Cornell University 
Press; 1979. 
[63] Lopez D, Mijangos C, Munoz ME, Santamaria A. Viscoelastic Properties of 
Thermoreversible Gels from Chemically Modified PVCs&#x2020. Macromolecules. 
1996;29:7108-15. 
[64] Hernández R, Sarafian A, López D, Mijangos C. Viscoelastic properties of 
poly(vinyl alcohol) hydrogels and ferrogels obtained through freezing-thawing cycles. 
Polymer. 2004;45:5543-9. 
[65] Zamora-Mora V, Fernández-Gutiérrez M, Román JS, Goya G, Hernández R, 
Mijangos C. Magnetic core–shell chitosan nanoparticles: Rheological characterization 
and hyperthermia application. Carbohydrate Polymers. 2014;102:691-8. 
[66] Kim B, Lee E, Kim Y, Park S, Khang G, Lee D. Dual Acid-Responsive Micelle-
Forming Anticancer Polymers as New Anticancer Therapeutics. Advanced Functional 
Materials. 2013;23:5091-7. 
 Chitosan macrogels 
87 
 
[67] de Gennes PG. Scaling concepts in polymer physics. London1979. 
[68] Guenet JM, Rochas C. Agarose sols and gels revisited. Macromolecular Symposia. 
2006;242:65-70. 
[69] Jones JL, Marques CM. Rigid polymer network models. Journal de Physique. 
1990;51. 
[70] Guenet JM. Polymer-solvent molecular compounds: Elsevier; 2008. 
[71] te Nijenhuis K. Agarose.  Thermoreversible Networks: Springer Berlin Heidelberg; 
1997. p. 194-202. 
[72] Fernández E, Hernández R, Teresa Cuberes M, Mijangos C, López D. New 
hydrogels from interpenetrated physical gels of agarose and chemical gels of 
polyacrylamide: Effect of relative concentration and crosslinking degree on the 
viscoelastic and thermal properties. Journal of Polymer Science Part B: Polymer 
Physics. 2010;48:2403-12. 
[73] Rochas C, Brulet A, Guenet J-M. Thermally reversible Gelation of Agarose in 
Water/Dimethyl Sulfoxide Mixtures. Macromolecules. 1994;27:3830-5. 
[74] Ramzi M, Rochas C, Guenet J-M. Structure−Properties Relation for Agarose 
Thermoreversible Gels in Binary Solvents. Macromolecules. 1998;31:6106-11. 
[75] Ulrich TA, Jain A, Tanner K, MacKay JL, Kumar S. Probing cellular 
mechanobiology in three-dimensional culture with collagen–agarose matrices. 
Biomaterials. 2010;31:1875-84. 
[76] Lake SP, Hald ES, Barocas VH. Collagen-agarose co-gels as a model for collagen–
matrix interaction in soft tissues subjected to indentation. Journal of Biomedical 
Materials Research Part A. 2011;99A:507-15. 
[77] Amici E, Clark AH, Normand V, Johnson NB. Interpenetrating Network Formation 
in Agarose−κ-Carrageenan Gel Composites. Biomacromolecules. 2002;3:466-74. 
[78] Meena R, Lehnen R, Schmitt U, Saake B. Physicochemical and rheological 
properties of agarose/xylans composite hydrogel materials. Polymer Composites. 
2013;34:978-88. 
[79] Lima Jr E, Torres TE, Rossi LM, Rechenberg HR, Berquo TS, Ibarra A, et al. Size 
dependence of the magnetic relaxation and specific power absorption in iron oxide 
nanoparticles. Journal of Nanoparticle Research. 2013;15:1-11. 
[80] Ganguly K, Aminabhavi TM, Kulkarni AR. Colon Targeting of 5-Fluorouracil 
Using Polyethylene Glycol Cross-linked Chitosan Microspheres Enteric Coated with 
Chapter 3 
88 
 
Cellulose Acetate Phthalate. Industrial & Engineering Chemistry Research. 
2011;50:11797-807. 
[81] Zhu L, Ma J, Jia N, Zhao Y, Shen H. Chitosan-coated magnetic nanoparticles as 
carriers of 5-Fluorouracil: Preparation, characterization and cytotoxicity studies. 
Colloids and Surfaces B: Biointerfaces. 2009;68:1-6. 
[82] Ojugo ASE, McSheehy PMJ, Stubbs M, Alder G, Bashford CL, Maxwell RJ, et al. 
Influence of pH on the uptake of 5-fluorouracil into isolated tumour cells. British 
Journal of Cancer. 1998;77:873-9. 
[83] Rao KSVK, Chung I, Reddy KM, Ha C-S. PMMA-based microgels for controlled 
release of an anticancer drug. Journal of Applied Polymer Science. 2009;111:845-53. 
 
  
 
 
Chapter 4 
CHITOSAN MICROGELS THROUGH 
MICROFLUIDICS 
 
 
Chapter 4 
90 
 
  Chitosan microgels through microfluidics 
91 
 
This chapter describes the preparation and characterization of chitosan microgels 
through microfluidics. It includes the design and fabrication of two types of 
microfluidics droplets generator, T-junction and flow-focusing. It also describes the 
microfluidics emulsification and generation of three kinds of droplets: chitosan, 
composite chitosan/agarose and ferrofluid loaded chitosan/agarose, by means of 
different crosslinking processes. 
 
4.1 INTRODUCTION 
 
It is currently well-established that continuous microfluidic (MF) synthesis and 
assembly of polymer particles offers a facile approach to the generation of microgels 
with dimensions in the range of tens to hundreds of micrometres[1]. The distinct 
features of these particles include their very narrow polydispersity and controllable size, 
compositions and morphologies.[1-7] Microfluidic preparation of microgels have been 
explored for a broad spectrum of biopolymers, including  alginate[8], gelatin[9], 
chitosan [10-13], agarose,[14-18] and κ-carrageenan and carboxymethylcellulose[19]. 
Nowadays, research in this field is developing toward well-defined applications of 
microgel particles prepared by the MF means, which is sometimes challenging when a 
microgel is formed from a single polymer. Microparticles preparation from single based 
precursor, usually presents several drawbacks, as for example: systems require 
potentially cytotoxic crosslinkers or photo-initiators and generally have poor 
mechanical properties[13]. Taking into account these drawbacks, this kind of 
microparticles could be discarded for biomedical applications.  
Combining several polymers in microgel particles enables the realization of 
synergetic properties among the two or more polymers[20]. Concerning composite 
chitosan, although, they could be interesting for many applications, until the present few 
works has been carried out in the literature. For instance, monodispersed microgels from 
a triple interpenetrating network (3XN) based on partially oxidized dextran (Odex), 
Teleostean, and N-carboxyethyl chitosan (CEC) had been prepared by MF[13]. 
Moreover, blending of chitosan with agarose, a neutral polysaccharide that forms 
hydrogel at low temperatures, allows chitosan to retain its response to pH and, at the 
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same time, it allows to get termoreversible materials as a consequence of the response to 
temperature of the agarose gels[21]. For thus, chitosan and agarose has attracted keen 
interest for its dual (pH and temperature) response properties attributed to each of the 
constituent polymers. Although, in the literature have been reported different methods 
of preparation as a suspension crosslinking method[22] and water-in-oil emulsion 
technique[23], but this system has never been prepared by microfluidics.    
The general objective of this work is to investigate the viability of microfluidics 
technique to prepare monodispersed chitosan microgels and composite chitosan/agarose 
microgels. It includes the selection, design and preparation of microfluidics devices and 
the generation of different types of chitosan microgels. In order to achieve the 
objectives, different factor were evaluated: crosslinking reactions of chitosan (off and 
on chip), different geometries and some parameters such as concentrations and flow 
rates. 
Three kinds of chitosan microgels by MF emulsification have been explorer: 
rough chitosan microgels, composite chitosan/agarose microgels and ferrofluid 
chitosan/agarose microgels. Then, it is studying the subsequent gelation of the precursor 
droplets, in order to obtain particles of controlled size and with narrow polydispersity. 
Three composite chitosan/agarose microgels were prepared varying the agarose 
concentrations, which were selected based on the good properties of composite 
macrogels observed in the chapter 3.   
 
4.2 EXPERIMENTAL PART 
 
4.2.1 Materials 
 
Chitosan, ultra-low gelling temperature agarose and ferrofluid employed in this 
work were the same described in chapter 3. Non-ionic surfactant Span-80, acetic acid, 
sodium tripolyphosphate, phosphate buffered saline (PBS), pH 7.4, hexane and mineral 
oil (viscosity 30 cPs) were supplied by Aldrich-Sigma (Canada) and used as received.  
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Photoresist resin (SU-8 50, 3050) was purchased from Microchem Co. (MA, 
USA). Sylgard 184 Silicon Elastomer kit was received from Dow Corning Corp. 
(Midland, MI) and was mixed with the curing agent containing a crosslinker (dimethyl-
methylhydrogen siloxane, Aldrich) and an inhibitor (tetramethyltetravinyl 
cyclotetrasiloxane, Aldrich) at 10:1 (w/w) ratio. The poly(dimethylsiloxane) (PDMS) 
elastomer was prepared from Sylgard® 184 (Dow Corning Cop., USA). The deionized 
water was obtained from the Millipore Milli-Q water purification system.  
 
4.2.2 Fabrication of microfluidics devices. 
 
Microfluidic devices were fabricated trough soft lithography. For soft 
lithography, moulds are fabricated through photolithography which is a well-established 
and widely used process for patterning structures out of a photoresist on a substrate 
(typically a silicon wafer). All the devices were prepared in Department of Chemistry, 
University of Toronto, Canada, in collaboration with Kumacheva's Group. To achieve 
the different devices, the following methodology and steps were performed.  
 
i. Mask design  
Masks (or photomasks) of microfluidic channels of microdevice were previously 
designed using AutoCad 2007® (Autodesk Inc., USA) software. Different designs were 
printed on high-resolution transparencies (Pacific Arts and Designs Inc., Markham, 
Canada) using ultra-high resolution printers with a resolution of 20,000 dpi. In this work 
different types of mask have been designed and will be reports in the next section 4.2.3.  
 
ii. Microfabrication of Negative Masters: Silicon Masters 
Silicon (Si) negative masters, who serve as a mold for PDMS to be performed in 
the next step[24], were prepared in a level 6 cleanroom facility (Bahen Center) at the 
University of Toronto. Si subtract masters consist of a positive bas-relief of photoresist 
on a silicon wafer. 
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Fabrication of the negative masters with microchannel features was carried out 
with SU-8 photoresist (SU-8 50) deposited on 10 cm diameter silicon (Si) wafer[25]. 
Previously, the Si wafers were washed several times with acetone and methanol. The 
surface of the substrate was dried by blowing dry N2 gas. Then, spin coating with SU-8 
photoresist at a typical spin rate of 2000 rpm on the Si wafer, enabled the formation of 
50 μm height features. After the spin-coating process, the photoresist layer was 
thermally baked to evaporate the solvent, γ-butyrolactone. Silicon wafers required only 
a single spin-coated layer of the photoresist prior to the generation of the microchannel 
patterns.  
In the next step, the photomask was placed overtop the photoresist layer/ Si 
wafers, and the system was exposed to UV-light (Karl Suss MA6 mask aligner, 
λ=365~405 nm) (Figure 4.1) to cure the photoresist and create the patterned 
microchannels (Figure 4.2, step I). A typical exposure time was approximately 30 sec.  
 
 
Figure 4.1. Equipment for UV exposure (into the clean room).  
 
Following UV exposure, a post-bake process was conducted to enhance the 
crosslinking of the UV-exposed areas of the photoresist. The post-baked wafers with the 
crosslinked patterns of the microchannels were immersed during 10 min in a developer 
solution (1-methoxy-2-propanol acetate) to remove the non-crosslinked regions of the 
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photoresist. The substrates with the microchannel patterns were rinsed several times 
with isopropanol and methanol and dried under a gentle stream of nitrogen (Figure 4.2, 
step II). 
 
iii. Fabrication of Microfluidic Devices: PDMS Microfluidic Devices  
Microfluidic (MF) devices were fabricated in poly(dimethylsiloxane) (PDMS) 
elastomer using a standard soft-lithographic procedure[24]. The PDMS elastomer was 
prepared from Sylgard® 184, which contains vinyl-terminated dimethylsiloxane 
oligomers, a platinum catalyst, and a silica filler (dimethylvinylated and trimethylated 
silica)[26].  
The base polymer was mixed with the curing agent containing a crosslinker 
(dimethyl-methylhydrogen siloxane) and an inhibitor (tetramethyltetravinyl 
cyclotetrasiloxane) at 10:1 (w/w) ratio. Air was removed from the mixture under 
vacuum (Isotemp* Model 282A Vacuum Oven, Fisher Scientific*) during 20 min.   
The mixture was poured onto the silicon negative master and baked at 75 °C in 
an oven (Mechanical Convection Oven DKN 400, Yamatp Scientific America Inc.) for 
at least 4 h.  (Figure 4.2, step III). After curing, the PDMS replica was obtaining by 
peeling from the master, (Figure 4.2, step IV) and holes were created with a blunt-
tipped needle at the designated positions, which correspond to the inlets connections of 
the dispersed and oil phases and outlet tubing of the MF device. Next, in order to close 
the circuit (Figure 4.2, step V) the PDMS replica and a plane PDMS sheet were 
oxidized in a plasma cleaner chamber (PDC-3XG, Harrick, USA) for 90 sec. and after 
the plasma-treatment the replica and the plane PDMS sheet were brought in contact and 
sealed immediately. Both, plasma-treatment and sealing process will be explained in 
detail ahead. 
 Finally, polytetrafluoroethylene tube of 0.05 cm outer diameter, Small Parts, 
USA) was forced tightly into the holes and then the system is ready to carry out the 
experiment by microfluidic device.  
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iv. Plasma Cleaner Operation  
The plasma cleaner operation goes as follows: once PDMS is peeled off from the 
master, it is cleaned with a tape to ensure that there is no dust on the surfaces. Then, 
PDMS samples are placed into the chamber of plasma cleaner (using a quartz tray) with 
the bonding surfaces facing up. Once the plasma cleaner door is closed, the Plasma-
Flow has to be turn on in order to reach the desired vacuum pressure inside the chamber 
~80Pa. Once the desire pressure is reached the plasma cleaner is turned on and the 
PDMS samples are let inside the chamber during 90 sec. Finally PDMS samples are 
sealed carefully avoiding bubbles between the surfaces sealed. 
 
step I
step II
step III
step IV
step V
replica
plane PDMS sheet  
Figure 4.2. Schematic representation of the steps involved in the preparation of the microfluidic device. 
 
v. Sealing 
One advantage of PDMS is that it can seal to itself, or to other surfaces, 
reversibly or irreversibly and without distortion of the channels [27, 28]. Sealing of 
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PDMS channels is substantially simpler than sealing channels in glass, silicon, or 
thermoplastics[28-30]. PDMS that has been molded against a smooth surface can 
conformally contact other smooth surfaces, even if they are nonplanar, because PDMS 
is elastomeric. A reversible seal provided by simple van der Waals contact is watertight 
but cannot withstand pressures greater than ~0.35 Pa[27]. Adhesive tapes-silicone or 
cellophane also seal the PDMS channels reversibly[31].  
In order to form an irreversible seal both PDMS surfaces were exposed to air 
plasma for 90 sec. Oxygen plasma surface treatment is one of several techniques that 
exist for bonding cured PDMS pieces. This treatment generates silanol groups (Si-OH) 
on the surface of the PDMS by the oxidation of methyl groups [32]. Surface-oxidized 
PDMS can seal to itself, glass, silicon, polystyrene, polyethylene, or silicon nitride, 
provided that these surfaces have also been exposed to air plasma. This sealing process, 
while simple and reproducible, requires technical agility. After surface activation, the 
two surfaces must be brought into contact quickly (<1 min) after oxidation, because the 
surface of the oxidized PDMS reconstructs in air [33, 34]. Contact with water or polar 
organic solvents maintains the hydrophilic nature of the surface indefinitely[35].  
 
4.2.3. Device design 
 
 Devices with different geometries were designed with the aim to achieve stable 
and controlled conditions for the generation of chitosan droplets with narrow size 
distribution. These requirements can be precisely achieved by passive ways through 
tuning the geometry of microfluidic devices. In this work, two types of microfluidics 
generator of droplets, T-junction and flow-focusing were selected. In flow focusing 
geometry different number of inlets was employed. Therefore, T-junction and flow-
focusing droplet generators were classified as a function of the number of inlets. In this 
section, we will describe the main features of each droplet generator. 
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i. T-junction droplet generator (two inlets).  
Figure 4.3 shows a T-junction geometry device employed for droplet generation. 
Briefly, T-junction geometry consists of a horizontal channel and a perpendicular 
channel resembling the two branches of a “T”, where the continuous and dispersed 
phases are introduced, respectively. This device was designated as device 1. 
 
 
Figure 4.3. T-junction geometry employed for droplets generation (device 1). 
 
 This geometry (Figure 4.3) was only employed for emulsification of chitosan 
solutions. The device was fabricated with the follows dimension: 80 µm for main 
channel (1) and 37 µm perpendicular channel (2).  
 
ii. Flow-focusing droplet generator.  
Three different flow focusing droplets generator were employed, depending on the 
number of inlets. Next, we describe all the geometries: 
 
- Droplet generator by flow-focusing (two inlets).   
The flow-focusing geometry employed for droplets generation with two inlets, 
one for the dispersed phase and the other for the continuous phase, is shown in Figure 
4.4. Briefly, the continuous phase was supplied by the inlet and then splitted in two 
branches (sides) of the device; the liquid stream corresponding to the dispersed phase 
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was supplied from a central channel. The continuous phase surrounds the inner, 
immiscible liquid so that the inner thread becomes unstable and breaks in the orifice in a 
periodic manner to release droplets into the outlet channel. 
 
 
Figure 4.4. Flow-focusing droplet generator with two inlets (device 2). 
 
The height of the channel was 50 µm. The width of the horizontal channel 
supplying the continuous phase and dispersed phase were 70 µm. The length of the 
mixing channel was 1.02 cm. The device was named as device 2. 
 
- Droplet generator by flow-focusing (three inlets).   
In this case, the principle of droplet generation is similar to                                                         
that of device 2, but with some changes: First, it was included another inlet, which was 
used for the incorporation of a second dispersed phase, as will explain ahead. The 
device was named as device 3. Moreover, at the point where the formation of the 
droplets takes place ( ), three design were used.  
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Figure 4.5. Flow-focusing droplet generator with three inlets (device 3). 
 
- Droplet generator by flow-focusing (four inlets).   
Device 4 (Figure 4.6) included a fourth inlet (middle inlet) for another dispersed 
phase. Moreover, this device includes two serpentines, the first one was used to improve 
the interaction between all dispersed phases, and the second one was used to improve 
the crosslinking process of the microgels obtaining trough microfluidics. 
 
 
Figure 4.6. Flow-focusing droplet generator with four inlets (device 4). 
 
4.2.4. Generation of chitosan and composite chitosan droplets by 
microfluidic emulsification. 
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In general, microfluidic approaches for making droplets involve the injection of 
one liquid phase (the dispersed phase) into another immiscible liquid phase (the 
continuous phase) through a specially designed microfluidic device[36]. Droplets are 
sheared off at the junction where the two phases meet. In this work the most common 
geometries were employed T-junction and flow focusing as droplet generators.  
In this section, we assessed the possibility of emulsification of different 
solutions (chitosan, agarose and chitosan+Fe) by microfluidics, as well the formation of 
chitosan microgels by studying different crosslinking processes. The respective 
conditions and concentration it will be detailed in each experiment.  
 
4.2.4.1 Generation of chitosan droplets. 
 
The generation of chitosan droplets was studied by two different droplets generators, 
as it is detailed below: 
 
i. Chitosan droplets by T-junction droplet generator.  
 Chitosan 0.5% (w/v) solution was used as dispersed phase for this experiment 
(see Table 4.1). For that, chitosan powder for a final concentration of 0.5% (w/v) was 
dissolved in acetic acid 1% (v/v) and used as dispersed phase. Mineral oil containing 
3% (w/v) of the non-ionic surfactant Span 80 was used as continuous phase and was 
injected in the second inlet. Device 1 was employed for this experiment (Figure 4.3). 
The dispersed phase and mineral oil were supplied to the T-junction droplet generator, 
using two independent syringe pumps (Harvard Apparatus 33 Dual Syringe Pump, 
USA). The experiment was carried at room temperature. Volumetric flow rate, Qo, of 
the oil phase was 2.0, 2.1, 2.3 and 2.5 mL/h, while the flow rate of the dispersed phase, 
Qd, was fixed at 0.1 mL/h. 
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ii. Chitosan droplets by flow-focusing droplet generator.   
Chitosan droplets were also generated employing three different flow-focusing 
droplets generators, corresponding to devices 2-4.  
 
- Droplet generation by flow-focusing. Crosslinking reaction off-chip (two inlets).   
 Crosslinked reaction is a key issue for chitosan microgels formation trough 
microfluidics, for this reason this first experiments is based on chitosan emulsification 
and then the crooslinked reaction off-chip. A device with two inlets (device 2) was 
employed for this experiment (Figure 4.4). In this case, an aqueous chitosan solution 
0.5% (w/v) was employed as dispersed phase and continuous phase was mineral oil + 
Span 80 (3% w/v). Both phases were supplied to the flow focusing droplet generator, 
using two independent syringe pumps. After, chitosan emulsification, the droplets were 
collected in a reservoir containing 5 mL of a mixture of sodium tripolyphosphate (TPP) 
solution with a concentration at 5% (w/v) and hexane in a volume ratio of 1/1. 
Volumetric flow rate, Qo, of the oil phase was 1.2 and 1.6 mL/h, while the flow rate of 
the dispersed phase, Qd, was 0.5 and 0.2 mL/h respectively. The experiment was carried 
out at room temperature. The emulsion collected in the reservoir was centrifuged at 
14000 rpm for 10 min (Eppendorf Microcentrifuge, Model 5430R) in order to recover 
the resulting chitosan microgels.  
 
- Droplet generation by flow-focusing. Crosslinking reaction on-chip (three 
inlets). 
 In this case, it is studied the viability of a crosslinking reaction on-chip. For that 
TPP solution with a concentration of 0.5% (w/v) was employed as the second dispersed 
phase (see Figure 4.5), and the other dispersed phase was the aqueous chitosan solution 
0.5% (w/v), see Table 4.1. Mineral oil + Span 80 (3% w/v) was employed as continuous 
phase. Moreover, at the junction point where the formation of the droplets takes place, 
three different designs were employed that will be discussed in the Results and 
Discussion part. The experiment was carried at room temperature. Their dimensions 
were the same to those reported for the geometry shown in previous example of 
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crosslinking off-chip (Figure 4.4), the width of channels were 70 µm. Volumetric flow 
rates, Qo, of the oil phase was 0.4 mL/h, while the flow rates corresponding to the 
chitosan solution and the TPP solution were set to 0.5 mL/h and 0.25 mL/h, 
respectively.  
 
- Droplet generation by flow-focusing. Crosslinking reaction on- chip (four 
inlets).  
 This experiment is based on the previous experiment with some modifications. 
First, a third dispersed phase was included consisting of acetic acid 1% (v/v) in order to 
reduce the interaction among polymer-crosslinking agent. Moreover, chitosan and TPP 
solutions concentrations were changed. Chitosan solution was prepared with a final 
concentration of 0.25% (w/v) in acidic acid 1% (v/v) and TPP solution to a final 
concentration of 0.05% (w/v), see Table 4.1. Mineral oil + Span 80 (3% w/v) was 
employed as continuous phase. Volumetric flow rates, Qo, of the oil phase was 0.4, 0.55 
and 0.7 mL/hr, while the flow rate of chitosan solution, was 0.3 mL/h, for TPP solution 
was 0.4 mL/h and for acidic acid was 0.5 mL/h. The experiment was carried at room 
temperature. 
 
Table 4.1. Precursor solutions employed in microfluidic emulsification and generation 
of chitosan droplets experiments. 
Geometry Device 
employed 
Dispersed phase Type of 
Crosslinking 
 
T-junction 
1 chitosan 0.5% (w/v) * 
 
 
 
Flow-Focusing 
2 chitosan 0.5% (w/v) Off-chip 
3 chitosan 0.5% (w/v) and 
TPP 0.5%(w/v) 
On-chip 
4 chitosan 0.25% (w/v),   
TPP 0.05% (w/v) and  
acetic acid 1% (v/v) 
On-chip 
* Only emulsification through microfluidics was prepared. 
**For all samples, the continuous phase was Mineral oil+Span80. 
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4.2.4.2 Generation of composite chitosan/agarose microgels trough flow-focusing 
regime.  
 
Composite chitosan/agarose microgels were prepared by varying agarose 
concentration, which was controlled by changing agarose content in the precursor 
chitosan/agarose solution. Different amounts of agarose were dissolved at 60 °C in 
0.5% (w/v) aqueous chitosan solutions containing 1% (v/v) of acetic acid. This 
concentration was selected because viscosity of solution was appropriate for 
microfluidics experiments. The concentration of agarose in the mixed solution was 1.0, 
1.5 and 2.0% (w/v). The samples were designated as chitosan/agarose-1, 
chitosan/agarose-1.5 and chitosan/agarose-2 (Table 4.2). The chitosan-free sample was 
used as a control and was labeled as agarose-1.5. These concentrations are the same 
used for composite macrogels.  
Aqueous chitosan/agarose solution and mineral oil containing 3 w/v % of the 
non-ionic surfactant Span 80 heated to 37 ºC were supplied to the flow-focusing MF 
droplet generator (Figure 4.4) using two independent syringe pumps. Following MF 
emulsification, the droplets travelled through the downstream channel and exited the 
device through the outlet tubing. Volumetric flow rate, Qo, of the oil phase was varied 
from 0.05 to 0.3 mL/h, while the flow rate of the chitosan/agarose solution, Qd, was 
fixed at 0.05 mL/h. 
  The outlet tubing was enclosed within a hose connected to a water circulator 
cooled to 4 ºC by a 1:4 vol/vol mixture glycerol and water. The droplets moved through 
the cooled tubing, where they gelled and were collected in a 15 mL vial containing PBS 
solution (pH 7.4). The vial was placed on an ice bath for 45 min to ensure complete 
gelation of the composite microgels. The resulting suspension was centrifuged at 14000 
rpm for 30 min (Eppendorf Microcentrifuge, Model 5430R), then washed with a PBS 
buffer, and transferred into a PBS buffer (pH 7.4). 
 
 
  Chitosan microgels through microfluidics 
105 
 
4.2.4.3 Microfluidic emulsification and generation of the ferrofluid loaded 
chitosan/agarose microgels (device 2). 
 
For this experiment, composite chitosan/agarose with an agarose concentration 
of 1.5% (w/v) (Chitosan/agarose-1.5) was selected, and the same procedure explained 
before was used. Then, two different ferrofluid concentrations (2% and 5 % (w/v) were 
dispersed in Milli-Q water. Each of this ferrofluid solution was mixed under vortex 
agitation with chitosan/agarose-1.5 in a volume ratio of 6:1, until to get a homogeneous 
sample. Also, ferrofluid 5% (w/v) loaded agarose-1.5 was prepared following the same 
procedure. The samples were designated as chitosan/agarose-1.5+Fe2%, 
chitosan/agarose-1.5+Fe5% and agarose-1.5+Fe5% (Table 4.2). Each dispersed solution 
and mineral oil containing 3% (w/v) of the non-ionic surfactant Span 80 was heated to 
37 ºC and supplied to the flow-focusing MF droplet generator (Device 2), using two 
independent syringe pumps. Volumetric flow rate, Qo, of the oil phase was varied from 
0.05 to 0.4 mL/h, while the flow rate of the chitosan/agarose solution, Qd, was 0.05 
mL/h. 
 Table 4.2. Concentrations of agarose and chitosan in precursor solutions. 
Sample Agarose (% w/v) Chitosan (% w/v) Fe (%w/v) 
Agarose-1.5  1.5 0 0 
Chitosan/agarose-1  1 0.5 0 
Chitosan/agarose-1.5  1.5 0.5 0 
Chitosan/agarose-2  2 0.5 0 
Agarose-1.5+Fe5%  1.5 0 5 
Chitosan/agarose-
1.5+Fe2% 
1.5 0.5 2 
Chitosan/agarose-
1.5+Fe5% 
1.5 0.5 5 
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4.2.5 Characterization of chitosan droplets and chitosan/agarose microgels. 
The diameters of the precursor droplets and the corresponding microgels were 
determined by analyzing optical microscopy images of 20 droplets or microgels using 
Image Pro 5.0 (media Cybernetics, USA) software. For composite chitosan microgels, 
precursor droplets and the corresponding microgels were determined by analyzing 
optical microscopy images of 100 droplets or microgels. The polydispersity is expressed 
as the coefficient of variance (CV) and it is defined as CV (%) = (σ/D) x 100, where σ is 
the standard deviation of droplet diameter (µm) and D is the mean diameter of the 
droplets (µm). 
 
 
4.3 RESULTS AND DISCUSSION 
 
 In this work, microfluidics has been used as technique that allows studying the 
transformation of chitosan precursor droplets into microgels. This fact was achieved 
mainly by two physicals mechanisms. On the one hand, electrostatic interactions among 
chitosan and TPP allow the preparation of chitosan microgels. On the other hand, 
composite chitosan/agarose microgels were obtained by thermally induced gelation. It is 
important to highlight the versatility of MF technique because offers the possibility of 
changing easily the configuration geometry. In this work four different designs were 
prepared and comparatively analyzed by employing T-junction and flow focusing 
geometries, in order to prepare chitosan and composite chitosan microparticles.  
 
4.3.1 Generation of chitosan droplets by microfluidic emulsification. 
 
In this section different chitosan droplets were obtained. For that, different 
droplets generators, T-junction and flow-focusing were employed. 
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i. Generation of chitosan droplets with T-junction geometry (device 1).   
First, in this work was assessed the emulsification of chitosan, which the 
mechanism of droplet formation results from the competition between the shear stress 
imposed by the flow of the continuous phase and the interfacial force[37]. The 
emulsification of chitosan was obtained using T-junction geometry (device 1). Figure 
4.7 shows the formation of chitosan droplets in T-junction point (Figure 4.7-a) and the 
variation in its size, plotted as a function of the flow rate of the continuous oil phase Q0 
and constant Qd= 0.1 mL/h, obtained by MF (Figure 4.7-b). 
 
Figure 4.7. a) Optical microscopy images of the T-junction generator of chitosan 0.5%. b) Variation in 
the mean diameter, D, of droplets formed by T-junction MF emulsification of chitosan0.5% (■). 
 
As can be observed in the Figure 4.7-a, chitosan droplets presented almost 
spherical shape. However, a jetting transition was observed, when the flow is very slow 
and therefore it is difficult overcome the surface tension. This kind of effect is always 
unstable for droplets formation. Figure 4.7-b shows, the variation of the mean diameter 
D, as a functions of flow rate of the continuous phase. However, the droplet size 
changed in a random way with the increase of the flow rate of the continuous phase 
(Qo). Therefore, the control over the droplets size was very difficult to keep and the 
polydispersity increased.    
After checking up the emulsification of chitosan employing a T-junction droplet 
generator, unstable conditions and high polydispersity were obtained. Moreover, cross-
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linked reaction arises as key question to obtain chitosan microgels. For that, we propose 
some alternatives to achieve chitosan microgels.  
 
ii. Generation of chitosan droplets with flow-focusing geometry. Crosslinking 
reaction off-chip (device 2).  
Figure 4.8 shows the optical images corresponding to the formation of chitosan 
droplets inside a flow-focusing device with two-inlets.  In this case, a chitosan solution 
0.5% (w/v) was employed as dispersed phase. As can be observed in Figure 4.8, 
chitosan emulsification was achieved and the average diameter calculated for chitosan 
droplets was 16 μm with a CV of 4.6%, which indicates that chitosan droplets are nearly 
monodisperse. 
As it is well known, two different regimes can occur during the emulsification 
process, the dripping and the jetting regime [38]. A jetting regime can be observed in 
the formation of chitosan droplets in Figure 4.8. This regime is obtained when a 
continuous thread of the dispersed phase extends into the outlet channel and breaks far 
downstream of the orifice [38]. This kind of regime is no desirable, because it is 
unstable and the droplets obtained are usually considerable smaller than the width of the 
orifice.  In fact, droplets obtained under jetting regime are accompanied of satellite 
droplets, which increase their CV, even if in our system we did not observe the 
formation of satellite droplets.  
 
Figure 4.8. Formation of chitosan droplets with flow- focusing device with two-inlets. 
 
 The droplets moved through the downstream channel and they were collected 
off-chip in a reservoir containing a mixture of TPP solution+hexane, in order to achieve 
the crosslinking of chitosan droplets. This process takes place when the droplets 
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gradually solidify from the surface to the inside[12]. However, it was observed chitosan 
droplets immersed into a hexane/TPP solution in the reservoir, therefore, it is difficult to 
ensure an appropriate contact with the TPP. On the other hand, the resulting microgels 
could not be separated by centrifugation due to their small size (16 µm) and a 
homogeneous crosslinking process for chitosan droplets was difficult to achieve. 
Although previous investigations reported the achieving of chitosan microparticles and 
chitosan droplets off-chip [12], however, the sizes obtained were ~300 µm. In order to 
improve the crosslinking process maintaining the size of the particles <100 µm, we 
decided to change the protocol of fabrication of chitosan microgels to ensure the 
interaction among the chitosan droplets and the crosslinking agent (TPP) by a three 
inlets flow-focusing device, described below. 
  
iii. Generation of chitosan droplets with flow-focusing geometry. Crosslinking 
reaction on-chip with TPP (device 3). 
In order to prepare chitosan microgels and to ensure their crosslinking reaction, 
TPP solution was included as a second dispersed phase, enabling chitosan-TPP 
interaction inside the microfluidic device. For this experiment, it was employed a device 
with three inlets (device 3), shown in Figure 4.5. Figure 4.9 shows the main results 
obtained for this experiment. As a first step, a serpentine prior to the junction was added 
to the geometry device in order to increase the time of chitosan-TPP interaction and thus 
facilitate the crosslinking of chitosan prior to droplet formation. The results shown in 
Figure 4.9-a allow to observe fiber formation at the junction point where chitosan 
droplets are formed. The following conditions were employed: chitosan and TPP 
concentration of 0.5% (w/v) and flow rate of the oil phase of Qo 0.4 mL/hr, while the 
flow rates corresponding to the chitosan solution and the TPP solution were set to 0.5 
mL/h and 0.25 mL/h, respectively. In fact, only a few seconds are necessary to achieve 
the crosslinking reaction of chitosan with TPP, therefore it is very hard to overcome the 
surface tension of the final fiber.    
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Figure 4.9. Images corresponding at two designs of the three-inlets flow focusing microfluidic device. 
The inset in Figure 4-b shows the fiber formation. 
 
In order to reduce time of chitosan-TPP interaction, a second geometry device 
was designed in which the serpentine prior to the flow focusing junction was eliminated 
and the results are shown in Figure 4.9-b. In this case, unstable droplets were obtained 
which also gave rise to fiber formation (see the inset image in Figure 4b). 
According to the results shown in Figure 4.9, a three-inlets flow focusing MF 
device does not allow the generation of chitosan droplets and, instead, fiber formation is 
observed. 
 
iv. Generation of chitosan droplets with flow-focusing geometry. Crosslinking 
reaction on-chip with TPP (device 4).  
In order to avoid the formations of the fiber obtained in the section 4.3.1-iii, a 
four-inlet device was designed, with the objective to reduce the interaction among 
chitosan and TPP. The fourth inlet consists in an aqueous solution of acetic acid. In this 
way, as chitosan is dissolved in acetic acid, the chitosan-TPP interaction should 
diminish. Figure 4.10 shows that the incorporation of the fourth inlet (central channel) 
for acidic acid 1% (v/v) the keeping concentrations of chitosan 0.25% (w/v) and TPP 
0.05% (w/v), the fiber formation was avoided. In order to improve the mixing of 
chitosan and TPP, a first serpentine was included immediately after the emulsification 
of chitosan. With the objective to increase the residence time and therefore the 
interaction between chitosan and TPP and in the last term to promote hardening of the 
resulting chitosan microgels, a second serpentine was included in the outlet channel.  
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Figure 4.10. Optical image for crosslinking reaction on-chip in a four-inlet flow focusing microfluidic 
device (device 4). 
  
Figure 4.11 shows optical images corresponding to chitosan droplets formed 
across different parts of the four-inlet device. Three different flow rates of the oil phase 
were employed: 0.4, 0.55 and 0.7 mL/h. The flow rates of the three dispersed phases, 
chitosan, TPP and acidic acid were fixed at 0.3 mL/h, 0.4 mL/h and 0.5 mL/h, 
respectively. This geometry allows mixing chitosan with TPP, mainly in the first 
serpentine (left column, Figure 4.11). The successful formation of chitosan microgels 
under these conditions demonstrates that the stability of the system is improved with 
respect to the experiment performed within the three-inlet device (Figure 4.9) and that 
the concentrations employed were appropriate. Besides, the fiber formation was avoided 
for all the flow rates of the oil phase under study. The second serpentine was added to 
the design in order to increase the residence time of the chitosan microgels within the 
microfluidic device and hence to promote hardening of the resulting chitosan microgels 
(center column, Figure 4.11). Finally, chitosan microgels exited the device through the 
outlet tubing as shown in the images on the right column.  
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Figure 4.11. Optical images of chitosan droplets obtained at different flow rates of the oil phase in a 
four-inlets flow focusing microfluidic device.  Images on the left column correspond to chitosan microgels 
moving downstream into the first serpentine, images in the center column correspond to chitosan 
microgels into the second serpentine and images on the right column correspond to chitosan microgels 
exiting the device through the outlet tubing (on-chip chitosan microgels). 
 
It is important to note that the microgel shape within the MF channel is not 
spherical due to geometry constrictions which give rise to elongated microgel shapes 
which are known as plugs[39]. This is mainly observed in the images corresponding to 
chitosan microgels into the first and the second serpentine (left and center columns in 
Figure 4.11 respectively). Once chitosan microgels exit the device through the outlet 
tubing they get a spherical shape as can be observed in the images shown in the right 
column in Figure 5. From analysis of these optical images, the average diameter of the 
chitosan microgels on-chip decreased with the flow rate of the oil phase being 68, 57 
and 42 μm for Qo of 0.4, 0.55 and 0.7 mL/h.  
Figure 4.12-a shows an optical micrograph corresponding to the chitosan 
microgels off-chip (outside the MF device) prepared with a flow rate, Qo of 0.55 mL/h. 
(Figure 4.11) which presented a spherical shape. The distribution of diameters 
corresponding to chitosan microgels on-chip (before exiting the device) and off-chip 
(outside the device) is shown in Figure 13-b.  
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Figure 4.12. a) Optical micrographs for chitosan microgels, b) The black curve corresponds to the 
distribution of the diameters of chitosan microgels before exiting the device and the red curve 
corresponds to the distribution of the diameters of chitosan microgels outside the device, for a flow rate 
of the continuous phase, Qo of 0.55 mL/h. The experimental data points were fitted to Gaussian 
distribution.  
 
As can be observed in Figure 12-b, there is an important difference regarding the 
average diameter obtained for chitosan microgels before and after exiting the outlet 
tubing of the MF device. The average diameter corresponding to the chitosan microgels 
off-chip is 10 µm which presented an important reduction with respect to their size 
inside the device being 60 µm. The fact that the mean diameter decreases in the final 
chitosan microgels with respect to the chitosan microgels on-chip suggests the 
possibility to tune the final particle size diameter by varying the residence time of the 
chitosan microgels in the MF device. Also, it could be due to partial expulsion of water 
from the microgels when complete gelation occurred. This can be achieved by adjusting 
several experimental parameters such as the flow rate of the oil phase.  
Although, to keep all streams working at good conditions is a very difficult task 
and in some cases, the fiber formation was obtained, nevertheless chitosan 
microparticles of controlled and monodispersed size can be obtained by varying the 
geometry of MF devices and flow rates. In order to develop multifunctional 
microparticles two other systems have been investigated. For that, was included a 
second polymer with interesting properties, agarose. It is a neutral polysaccharide that 
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forms thermoreversible gels upon cooling agarose aqueous solutions. Taking into 
account this property, we proposed chitosan/agarose microgels trough microfluidics. 
 
4.3.2 Microfluidic preparation of chitosan/agarose microgels in a two 
inlets flow focusing microfluidic device.  
 
Chitosan/agarose microgel particles were prepared by the technique of 
microfluidics employing the equipment shown on Figure 4.13. The incorporation of a 
chamber was necessary, with the aim to keep the appropriated temperature (37 °C) for 
the experiments. A zoom in the Figure 4.13 allows observing in detail the equipment 
and the device employed. In this study, a flow-focusing droplets generator with two 
inlets was employed.  
 
 
Figure 4.13. Microfluidics equipment employed for chitosan/agarose microgels preparation. 
 
Different compositions of chitosan/agarose aqueous solutions and mineral oil 
containing 3% (w/v) of Span 80, were forced into the orifice of the MF device, as 
shown in Figure 4.14. Volumetric flow rate of the oil phase, Qo, was varied from 0.05 to 
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0.3 mL/h, while the flow rate of the dispersed phase, chitosan/agarose solution, Qd, was 
fixed at 0.05 mL/h.   
 
 
Figure 4.14. Schematic of the MF preparation of microgels from chitosan/agarose solutions. 
Emulsification of the chitosan/agarose solution at 37 ºC in a flow-focusing droplet generator is followed 
by crosslinking of the precursor droplets upon cooling to 4 ºC. The height of the channel was 50 µm. The 
width of the horizontal channel supplying the mineral oil and the chitosan/agarose solution were 70 µm. 
The length of the mixing channel was 1.02 cm. 
  
The stream of the chitosan/agarose solution periodically broke up to release 
droplets. The formation of droplets occurred in the flow-focusing regime[40] at a 
frequency of 1,200 s-1. The formation of primary droplets was accompanied by the 
formation of small ~3 μm diameter satellite droplets (not show here). This kind of 
droplets (satellite droplets) are byproducts in the droplet formation process for the 
preparation of uniform microparticles[12]. With increasing volumetric flow rate, Qo, of 
the oil phase from 0.05 to 0.30 mL/h, the diameter of primary droplets is reduced 
(Figure 4.15-a). This fact is due to the increasing of shear stress imposed by the oil 
phase on the aqueous stream.  
This tendency was corroborated in the study of the variation of the mean 
diameter D of the droplets formed from the others mixed solutions, chitosan/agarose-1, 
chitosan/agarose-1.5, chitosan/agarose-2 and agarose-1.5, as a function of the flow rate 
of the oil phase (Figure 4.15-b). The average diameter of droplets was tuned from 42 to 
18 μm by varying Qo from 0.05 to 0.3 mL/h, while maintaining constant the flow rate of 
the chitosan/agarose solution, Qd, at 0.05 mL/h.  
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Moreover, it was also analyzed the influence of agarose concentration for a 
particular Qo. It was observed that the diameter of droplets increases with increasing 
agarose concentration in the chitosan/agarose solutions for a specific Qo. This fact can 
be explained by the increasing in viscosity of the solution[41, 42]. A similar trend was 
observed for the droplets of chitosan/agarose-1.5 solution, compared to the droplets of 
agarose-1.5 solution. For all the chitosan/agarose and agarose solutions, MF 
emulsification produced primary droplets with polydispersity not exceeding 1.5%. 
 
 
Figure 4.15. a) Optical microscopy images of the chitosan/agarose-1.5 droplets obtained at Q0 of 0.1 
mL/hr (top) and 0.35 mL/hr (bottom) at Qd=0.05 mL/h. The scale bar is 70 μm.  b) Variation in the mean 
diameter, D, of droplets formed by MF emulsification of chitosan/agarose-1 (■), chitosan/agarose-1.5 
(■), chitosan/agarose-2 (■) and agarose-1.5 (■) solutions, plotted as a function of the flow rate of the 
continuous oil phase. Qd=0.05 mL/h.  
 
  
The precursor droplets exiting the MF device were cooled down in the outlet 
tubing to induce agarose gelation, while the chitosan molecules were distributed within 
the agarose network. These droplets were collected in PBS solutions at low temperature. 
Additional off-chip post-gelation yielded transparent microgels with a well-defined 
round shape and polydispersity below 1.5 %. A representative image of 
chitosan/agarose-1 microgels generated at Qo=0.20 mL/hr and Qd=0.05 mL/h, which 
were transferred in PBS solution, was shown in Figure 4.16. The average diameter of 
the microgels was 18.4±2.3 µm, ~30% smaller than the diameter of the corresponding 
precursor droplets, owing to microgel shrinkage upon gelation.  
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Figure 4.16. a) Optical microscopy image of chitosan/agarose-1 microgel in the PBS buffer at 25 oC. The 
droplets were generated at Qo= 0.20 mL/h and Qd = 0.05 mL/h, transferred in PBS solution and post-
gelled at 4 oC. b) Distribution of the diameters of droplets of chitosan/agarose-1 solution (black curve) 
and of the corresponding microgels (red curve). The experimental data points were fitted to Gaussian 
distribution.   
 
4.3.3Microfluidic emulsification and generation of the ferrofluid loaded 
chitosan/agarose microgels in a two inlets flow focusing microfluidic 
device.  
 
In this section, we propose a ferrofluid loaded chitosan/agarose microgel through 
microfluidics. Some magnetic chitosan microparticles[43] have been prepared trough 
microfluidics; however, for the best of our knowledge this is the first time that is 
reported ferrofluid loaded composite chitosan/agarose microgels through microfluidics 
with flow-focusing droplet generator.  
Chitosan/agarose-1.5 solution was select to study the incorporation of ferrofluid 
(2 and 5% w/v) and consequently the microgel formation through MF. Agarose-1.5 
loaded with ferrofluid at 5% (w/v) was used as a control. Figure 4.17 shows the 
variation in the mean diameter of droplet on function of the flow rate of the oil phase for 
samples under study, which a higher flow rate of the oil phase, the diameter of droplets 
reduced for all the samples.  
 
Chapter 4 
118 
 
 
Figure 4.17. Optical microscopy images of magnetic droplets obtained at Q0 of 0.05, 0.15, 0.25 and 0.35 
mL/h at Qd=0.05 mL/h. The scale bar is 70 μm. 
 
   Figure 4.18 shows the mean diameter D, of the droplets formed from 
chitosan/agarose-1.5+Fe2%, chitosan/agarose-1.5+Fe5%, and agarose-1.5+Fe5% 
solutions, plotted as a function of the flow rate of the oil phase. As can be observed, at 
low flow rate of the oil phase (0.05 mL/h) it was observed a significant different of 
droplet size among all the samples under study. Chitosan/agarose-1.5 presented a 
droplet size around 46 µm, whilst chitosan/agarose-1.5+Fe2%, chitosan/agarose-
1.5+Fe5%, and agarose-1.5+Fe5% presented a droplet size of 51 µm, 70 µm and 56 µm, 
respectively. This change on their droplets size as a function of ferrofluid content, at Qo 
of 0.05 mL/h, could be explained for a slight increase of their respective viscosity. 
Therefore, break up the stream of samples loaded with ferrofluid was more difficult, 
consequently their droplet size increased. Moreover, Figure 4.18 shows that a higher Qo, 
the droplet size decreased for all the samples under study, being the droplets size 
independent of ferrofluid content, even for agarose1.5+Fe5%.    
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Figure 4.18. Variation in the mean diameter, D, of droplets formed by MF emulsification of 
chitosan/agarose-1.5+Fe2% (■), chitosan/agarose -1.5+Fe5% (•), agarose-1.5+Fe5% (▼) and 
chitosan/agarose-1.5 (   ) solutions, plotted as a function of the flow rate of the continuous oil phase. 
Qd=0.05 mL/h. 
  
 Figure 4.19 shows the optical microscopy image of agarose-1.5+Fe5% microgel 
in the PBS buffer at 25 ºC. These microgels present a well defined spherical shape and 
with a good polydispersity, their average diameter calculated was 28 μm with a CV of 
7%. 
 
 
Figure 4.19. Optical microscopy image of agarose-1.5+Fe5% microgel.  
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  Composite chitosan/agarose and ferrofluid loaded chitosan/agarose microgels 
were successfully prepared by microfluidics. Taking into account, the results obtained 
in the chapter 3 related with composite chitosan/agarose macrogels, can be suggest that 
these microgels presented as well good properties as their respective macrogels. 
However, it is important corroborate this hypothesis.  
 
4.4 CONCLUSIONS  
 
 In the study of preparation of different protocols for chitosan microgels through 
microfluidics, the following conclusions can be drawn:  
 For the generation of chitosan droplets was necessary change several parameters 
such as geometry, concentrations and crosslinking reaction.  
 In this work, we set up a microfluidic device in order to achieve crosslinking of 
chitosan with TPP on-chip as an alternative to crosslinking off-chip that does not assure 
homogenous crosslinking. Crosslinking reaction on-chip among chitosan and TPP was 
very fast and presented some drawbacks such as fiber formation. This fact prevented 
droplet formation and high polydispersity of the droplets. For this reason, a four-inlet 
MF device was designed that allowed to obtain chitosan microgels with sizes around 10 
microns and a CV lower than 13%. It is important to note that the final size of chitosan 
microgels could be tuned by varying the residence time of the chitosan microgels inside 
the chip. The microfluidics technique allows to easily change the geometry 
configuration, and to control several experimental parameters such as the flow rates of 
the aqueous and the organic phase at the same time. 
 Finally, our work provides a useful strategy for the preparation of composite 
chitosan/agarose microgels and ferrofluid loaded chitosan/agarose microgels by the MF 
method as a means to obtain colloidal materials with narrow particle size distribution 
and potential candidates for their employment in controlled drug release applications or 
another biomedical application. 
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This chapter described first the preparation of chitosan nanoparticles by 
electrostatic interaction among positively charged chitosan and negatively charged 
sodium tripolyphosphate (TPP) molecules, which act as crosslinking agent. It also 
includes, the optimization of the protocols used for chitosan nanoparticles preparation. 
Secondly, this section describes the synthesis of chitosan nanoparticles loaded with 
ferrofluid. After that, all chitosan nanoparticles were characterized by morphological 
studies, structural analysis, thermal stability, rheological studies, and cytotoxicity. 
Finally, chitosan nanoparticles loaded with ferrofluid were evaluated for hyperthermia 
applications. 
 
5.1. INTRODUCTION  
 
In recent years, the preparation of magnetic chitosan nanoparticles has attracted 
a great attention in the research community in order to develop thermoseeds for 
magnetic hyperthermia that can be injected for localized therapy [1-3]. This challenge 
with the fact that sodium tripolyphosphate (TPP) is a polyanion categorized as being 
GRAS (generally recognized as safe) by the FDA (Food and Drug administration)[4]. It 
has made chitosan nanoparticles crosslinked with TPP, be applied for many biomedical 
applications, as gene delivery[5], to immobilize enzymes[6] and drug delivery[7-10]. 
Also, the crosslinking reaction of chitosan with TPP constitutes a mild and efficient 
method to achieve chitosan nanoparticles [11, 12]. Because, chitosan particles are 
formed mainly through the electrostatic interaction between positively charged chitosan 
and negatively charged TPP molecules. Magnetic chitosan nanoparticles can be 
prepared in situ with tiny pools of water-in-oil microemulsion containing chitosan and 
ferrous salt as micro-reactors by adding the basic precipitant, NaOH, into the micro-
emulsion[13]. The encapsulation of preformed iron oxide nanoparticles can be 
stabilized by crosslinking chitosan with glutaraldehyde[14] or tripolyphosphate salts 
(TPP).  
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The understanding of the macroscopic rheological properties of the resulting 
aqueous colloidal dispersions is of paramount importance for the design of biomedical 
applications[15]. In a recent report, the packing of chitosan nanoparticles to form 
microgels from aqueous suspensions was ascertained through rheological measurements 
for samples with different particle sizes obtained by varying the chitosan to TPP ratio. It 
is well known, that nanoparticles can aggregate to form clusters that are mass fractal objects, these clusters would then interconnect, leading to a liquid-like to solid-like 
transition, that means can be considered as gel[16]. In order to study the packing of 
chitosan nanoparticles and try to understand if the elastic properties are consequence of 
the intrinsic elasticity of the particles or, on the contrary, by interactions among 
particles, fractal analysis rises as suitable tool to study the colloidal structure of chitosan 
nanoparticles dispersion. There are many scaling theories that can be applied for fractal 
analysis as was described in the introduction. However in this work, we study the gel 
behavior of chitosan nanoparticles when we apply a shear rate to the system and then 
will be analyzed if chitosan nanoparticles are able to overcome the repulsive interaction 
energy barrier, leading to the formation of a gel. Specifically, Wu and Morbidelli 
model, is based on previous models[17] where the scaling model is defined by two 
separate regimes: the strong-link regime at low particle concentrations and the weak-
link regime at high particle concentrations.[18] But the main feature is that Wu and 
Morbidelli model includes a third regime, the intermediate regime, which considerer the 
elastic contributions of both inter- and intrafloc links. Even the interest of magnetic 
chitosan nanoparticles to be applied into the body as injectable system and where it has 
not been reported in the literature a deeply study of the correlation of composition, 
rheology and application. 
In this chapter, first the preparation of chitosan nanoparticles is described and 
then the encapsulation of ferrofluid nanoparticles into chitosan nanoparticles 
crosslinked with TPP. This work has as objective, to answer to requirements if the 
chitosan nanoparticles can be considered as injectable material. For that, the rheological 
properties of the aqueous dispersions were investigated through dynamic rheological 
measurements. The rheological characterization will allow determining the structural 
organization of these materials by relating their linear viscoelastic properties to their 
properties in dispersion by means of scaling laws [19, 20]. The work extends to a study 
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on remote heating by a magnetic field and the study of cytotoxicity to evaluate the 
application of the materials obtained in magnetic hyperthermia treatment. 
 
5.2. EXPERIMENTAL PART  
 
5.2.1 Materials 
 
Chitosan supplied by Polymers Laboratory, National University, Costa Rica and 
ferrofluid, were the same previously described in chapter 3.  
Acetic acid (Aldrich) and sodium tripolyphosphate (Aldrich) were used as 
received. For the biological tested were used fibroblasts of human embryonic skin 
(HFB, Innoprot). The culture medium was Dulbecco’s modified Eagle’s medium 
enriched with4500 mg/mL of glucose (DMEM, Sigma) and supplemented with 10% 
fetal bovine serum (GIBCO, Life Technologies, Spain), 200 mMl-glutamine, 100 
units/mL penicillin and 100 mg/mL streptomycin,modified with HEPES (Sigma, 
Spain). The Alamar Blue (AB) was provided by Serotec, Spain. 
 
5.2.2 Preparation of chitosan–sodium tripolyphosphate nanoparticles 
(CS+TPP).  
 
Chitosan nanoparticles were prepared as reported elsewhere[12] with some 
modifications. In this experiment, different parameters involved in chitosan 
nanoparticles preparation were assessed such as, concentrations of chitosan and sodium 
tripolyphosphate (TPP) and chitosan:TPP volumetric ratios. First, chitosan solutions of 
different concentrations (0.05, 0.2 and 0.5% (w/v) were prepared by dissolving the 
appropriate amount of chitosan in 1% (w/v) acetic acid solution. Then, sodium 
tripolyphosphate (TPP) was dissolved in Milli-Q water to a final concentration of 0.05% 
and 0.5% (w/v). Chitosan nanoparticles were formed instantly at room temperature by 
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dropwise addition of TPP solution into a 30 mL of chitosan stock solution under severe 
magnetic stirring (8600 rpm). The nanoparticles were formed at selected chitosan:TPP 
volumetric ratios of 20:1, 5:1, 2.5:1, 2:1 and 1.7:1.  
Finally, chitosan nanoparticles are collected by centrifugation and washed one 
time with distilled water. Aqueous dispersions of CS+TPP nanoparticles were 
centrifuged at 5000 rpm, for 20 min. The residue containing the big particles is 
discarded and the supernatant, where the small CS+TPP nanoparticles remain, is 
collected. The supernatant was separated and then it was dried by lyophilization. Table 
5.1, shows all the samples prepared in this section and their respectives names.  
 
Table 5.1. All chitosan nanoparticles prepared and their respective names. 
TPP Concentrations of chitosan % (w/v) 
Concentration 
% (w/v) 
Ratios 
CS:TPP 0,05% 0,20% 0,50% 
0,05% 
20:1 x x x 
5:1 x x x 
2.5:1 x x x 
2:1 x x x 
1.7:1 x x x 
  
 
      
0,50% 
20:1 x x  x 
5:1 x x 0.5CS-0.5TPP   
2.5:1 x x x 
2:1 x x x 
1.7:1 x x x 
 
Samples were named as follow: xCS-yTPP, where x represents the concentration 
of chitosan and y the concentration of TPP employed. 
 
5.2.3 Preparation of ferrofluid loaded chitosan nanoparticles (NP+Fe). 
  
First, for this study was selected a chitosan and TPP concentration of 0.5% 
(w/v). The method of preparation for these solutions was the same described in the 
previous section. 
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Chitosan nanoparticles loaded with three different ferrofluid contents (NP+Fe) 
were prepared by the following steps: firstly, a determined amount of pure ferrofluid 
was dispersed in 5 mL of Mili-Q water in order to yield final concentrations of 0.5, 2 
and 5% (w/v). The resulting ferrofluid solution (5 mL) was added under vigorous 
stirring to 30 mL of a chitosan solution (0.5% w/v, pH=3.5) in 1% (v/v) acetic acid in a 
N2 atmosphere. Secondly, an aqueous TPP solution (0.5% w/v, pH=9.2) was dropped 
into the chitosan solution containing ferrofluid nanoparticles (final pH~4, for all the 
samples). This step allowed encapsulating ferrofluid nanoparticles into CS+TPP 
nanoparticles, as will be demonstrated. Finally, aqueous dispersions of NP+Fe 
nanoparticles were washed one time with distilled water and were centrifuged at 5000 
rpm, for 20 min. As in the previous section the supernatant of NP+Fe was separated and 
subjected to freeze-drying and storage. 
The ferrofluid concentration in the chitosan nanoparticles was determined 
through UV spectroscopy. Samples were digested in HNO3 and HCl 6M and iron 
concentration was measured spectrophotometrically at the λmax of 478 nm. Ferrofluid 
loaded chitosan nanoparticles were named NP+Fex, where x correspond to 1, 3.2 and 
5.6% (w/v) of ferrofluid, determined by UV spectroscopy, see Table 5.2. 
 
Table 5.2. Chitosan nanoparticles loaded with ferrofluid and the control. 
Sample Chitosan         
(% w/v) 
TPP (% w/v) Fe (% w/v)* 
CS+TPP 0.5 0.5 - 
NP+Fe1% 0.5 0.5 1 
NP+Fe3.2% 0.5 0.5 3.2 
NP+Fe5.6% 0.5 0.5 5.6 
* Determined by UV spectroscopy. 
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5.2.4 Characterization  
 
i. Determination of particle size and zeta potential of chitosan nanoparticles 
by Dynamic Light Scattering  
Dynamic light scattering (DLS, Malvern Nanosizer Nano S) was employed for 
the determination of electrophoretic mobility (surface charge) and hydrodynamic 
diameter of chitosan nanoparticles and ferrofluid loaded chitosan nanoparticles 
dispersed in Mili-Q water at 25 °C, the resulting pH of the dispersions was 4.5. For 
hydrodynamic diameter determinations, a backscattering detection angle of 173° was 
employed. The electrophoretic mobility was transformed into zeta potential using the 
Smoluchowski equation.  All measurements were repeated three times and the average 
of three runs was taken as the result.  
 
ii. Morphological studies  
 
- Scanning Electron Microscopy (SEM) and Scanning Electron Microscopy with 
electron transmission (FESEM)  
The morphologies of the chitosan nanoparticles were observed with SEM (XL30 
ESEM, Philips). One drop of chitosan nanoparticles dispersion was dropped on a flat 
microscopy glass. All samples were kept at room temperature overnight to dry the 
sample by evaporation of the water. Subsequently the dried sample was coated with an 
ultrathin coating of gold deposited on the sample by high-vacuum metallization. 
Micrographs of the chitosan nanoparticles loaded with ferrofluid were taken 
using a FESEM Hitachi model SU8000 HRSEM used in the TE (electron transmission) 
detector bright field mode and SE operated at 0.5-30 KV. One drop corresponding to 
aqueous dispersions of each of the samples under study was deposited on the Formvar 
carbon-coated Cu grid. 
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- Atomic Force Microscopy (AFM) 
AFM images of CS+TPP were obtained with a Multimode Scanning probe 
microscope (di NanoScope IVa Controller, Veeco) in contact mode and using a 
Veeco/Bruker, model RTESP cantilever with a 300 kHz resonant frequency and a 
nominal force constant near 40 N/m. Topographic images were recorded in the 
conventional height mode (tapping mode, normal AFM) at a scan rate of 0.5 and 1.5 Hz. 
The nanoparticles diameter was calculated using the ImageJ software and was the 
average of 100 nanoparticles. 
 
 
iii. Study of the chemical structure by Attenuated Total Reflection Fourier 
Transformed Infra-Red Spectroscopy (ATR-FTIR) 
Attenuated Total Reflection Fourier Transformed Infra-Red Spectroscopy (ATR-
FTIR) was carried out on freeze-dried samples. ATR-FTIR was performed on a 
Spectrum One FT-IR Spectrometer of Perkin Elmer. The spectra were scanned over the 
wave number range of 4000 to 450 cm–1 at a resolution of 2 cm-1. 
 
iv. Determination of crystallinity by X-ray diffraction measurements (XRD)  
The crystallinity of the chitosan nanoparticles and chitosan nanoparticles loaded 
with ferrofluid was determined by X-ray diffraction (XRD). The X-ray diffraction 
(XRD) spectra of chitosan, CS+TPP and NP+Fe 3.2% were performed using a Bruker 
Advance D8 X-ray diffraction spectrometer with a CuKα target at 40 kV and 50mA.  
The sample was scanned from 5º to 70º at 2θ.  
 
v. Thermal stability by thermogravimetric analysis (TGA) 
Thermogravimetric analysis (TGA) was carried out on a Q500 TA Instruments 
thermal gravimetric analyzer.  Each freeze-dried sample under study (10–15 mg) was 
placed in the TGA furnace and the measurements were carried out under nitrogen 
atmosphere with a heating rate of 10 ºC/min from 25 to 700 ºC. 
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5.2.5 Rheological studies by dynamic oscillatory measurements 
 
Viscoelastic behavior of samples has been performed by dynamic oscillatory 
measurements. Then, the structural organization of chitosan nanoparticles will be 
determining by fractal analysis. 
 
i. Dynamic oscillatory study. 
Dynamic oscillatory measurements were performed in a AR-G2 rheometer (TA 
Instruments, USA). The geometry used was 60 mm acrylic parallel plates. Samples 
under study were dispersed in ultrapure water at concentrations ranging from 0.5 to 2% 
(w/v). This range was chosen because concentrations higher than 2% (w/v) did not 
allow the homogeneous dispersion of the samples in water and lower than 0.5% w/v did 
not allow the rheological characterization due to the torque limit. Strain sweep tests 
were carried out at a constant, nondestructive 0.5 Hz frequency. All measurements were 
done at room temperature. 
 
ii. Fractal analysis of chitosan nanoparticles. 
In order to understand the gel network formation in suspensions, the scaling 
concept based on the fractal model was applied. For that, it has been employed the 
scaling theories developed by Shih et al. and Wu and Morbidelli, described in chapter 2.  
 
5.2.6 In vitro studies of chitosan nanoparticles 
 
In order to consider the chitosan nanoparticles prepared in this work for 
biomedical applications, it is necessary to assess their cytotoxicity. For that, the 
following analyses were employed. 
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i. Morphological analysis of Fibroblast treated with NP+Fe by Scanning 
Electron Microscopy (SEM). 
Sample preparation required the seed of approximately 5x105 cells (Fibroblast) 
per coverslip. After 24 h of incubation, the medium was replaced, as example, with the 
corresponding aqueous dispersion of NP+Fe3.2% at a concentration of 0.6 mg/mL and 
incubated at 37ºC for 24 h. Then, samples were washed twice with PBS to remove 
excess NP+Fe3.2% and then fixed with glutaraldehyde. The dehydration process was 
conducted using increasing concentrations of ethanol. Samples were then gold-coated 
and observed using a Nova 200 NanoLab, FEI Company, The Netherlands. SEM 
images were observed using the electron beam at a voltage of 5 kV and current of 0.4 
nA. This experiment was carried out in the Institute of Nanoscience of Aragon, 
Zaragoza in collaboration with the Professor Gerardo Goya.  
 
ii. Cell culture conditions  
The biological response to the materials was tested with fibroblasts of human 
embryonic skin (FBH).  
The culture medium was changed at selected time intervals with little 
disturbance to culture conditions. Cells without treatment were used as a negative 
control. NP+Fe samples were dispersed in fresh medium without phenol red at different 
concentrations. Samples were sterilized with a UV lamp (HNS OSRAM, 263 nm, 3.6 
UVC/W) at a power of 11W for 4 h. Sterile plastic was supplied by Sasrtedt, Spain. 
 
iii. Cytotoxicity analysis. Alamar Blue Assay 
For determination of cytotoxicity, the Alamar Blue (AB was provided by 
Serotec, Spain) assay was performed. Cells were seeded at a density of 8x104 cells/mL 
in complete medium in a sterile 96-well culture plate and incubated to confluence, 
which means that a monolayer of cells is formed.  
After 24 h of incubation, the medium was replaced with the corresponding 
aqueous dispersions of three NP+Fe samples at different concentrations (Table 5.3) and 
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incubated at 37 ºC in humidified air with 5% CO2 for 24 h. After this time, a solution of 
AB was prepared in warm medium without phenol red and the plates were incubated at 
37 ºC for 4 h. Finally, fluorescence was measured with a Biotek Synergy HT detector 
using an emission wavelength of 590 nm and an excitation wavelength of 530 nm.  
In order to determine cell viability, the experiment was performed at different 
nanoparticles concentration. Cell viability (CV) was calculated with the following 
equation: 
  
 
where FDS, FDB, and FDC are the fluorescence density of the AB for the sample (S), 
blank (B) (culture medium without cells), and control (C). 
 
Table 5.3. Experimental concentrations (mg/mL) employed in cytotoxicity Alamar blue 
assay. 
D1: 2.50mg/mL D6: 0,078 mg/mL 
D2: 1.250 mg/mL D7: 0,039mg/mL 
D3: 0,625 mg/mL D8: 0,020 mg/mL 
D4: 0,313 mg/mL D9: 0,010 mg/mL 
D5: 0,156 mg/mL D10: 0,005 mg/mL 
  D11 0,002 mg/mL 
 
iv. Lactate dehydrogenase assay 
In order to study if the cell death is due to damage in the plasma membrane, 
lactate dehydrogenase was carried out. For that, LDH cytotoxicity assay kit (Innoprot, 
Spain) was employed. LDH catalyses the reduction of NAD+ to NADH in the presence 
of L-lactate, while the formation of NADH can be measured in a coupled reaction in 
which the tetrazolium salt is reduced to a red formazan product. The amount of the 
highly colored and soluble formazan can be measured at 490 nm 
spectrophotometrically. 
 






−
−
×=
BC
Bs
FDFD
FDFDCV 100
Equation 5.1 
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The protocol is analogous to the Alamar Blue assay. The concentrations 
employed for the preparation of aqueous dispersions of NP+Fe samples were 1 and 0.05 
mg/mL. 
 
5.2.7 Determination of Magnetic Remote Heating.    
 
The specific power absorption (SPA) of the aqueous dispersions of NP+Fe 
samples at a 5% (w/v) concentration was measured with a commercial AC field 
applicator (DM100 by nB nanoscale Biomagnetics, Spain) working at ƒ=580 kHz and 
24 kA/m (≈300 Oe). Experiments were carried within a thermally -insulated working 
space of about 1 cm3, using a closed container of 1.0 mL volume conditioned for 
measurements in liquid phase. A schematic representation of the equipment is shown in 
Figure 5.1-a and a photograph of the commercial equipment employed is shown in 5.1-
b. This experiment was carried out in the Institute of Nanoscience of Aragon, Zaragoza 
in collaboration with the Professor Gerardo Goya.  
 
 
Figure 5.1. a) Scheme of hyperthermia experiments and b) commercial equipment AC field applicator 
(DM100).   
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5.3. RESULTS AND DISCUSSION  
  
5.3.1 Optimization of experimental conditions for the preparation of 
chitosan nanoparticles. 
 
Particle size is one of the most important issues for biomedical applications. For 
this reason, it was necessary to study the influence of the main experimental parameters 
such as chitosan and TPP concentrations and volumetric ratios, in order to select the 
better conditions to obtain nanoparticles with an appropriate size.  
Chitosan nanoparticles were synthesized by the ionic crosslinking reaction 
method between the protonized ammonium groups of chitosan and the tripolyphosphate 
anions of TPP, as Figure 5.2 shows. 
 
 
 
Figure 5.2. Scheme of chitosan nanoparticles formation. 
 
The acid media guarantees the protonation of the amino groups of chitosan. 
Therefore, only for some speficic ratios among chitosan and TPP were favored the inter 
and intramolecular linkages created between TPP and the positively charged amino 
groups of CS, which are responsible of the particles formation. As a previous step, in 
order to select the most appropiated experimental parameters regarding chitosan and 
TPP concentration and volumetric rations, we checked the precipitation of aqueous 
solutions containing different volumetric rations between chitosan and TPP. As known, 
the apparition of a precipitate indicates the formation of big chitosan nanoparticles. On 
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the contrary, the presence of transparency indicates that particles were no formed. When 
the final solution is opalescent, the particles are found to be in the nanometric size. [12] 
Therefore, based on these assumptions, samples which presented precipitates and or 
were transparent, were discarded. 
Figure 5.3 shows representative photographs of chitosan nanoparticles, 
specifically for series 0.2CS-0.05TPP (Figure 5.3-a) and 0.2CS-0.5TPP (Figure 5.3-b). 
In the first photograph, it is possible to observe that final samples are very transparent 
and on the contrary, from Figure 5.3-b it is evident the different states of samples 
obtained on function of the volumetric ratio employed, transparent, precipitate and 
opalescence.  
Among of the series prepared, 0.5CS-0.5TPP was found to be the most 
appropriated in the almost all range of chitosan and TPP concentrations.  
 
 
Figure 5.3. Photograph of chitosan nanoparticles for a) 0.2CS-0.05TPP and b) 0.2CS-0.5TPP sample.  
 
Chitosan nanoparticles of series 0.5CS-0.5TPP were analyzed by Scanning 
Electron Microscopy (SEM). As an example, Figure 5.4 shows, SEM micrographs 
corresponding to the samples of the series 0.5CS-0.5TPP with three different CS:TPP 
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volumetric ratios, 20:1, 5:1 and 1.7:1. From these micrographs, it is that particles 
formations were favored only for some specific volumetric rations of chitosan and TPP.  
Therefore, sample 0.5CS-0.5TPP with a volumetric ratio of (5:1) presented a good 
dispersion and small particles size in the order of nanometer, later determined by AFM 
and dynamic light scattering. 
 
 
Figure 5.4. Micrograph corresponding to the sample 0.5CS-0.5TPP with different ratios CS:TPP. 
 
After to study different volumetric ratios among chitosan and the TPP as 
crosslinking agent and taking into account their final state (clear, opalescent or 
precipitate solutions), for the next experiment were select the following conditions: 
chitosan and TPP concentration of 0.5% (w/v) (0.5CS-0.5TPP) and a volumetric ratio of 
5:1. Sample will be denoted as CS+TPP. 
 
Figure 5.5 shows AFM results for CS+TPP nanoparticles. Figure 5.5-a, shows 
topography with a field of view of 2 × 2 μm and a height range of approximately 15.8 
nm, where it is evident its spherical shape and small size. In Figure 5.5-b, is shown the 
3D image and Figure 5.5-c corresponds to the frequency of CS+TPP nanoparticles 
counted from ImageJ and its Gaussian curve. The mean diameter of CS+TPP 
nanoparticles calculated by ImageJ is approximately 154 nm. 
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Figure 5.5. AFM images a) Topography (area 2 × 2 μm), b) 3D images and c) histogram, of CS+TPP. 
 
The crosslinking degree of CS+TPP nanoparticles was 68% as determined by the 
ninhydrin test. Ninhydrin is extensively used in the analytical determination of amino 
acids and related structures because it can react with a variety of primary and secondary 
amines producing Ruhemann purple color.  This product has a maximum absorbance at 
570 nm[21].  
 
5.3.2 Preparation of chitosan nanoparticles loaded with ferrofluid. 
 
Chitosan nanoparticles loaded with ferrofluid (NP+Fe) were prepared with 
concentrations of chitosan and TPP at 0.5% (w/v) selected in the previous section. 
NP+Fe were synthesized by the ionic crosslinking reaction between the 
protonized ammonium groups of chitosan and the tripolyphosphate anions of TPP. 
Ferrofluid with three concentrations (1, 3.2 and 5.6% (w/v)) were successully 
encapsulated into chitosan matrix, as later will be corroborated by FESEM. An 
electrostatic interaction is established in the reaction between chitosan and TPP, 
enabling the encapsulation of an amount of ferrofluid (negative surface charge) within a 
positive matrix (chitosan) and negative charge by its phosphate groups of TPP a acting 
as ionic crosslinking agent [22]. A schematic representation of the preparation of 
NP+Fe samples is shown in Figure 5.6.  
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Figure 5.6. Scheme of preparation of ferrofluid loaded chitosan nanoparticles. 
 
i. Determination of particle size and zeta potential. 
After the ferrofluid loaded chitosan nanoparticles preparation, particles size and 
zeta potencial were determined by Dynamic Light Scattering (DLS). As can be 
observed in Table 5.3, ferrofluid encapsulation gives rise to an increase in the size of 
NP+Fe particles with respect to the CS+TPP particles from 192 to 259 nm, as ferrofluid 
content is increased from 1 to 5.6%. This result might be attributed to the fact that 
ferrofluid nanoparticles are subjected to Van der Waals forces and magnetic dipole-
dipole interactions generated from residual magnetic moments[23].  Moreover, when 
compared particle size of CS+TPP obtained by AFM (described in the previous section) 
and DLS, the size obtained was 154 nm and 140 nm, respectively. The results are very 
similar and both techniques also corroborate that CS+TPP particles are in the 
nanometric range, which it is appropiated for biomedical applications. 
 
 
Ferrofluid loaded chitosan nanoparticles 
 
143 
 
Table 5.4. Ferrofluid concentration, mean particle size and zeta potential for samples 
under investigation.  
Sample Ferrofluid 
concentration* 
(mg/mL) 
Mean 
Particle 
Size  (nm) 
Zeta 
potencial 
(mV) 
CS+TPP  0 140± 1 63.4 ± 0.8 
NP+Fe1% 1.0 192 ± 2 57.2 ± 2.0 
NP+Fe3.2% 3.2 205 ± 3 59.3 ± 0.8 
NP+Fe5.6% 5.6 259 ± 1 57.9 ± 6.6 
*Determined through UV-vis spectroscopy. 
Data shown are the mean ± standard deviation 
 
Table 5.4 also reports the zeta potential for samples under investigation. The 
positive zeta potential encountered for the dispersion of CS+TPP sample (63.4 ±0.8 
mV) in Mili-Q water (pH 4.5), it is due to the protonated ammonium groups in the 
acidic environment. The zeta-potential of all the NP+Fe samples remain positive in the 
range of 57-63 mV, in close agreement with previous results obtained by Zu et al.,[23]. 
If we take into consideration that the zeta-potencial corresponding to the commercial 
ferrofluid is negative (-75.8±3.2 mV). The obtained results suggest its encapsulation 
into the chitosan nanoparticles as will be corroboted through Scanning Electron 
Microscopy with electron transmission (FESEM).   
 
ii. Morphological studies 
Figure 5.7 shows FESEM micrographs corresponding to the ferrofluid loaded 
chitosan nanoparticles prepared. As a first general result, it is observed that all samples 
presented a spherical shape. Nevertheless, it is not possible to ensure if ferrofluid is 
encapsulated into chitosan matrix. For that a bright field (BF) mode was employed.   
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Figure 5.7. Representative micrograph corresponding to magnetic chitosan nanoparticles: a) NP+Fe1%, 
b) NP+Fe3.2% and c)NP+Fe 5.6% by field emission scanning electron microscopy. 
 
Figure 5.8 shows bright field (BF) and SE image obtained for a representative 
micrograph corresponding to NP+Fe 5.6%.  
Bright field image allows confirming the core-shell encapsulation of ferrofluid 
within a layer of chitosan that constitutes the shell. SE image taken on the same spot 
shows the smooth surface of the chitosan nanoparticles which confirms the ferrofluid 
encapsulation with a core-shell morphology[24] A Bright field FESEM microscopy 
obtained for the sample NP+Fe 5.6% at a high magnification is also shown in the figure 
5.8-a, where it is very evident the core-shell morphology of NP+Fe 5.6% nanoparticles. 
 
 
Figure 5.8. Representative micrograph corresponding to the sample NP+Fe 5.6% by field emission 
scanning electron microscopy, corresponding to (a) bright field and (b) SE image. The inset in Figure 2a 
shows a magnification of a core-shell chitosan nanoparticle.  
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The crosslinking of TPP and chitosan in the presence of ferrofluid (Figure 5.6) 
gives rise to its encapsulation into the chitosan nanoparticles. Size measurements 
performed on images obtained through bright field microscopy allows estimating that 
the magnetic core size is in the range 75-220 nm whereas the shell size varies in the 
range 21-39 nm.  
 
iii. Analysis of the chemical structure.   
FT-IR spectroscopy is an appropriate technique to study the chitosan-TPP 
interaction. Figure 5.9 shows ATR-FTIR spectra of pure TPP, chitosan, CS+TPP and 
NP+Fe 3.2%. In the TPP spectrum (Figure 5.9-a), the following characteristic bands are 
observed: 1218 cm-1 (P=O stretching), 1143 cm-1 (symmetric and antisymmetric 
stretching vibrations in PO2 group), 1069 cm-1 (symmetric and antisymetric stretching 
vibrations of PO3 group), 898 cm-1 (antisymmetric stretching of the P-O-P bridge).  
 
 
 
 
 
 
 
 
 
 
Figure 5.9. FT-IR spectra corresponding to (a) TPP, (b) chitosan (c) NP+Fe 3.2% and (d) CS+TPP. 
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The characteristic vibrational absorption bands observed in the chitosan 
spectrum (Figure 5.9-b) are the band at 1593 cm-1 corresponding to the N-H bending 
vibration overlapping the amide II vibration and that at 1652 cm-1 that corresponds to 
the amide I vibration[25]. Absorption bands at 1153 cm-1 (antisymmetric stretching of 
the C-O-C bridge), 1089 cm-1 and 1033 cm-1 (skeletal vibrations involving the CO 
stretching) are characteristic of the chitosan saccharide structure[26].  
Therefore, since a shift in the δNH3 vibration may be expected when NH3+ groups 
interact electrostatically with the negatively charged sites of the TPP as previously 
shown for chitosan nanocomposites[27]. In fact, a shift of the δNH3 band towards a lower 
frequency is observed in the spectra corresponding to CS+TPP (Figure 5.9-d) and 
NP+Fe 3.2% (Figure 5.9-c) spectra for which the band at 1593 cm-1 (pointed in Figure 
5.9) shifts to 1570 and 1568 cm-1 respectively. In both cases, the shift of the band 
position and  the increase of intensity observed could be attributed to the ionic 
crosslinking between the NH3+ from chitosan and the P3O105- from TPP [28]. In both 
spectra, a new band at 1218 cm-1 appears that can be assigned to P=O stretching 
vibrations in phosphate ions (pointed in Figure 5.9). In the spectrum corresponding to 
NP+Fe 3.2% (Figure 5.9-c), it is not possible to observe the characteristic band of iron 
oxide[29] centered at 563 cm-1 because of the overlapping with characteristic bands 
from chitosan and TPP.    
 
iv. Determination of crystallinity by X-ray diffraction measurements (XRD) 
X-ray diffraction (XRD) was employed to identify the crystallinity properties of 
the chitosan nanoparticles loaded with ferrofluid. The X-ray diffractograms of chitosan 
(a), CS+TPP (b) and NP+Fe 3.2% (c) are shown in Figure 5.10. The diffractogram of 
chitosan shows the diffraction peaks at 2θ = 9.3° and 21.3º indicating its semicrystalline 
structure[30]. However, after the crosslinking reaction among chitosan and TPP, the 
CS+TPP diffractogram (Figure 5.10-b), shows reduction of the peak intensity, shift of 
peak positions and broadness of peaks to respect at chitosan diffractogram (Figure 5.10-
a). This fact can be attributed to modification in the arrangement of molecules in the 
crystal lattice of chitosan by the TPP, which is in agreement with the results reported in 
the literature [8, 31, 32]. Moreover, new peaks at 8.8º and 11.4º and 26º appear for 
CS+TPP diffractogram (Figure 5.10-b), associated to the interaction (the crosslinking 
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reaction) among chitosan and TPP. This suggest new arrangements of molecules in the 
crystal lattice induced by ionic interaction[31].   
As can be observed, chitosan nanoparticles loaded with ferrofluid (NP+Fe3.2%) 
diffractogram (Figure 5.10-c) are mainly amorphous, because the peaks corresponding 
to chitosan became much lower and wider. On the other hand, in agreement with the 
literature, it is observed news peaks at 30.1º, 35.6º, 42.8º, 54.1º, 57.3 and 62.8º which 
are related with XRD pattern of magnetite[30]. Therefore, this fact confirmed firstly, the 
presence of magnetite into the chitosan nanoparticles and secondly, that the coating 
process of chitosan does not result in the phase change of magnetite [33]. 
 
 
Figure 5.10. Wide angle X-ray diffractograms of: (a) chitosan, (b) CS+TPP and (c) NP+Fe 3.2%. 
 
v. Analysis of the thermal degradation of the samples under study. 
Thermal degradation of chitosan nanoparticles and ferrofluid loaded chitosan 
nanoparticles under study (Figure 5.11) was measured using thermogravimetric analysis 
(TGA). CS+TPP curve (Figure 5.11-a) presented three thermal steps. The first start at 
30 ºC and continues up to 80 ºC during which there was 11% of weight loss, due to the 
loss of water on the surface [34]. Then, a second step is observed, which present an 
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onset temperature of 115 ºC and continues until 200 ºC, with a weight loss of 8% 
attributed to dehydration of the sample[35]. This thermal transition is observed as well 
in TPP thermogram (the inset thermogram). Finally, a third step is observed, with an 
onset temperature of 240 °C and with a weight loss of ~43%, which may be related to 
the decomposition of chitosan. Finally, CS+TPP presented a residue of 38% at 600 ºC.  
Table 5.4, summarizes thermal steps for all samples under study and its corresponding 
weight loss.  
With regard to chitosan nanoparticles loaded with ferrofluid at 1% (Figure 5.11-
b), 3.2% (Figure 5.11-c) and 5.6% (Figure 5.11-d) presented similar TGA curves than 
CS+TPP curve. NP+Fe 1% presented the first steps at 30-100 ºC related with the loss of 
water on the surface, then a second step is observed as well, with an onset temperature 
of 125 ºC which suggest the weight loss (6%) attributed to dehydration of the sample. 
As can be observed, the weight loss of NP+Fe1% is lower than CS+TPP for the second 
thermal transitions. This fact could be explained for the interaction among ferrofluid 
and matrix; therefore the number of bonds with water molecules decreases. On the other 
hand, this interaction among ferrofluid and matrix increase the thermal stability for 
NP+Fe1% to respect at CS+TPP in this second thermal step. Finally, the last thermal 
step with an onset temperature of 234 ºC is attributed to decomposition of the organics 
components with a weight loss of 45%.  
However, NP+Fe3.2% and NP+Fe5.6% presented only two steps. The first star 
at 30 ºC and continues up to 170 ºC with a weight loss of 10% and 11% respectively, 
related with the loss of water. It is important to highlight that these samples do not 
present the second steps; this fact can suggest a higher interactions among magnetite 
and the matrix to respect at NP+Fe1% and CS+TPP. Finally, the last thermal step is 
observed as well, with an onset temperature of 231ºC and 224 °C, respectively, with a 
weight loss of 45% and 42%, respectively, attributed to decomposition of the chitosan 
matrix. 
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Figure 5.11. Thermal gravimetric curves of CS+TPP (a), NP+Fe1% (b), NP+Fe3.2% (c) and 
NP+Fe5.6% (d).  
 
It is important to highlight the influence of the incorporation of ferrofluid into 
chitosan nanoparticles. As can be observe in Table 5.5, the third thermal transitions that 
correspond to degradation of organic components (chitosan matrix) decrease as a 
function of ferrofluid content, where at higher ferrofluid content the onset temperature 
decreases. This fact can be explained by the addition of metal nanoparticles into 
polymers matrix. Previous works reported that the addition of metal nanoparticles may 
have a catalytic role in the degradation of polymer matrix[36]. On the other hand, XRD 
results showed that crystallinity property of the sample loaded with ferrofluid decrease. 
This fact could affect its thermal stability, owing to decrease in degree of crystallinity as 
a result of cross-linking, as previous works reported [37, 38]. Since, if the crystallinity 
properties decrease, the thermal stability decreases as well.     
The influence of the addition of ferrofluid was observed in the residue at 600 ºC, 
which was 3%, 6% and 10% for NP+Fe1%, NP+Fe3.2% and NP+Fe5.6%, respectively. 
This change is directly related with increasing of ferrofluid into chitosan nanoparticles, 
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however, these values presented a significant difference in comparison with ferrofluid 
content reported by UV spectroscopy.   
 
Table 5.5. Main thermal steps for samples under study. 
Sample Onset 
1º step      
(º C) 
% 
Weight 
loss 
Onset 
2º step      
(ºC) 
% 
Weight 
loss 
Onset 
3º step      
(ºC) 
% 
Weight 
loss 
Residue 
at      
600 ºC 
CS+TPP 30 11 115 8 240 42 38 
NP+Fe1% 30 9 125 6 234 45 41 
NP+Fe3.2% 30 10 - - 231 45 44 
NP+Fe5.6% 30 11 - - 224 42 48 
 
5.3.3 Rheological studies. Viscoelastic properties of aqueous dispersions 
of NP+Fe nanoparticles 
 
Recent results regarding the rheological behavior of aqueous dispersions of poly 
(acrylamide-acrylic acid) microgels outlined their macroscopic elasticity showing that 
the material behaves as a colloidal gel[19]. Taking into account these results, the 
rheological characterization of aqueous colloidal dispersions is of paramount 
importance, and allows anticipating their behavior under certain conditions of shear.  
Shear-thinning of a colloidal suspension could enable a more homogeneous and 
easy delivery of the material into the body in the case of injectable materials[15]. 
Moreover, the recovery of the elastic properties immediately after injection may prevent 
the flow of the colloidal solution and facilitate that the material remains on the target 
site[39]. A possible recovery of the elastic properties after shear-thinning was explored 
by comparing up and down strain sweeps carried out, as example on NP+Fe 3.2% 
sample. Figure 5.12 shows that as the strain diminishes, immediately after shear 
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thinning, a significant recovery of the elastic properties is observed and the sample 
recovered almost the initial elastic modulus.  
 
 
Figure 5.12.  (a) Evolution of the elastic modulus (full symbol) and viscous modulus (empty symbol) as a 
function of strain for an aqueous dispersion (1% w/v) of the sample NP+Fe 3.2%. First strain sweep 
(square) and second strain sweep (triangle). 
 
The results corresponding to the strain sweeps carried out on the samples 
CS+TPP (Figure 5.13-a), NP+Fe 1% (Figure 5.13-b), NP+Fe3.2% (Figure 5.13-c) and 
NP+Fe 5.6% (Figure 5.13-d) at different concentrations of the dispersion in water 
ranging from 0.5% (w/v) to 2% (w/v) are depicted in Figure 5.13. Chitosan 
nanoparticles and ferrofluid loaded chitosan nanoparticles synthetized, showed that for 
all the concentrations studied, the samples display a linear viscoelastic regime 
characterized by the independence of G´ and G´´ on the strain and yield up to a critical 
shear amplitude, γ0, above which the samples show a viscoelastic liquid-like behavior 
followed by apparent shear-thinning. However, for CS+TPP sample, it was not possible 
to measure concentrations lower than 1% (w/v) due to the inertia of the measurement.    
Shear-thinning could be attributed to the breaking apart of clusters formed 
among the particles at high shear amplitude. The increase in γ0 that occurs when the 
concentration of the dispersion increases from 0.5% (w/v) to 2% (w/v) indicates that 
clusters are less dense at lower dispersion concentrations. Therefore, once some inter-
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cluster bond that keep the interconnected network solid break, the sample may flow. 
The increase in the concentration of the dispersion gives an increase of the 
corresponding elastic modulus which could be associated to the intrinsic elastic 
properties of the different nanoparticles or the clusters.  
 
 
Figure 5.13. Evolution of the elastic modulus (full symbol) and loss modulus (empty symbol) for 0.5% w/v 
(square), 1% w/v (circle), 1.5% w/v (triangle), and 2% w/v (diamond) concentration of nanoparticles 
dispersion:  a) CS+TPP; b) NP+Fe 1%; c) NP+Fe 3.2% and d) NP+Fe 5.6%. 
 
According to Figure 5.13, it is observed the elastic modulus slight dependent of 
ferrofluid content specifically NP+Fe 5.6%, thus indicating the formation of a relatively 
weaker structure. This fact could be related with the particle size of these nanoparticles. 
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i. Determination of aggregating system. Fractal analysis 
Results obtained from strain sweeps carried out at different concentrations, 
reported on Figures 5.14-a and 5.14-b show that both elastic modulus and critical 
deformations presented dependence with the concentration. These results indicate the 
occurrence of an aggregating system that may form a gel which can be studied by 
applying a fractal analysis. As previously studied for the poly(acrylamide-acrylic acid) 
microgels system, the colloidal gel structure can be related to the rheological properties 
based on scaling laws[40]. 
A representation of the plateau values of G0 and γ0 already determined from the 
strain sweep experiments (Figure 5.13) is plotted as a function of concentration in 
double-logarithmic form in Figures 5.14-a and 5.14-b, respectively. 
 
 
Figure 5.14. (a) Elastic modulus plateau G0 and b) critical deformation, γ0, as a function of 
concentration of the aqueous dispersion: CS+TPP (■), NP+Fe 1% (●), NP+Fe 3.2% (▲), and NP+Fe 
5.6% (♦). 
 
As can be observe, the elastic modulus plateau, G0, increases as a function of the 
concentration of the dispersion for all the samples. The same behavior was observed for 
the critical deformation γ0, which indicates that as the concentration of the dispersion 
increases, it is necessary to apply more deformation to break the clusters. When samples 
with different ferrofluid contents are compared at the same concentration of the 
dispersion, an increase of the elastic modulus of the samples with ferrofluid content is 
observed with respect to the CS+TPP samples. 
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Both the elastic modulus and the critical deformation can be linearly fitted to 
relations of the type:  
                                                                                                                                  
                  
where  is the volume fraction and the exponents, A and B are the slopes corresponding 
to the fitting lines. 
According to the Wu and Morbidelli model[18], A and B have the form:  
                                              
                                                                              
                               
 
where D is  the fractal dimension and β is an auxiliary parameter defined as: 
                                 
 
where X represents the backbone fractal dimension or tortuosity of the network, whose 
value for a colloidal gel is in the range of 1-1.3[18]. α is a constant in the range [0, 1] 
which depends on the relation between the intra and the intermicroscopic elasticity 
which gives rise to the macroscopic elasticity in colloidal gels. α = 0 corresponds to a 
strong-link regime where interfloc links are stronger than intrafloc links so that the gel 
elasticity is dominated by the intramicroscopic elasticity. On the other hand, α = 1 
corresponds to a weak-link regime where interfloc links are weaker than intrafloc links, 
that is, the gel elasticity is dominated by the intermicroscopic elasticity [17]. In Figure 
5.15 is shown a representative scheme of interfloc and intrafloc links present in a 
colloidal gel. According to the Wu and Morbidelli model[18], intermediate regimes are 
obtained for values of α in the range 0 < α < 1. These intermediate regimes being 
between the weak-like and strong-like regime are more real and lead to intermediate 
situations where both inter- and intrafloc links contribute to the overall elasticity of the 
gel.  
AG ϕ≈0´
Bϕγ ≈0
D
A
−
=
3
β
D
B
−
−
=
3
2 β
)1)(2(1 αβ −++= X
Equation 5.2 
Equation 5.3 
Equation 5.4 
Equation 5.5 
Equation 5.6 
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Figure 5.15. Scheme of interfloc (dash line) and intrafloc (continue line) link in a colloidal gel.  
 
As can be observed, data represented in Figure 5.14 can be well fitted to a linear 
regression from which the slope is employed to determine the fractal dimension, D, and 
α constant. The results are summarized in Table 5.6.  
 
Table 5.6. Summary of the results obtained by applying Wu and Morbidelli’s scaling 
theory 
Sample A B D α Regime 
CS+TPP 6.2 5.9 2.8 0.9 weak 
NP+Fe 1% 3.4 3.3 2.7 0.9 weak 
NP+Fe 3.2% 5.3 5.3 2.8 1.0 weak 
NP+Fe 5.6% 4.4 4.7 2.7 1.0 weak 
 
Values corresponding to α are close to 1 in all cases which indicates that the 
samples are in the weak-like regime, that is, the interflocs links are weaker than 
intrafloc links. This implies that the macroscopic elasticity exhibited by the aqueous 
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dispersions is due to the establishment of interactions between the individual chitosan 
nanoparticles regardless the presence of ferrofluid. The fact that the interactions regime 
does not change with the ferrofluid concentration in aqueous dispersions of NP+Fe 
samples may be a consequence of the efficient encapsulation of ferrofluid inside the 
chitosan matrix.   
A fractal dimension of ~2.8 is found for all samples indicating the occurrence of 
dense fractal flocs. Interestingly, no change in fractal dimension is observed with the 
addition of ferrofluid to the material in agreement with the weak-like regime observed 
for all the samples, and the predominant interactions between the chitosan matrixes of 
the different nanoparticles. 
 
5.3.4 In vitro studies of chitosan nanoparticles 
 
Different kinds of experiments described in experimental part, have been carried 
out in order to establish the viability of ferrofluid loaded chitosan nanoparticles over 
Fibroblast. In this way, samples under study can be considered for biomedical 
applications. 
 
i. Morphological analysis of FBH treated with magnetic chitosan 
nanoparticles (NP+Fe 3.2%).  
 
Morphological analysis of Fibroblasts (FBH) treated with chitosan nanoparticles 
was studied by Scanning Electron Microscopy (SEM). As an example, Figures 5.16-a 
and 5.16-b show SEM images of FBH and FBH treated with NP+Fe 3.2% during 24 h, 
respectively. As can be observed, FBH is fully spread and well attached to the substrate; 
also, its surface was relatively smooth. On the other hand, Fibroblast treated with 
NP+Fe3.2% (Figure 5.16-b) are fully spread as well, which suggest its good cellular 
viability as will be confirmed trough cytotoxicity assay.  However, it is very clear that 
its surface is rougher (see the inset image). This change is due to addition of chitosan 
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nanoparticles to the medium, which may suggest a possible uptake or interaction with 
chitosan nanoparticles.  
 
 
Figure 5.16. SEM images of a) fibroblast and b) fibroblast treated with NP+Fe3.6%. The inset in Figure 
5.15-b shows a magnification of FBH. 
 
ii. Cytotoxicity study 
Figure 5.17 shows the results corresponding to the Alamar Blue assay carried 
out for all the samples under study dispersed at different concentrations in water.   
 
Figure 5.17. Alamar Blue assay results for all the samples under study and the negative control (c), cells 
without treatment. All the results are shown as mean 8 S.D. Asterisk (*) depicts a significant difference 
between the corresponding sample with respect to negative control (P < 0.05).  
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As can be observed, all the samples, including the ferrofluid exhibit a dose-
dependent effect. At high concentrations (2.5-1.25 mg/mL), the toxicity is significantly 
different between the ferrofluid and NP+Fe 1% and NP+Fe 3.2%. However, in the case 
of NP+Fe 5.6% a low cellular viability (<70%) is observed in comparison with the 
control even with CS+TPP or the ferrofluid. 
 
iii. Lactate dehydrogenase (LDH) assay. 
Lactate dehydrogenase (LDH), which is a soluble cytosolic enzyme present in 
most eukaryotic cells, releases into culture medium upon cell death due to damage of 
plasma membrane. The increase of the LDH activity in culture supernatant is 
proportional to the number of lysed cells.  
In order to establish the mechanism by which the NP+Fe samples tested with the 
AB assay gives rise to a decrease of the cellular viability, the test of lactate 
dehydrogenase (LDH) was performed. The LDH test allows determining whether the 
plasma membrane is damaged. The results plotted in Figure 5.18 indicate that the 
NP+Fe samples shows a cytotoxicity lower than 20% at the two concentrations tested (1 
and 0.05 mg/mL). Therefore, cell death is not due to damage in the plasma membrane. 
 
 
Figure 5.18. Lactate dehydrogenase assay results for NP+Fe at different concentrations.  
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From these results, it can be concluded that the cytotoxic effect of the ferrofluid 
is decreased when it is encapsulated inside chitosan nanoparticles. Therefore, NP+Fe 
samples do not compromise in vitro viability of this type of cells. 
 
5.3.5 Application ferrofluid loaded chitosan nanoparticles for magnetic 
hyperthermia 
 
In order to evaluate the potential application of ferrofluid loaded chitosan 
nanoparticles in magnetic hyperthermia, the heating performance of NP+Fe 
nanoparticles was carried out when are submitted to an alternating magnetic field. In 
Figure 5.19 is plotted the temperature increase as a functions of time for the three 
ferrofluid nanoparticles under study. From the Figure 5.19, we extracted the specific 
power absorption (SPA) from the initial slope of the temperature vs time curves, as can 
be observed in Figure 5.19 and explained in the following. 
 
Figure 5.19. Representative heating performance of a) NP+Fe 5.6%, b) NP+Fe 3.2% and c) NP+Fe 1%. 
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The SPA of the colloids was determined from the temperature increase (ΔT) of a 
given mass of the constituent nanoparticles (mNP) dispersed in a mass of liquid carrier 
(mLIQ) during the time interval (Δt) of the experiment, using the expression[41]: 
                      
 
 
where cLIQ and cNP are the specific heat capacities of the liquid carrier and the 
nanoparticles, respectively. Due to the low concentration, around 1% (w/v) of the 
magnetic material in the colloids we can use the approximation, 
LIQLIQNPNPLIQLIQ cmcmcm ≈+  , so that the equation to calculate SPA becomes: 
 
                             
 
Since the time dependence of temperature T is not linear, the slope of the T (t) is 
also a function of time. This is usually due to heat losses of the experimental setup, and 
thus a criterion is needed in order to extract reproducible and comparative information 
from experiments. We have chosen the criterion of the maximum derivative for 
calculating our SPA values, since this criterion has two main advantages: first, the 
maximum slope ΔT/Δt happens during the first few second of the experiment, and 
therefore during this short time the heating process can be considered as adiabatic. 
Second, because it occurs during the first seconds after the magnetic field is turned on, 
the maximum slope is located at an absolute temperature close to room temperature, 
irrespective of the final SPA value. Consequently, all SPA values are estimated at 
nearly the same (room) temperatures. 
The SPA values for all NP+Fe samples are shown in Table 5.7 together with the 
data calculated for the pure ferrofluid.  
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Table 5.7. Specific power absorption of the samples under study 
Sample ΔT/Δt Fe (mg/mL) SPA (W/g) 
FF 1,616 69,9 96,6 
NP+Fe 1% 0,003 1,9 8,4 
NP+Fe 3.2% 0,005 3,1 7,8 
NP+Fe 5.6% 0,007 5,6 5,3 
 
As can be observed, there are significant differences between the value reported 
for the ferrofluid and the values corresponding to the NP+Fe samples. This is a 
consequence of the low amount of magnetic material of the NP+Fe nanoparticles, as the 
specific power is given in unit mass of the composite nanoparticles. Therefore, these 
values could be improved if higher concentrations of ferrofluid within the chitosan 
nanoparticles can be encapsulated. In spite of the low SPA values reported here in 
comparison with the usually reported for pure ferrofluids, recent studies have outlined 
the capability of magnetic nanoparticles of inducing local damage in eukaryotic cells 
without increasing the macroscopic temperature, resulting in high percentages of cell 
death[42, 43]. It remains to be investigated whether similar mechanisms could be 
employed for intracellular drug release using magnetically loaded thermosensitive 
nanoparticles. 
 
5.4 CONCLUSIONS 
 
In the study of preparation, characterization and evaluation of properties, the 
following conclusions can be extracted. 
Chitosan nanoparticles were successfully prepared by ionic interactions among 
chitosan and TPP. Appropriated concentrations of reagents, chitosan and TPP were 
Chapter 5 
162 
 
determined for a success nanoparticles formation, being 0.5% (w/v) and with a 
volumetric ratio of 5:1, CS:TPP. Their particles size was determinate trough AFM 
analysis and DLS, where both techniques reported similar size, 154nm and 140 nm, 
respectively.  
Ferrofluid at different concentrations were encapsulated into chitosan 
nanoparticles, ionically crosslinked with TPP to yield magnetic core-shell chitosan 
nanoparticles with ferrofluid contents ranging from 1 to 5.6% (w/w). An increase in the 
size of the NP+Fe from 192 to 259 nm was observed as the ferrofluid content increased 
with respect to the chitosan nanoparticles without ferrofluid (140 nm). Ferrofluid loaded 
chitosan nanoparticles presented a positive zeta potential which indicated the 
encapsulation of ferrofluid into chitosan matrix, fact that was corroborated by FESEM 
images. Crystallinity properties of NP+Fe confirmed the presence of magnetite into the 
chitosan nanoparticles, also, evidence that coating process of chitosan did not result in 
the phase change of magnetite. The final thermal stability of NP+Fe decreased to 
respect at CS+TPP.  
A fractal analysis carried out on the results obtained from dynamic rheological 
experiments revealed the presence of interactions in between individual chitosan 
nanoparticles and the absence of formation of aggregates independently from the 
ferrofluid content. Finally, aqueous dispersions of NP+Fe flow at high strains and 
recover the initial elastic properties as the strain rate diminishes which demonstrates the 
shear-thinning properties of these materials.  
According the cytotoxicity assay, samples presented a dose-dependent effect and 
also was observed the cellular viability decreased as a function of ferrofluid content.  
Experiments on remote magnetic heating carried out on NP+Fe samples have revealed 
that aqueous dispersions (5% w/v) undergo an increase of temperature when subjected 
to an alternating magnetic field. Therefore, NP+Fe samples can be considered as 
potential candidates for magnetic hyperthermia due to their good biocompatibility 
demonstrated in the cytotoxicity studies and their ability to heat when submitted to an 
AMF.   
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Chapter 6 
IN VITRO STUDY OF MAGNETIC CHITOSAN 
NANOPARTICLES LOADED WITH 5-
FLUOROURACIL FOR MAGNETIC 
HYPERTHERMIA APPLICATIONS 
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This chapter described the preparation of chitosan nanoparticles loaded with 
ferrofluid and 5-Fluorouracil, a model chemotherapeutic drug. The drug release profile 
of these nanoparticles is analyzed as a function of pH and ferrofluid content. Moreover, 
all magnetic chitosan nanoparticles prepared in this study, have been assessed for in 
vitro magnetic hyperthermia applications. In addition, two protocols were proposed for 
hyperthermia experiments. Finally, cellular damage was analyzed through crystal violet 
staining and acridine orange and propidium iodide (AO/PI) staining.  
 
6.1. INTRODUCTION  
 
Polymeric based nano-carriers are important materials employed in many 
biomedical applications and have been developed in an assortment of morphologies 
including micelles [1, 2], nanoparticles [3-5], nanorods [6, 7], and so on. Specifically, 
polymeric nanoparticles (NPs) for biomedical applications provide several advantages 
including small particle size, increased drug efficacy, lowered toxicity, enhanced drug 
solubility and stability[8]. It is well known that polymeric nanoparticles prepared from 
biodegradable and biocompatible materials have advantages in biomedical applications 
[9]. Among them, chitosan is one of the materials that satisfy these requirements and 
therefore has become particularly attractive, especially when is employed as drug 
delivery carriers [10-12], permeating vectors for blood−brain barrier (BBB) [13], gene 
delivery[14] and pH-sensor[15] and hyperthermia agents[16-18]. 
As mentioned before, chitosan nanoparticles can be used as nano-carriers for 
drug delivery studies and 5-Fluorouracil (5-FU) was selected as a model drug, because 
it is well known its effective effect as chemotherapeutic anticancer drugs[19]. 5-FU has 
been extensively evaluated for its anticancer activity against several cancer models as 
colon, gastric, breast carcinomas and head and neck cancer[20]. There are also, several 
studies about 5-FU encapsulated chitosan nanoparticles for application as Ophthalmic 
delivery[21] or colorectal cancer[22, 23]. However, many of these chitosan 
nanoparticles loaded with 5-FU are composite matrix, such as chitosan-g-poly(N-
vinylcaprolactam) nanoparticles[24] or chitosan-PEG-gelatin[25].  
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As pointed in the general introduction, this study is also focused on 
hyperthermia applications for cancer treatment, by heating effectively and locally deep-
seated tumors. Moreover, hyperthermia treatment presents some advantages in 
comparison with other cancer treatments, as for example, chemotherapy, because it has 
few side effects as it is based on a higher sensibility of cancer cells to heat with regard 
to normal cells[26]. The latter fact has been explained because in cancer cells after 
hyperthermia treatment (temperatures achieved around 43 ºC), the oxygen supplied via 
the blood vessels is not sufficient to maintain the cells alive, whereas normal cells are 
not damaged even at higher temperatures[27]. In this regard, some studies of magnetic 
chitosan nanoparticles for hyperthermia applications are reported in the literature. 
However, in some cases their synthesis includes toxic reagents as example, Fe3O4 
loaded chitosan nanoparticles crosslinked with glutaraldehyde [28]. Also, other studies 
can be found as, coprecipitation of Fe3+ and Fe2+ with an aqueous NaOH solution and 
then encapsulated into chitosan matrix via a suspension crosslinking method[17], which 
require several steps. 
In recent years, much attention has been focused on development of 
nanoparticles that combined two or more treatments against different types of cancers 
by employing multifunctional nanoparticles. Multifunctional nanoparticles are based on 
materials that can response to external stimulus such as pH, temperature, magnetic and 
light and act as drug nano-carrier, as well[29]. Therefore, their synergistic effect will 
improve the cancer therapy. There are some studies that involved multifunctional 
nanoparticles for combined cancer therapy such as chemotherapy and gene therapy[30], 
pH-sensitive targeted delivery carriers[31], chemotherapy-biotherapy-hyperthermia[32].  
In order to enhance the therapeutic efficacy against cancer cells we propose on 
objective to develop a nano-carrier loaded with a model drug (5-FU) and ferrofluid into 
a chitosan matrix that is recognized as pH-sensitive. Moreover, chitosan matrix can help 
to provide the desirable characteristics of nanoparticles for hyperthermia application 
such as avoid ferrofluid agglomeration, an appropriated surface charge of nanoparticles 
for enhance cancer cell interaction[8] for its internalization and achieve the drug release. 
To the best of our knowledge, no study has been reported on the cancer therapy of 5-
Fluorouracil (5-FU) and ferrofluid loaded chitosan nanoparticles for in situ magnetic 
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hyperthermia applications in malignant human glioblastoma (A-172) and Fibroblasts 
(FBH).  
 
6.2 EXPERIMENTAL PART  
 
6.2.1. Materials 
 
Chitosan and ferrofluid employed in this work were the same described in 
chapter 3. 5-Fluorouracil (5-FU), acetic acid, sodium tripolyphosphate, acetate buffer 
(pH 5.2) and phosphate buffered saline (PBS pH 7.4) were purchased from Sigma 
Company (Sigma Company, St. Louis, MO, USA).  
 
6.2.2. Preparation of hybrid chitosan nanoparticles 
 
i. 5-Fluorouracil loaded chitosan nanoparticles (CS+FU) 
First, 5-fluorouracil was dissolved in 6 mL of an aqueous sodium 
tripolyphosphate (TPP) solution (0.5% w/v), to a final concentration of 0.5% (w/v). 
CS+FU nanoparticles were formed by dropwise addition of the TPP+5-FU solution into 
a chitosan stock solution (0.5% w/v) in a ratio chitosan: TPP+5-FU of 5:1, under 
mechanical stirring at room temperature. After reaction, CS+FU nanoparticles are 
collected by centrifugation and washed one time with distilled water. Then CS+FU 
nanoparticles were centrifuged at 5000 rpm, for 20 min. Only the supernatant is 
collected, because it is where the small CS+FU nanoparticles remain. Finally, the 
supernatant was separated and then it was dried by lyophilization.  
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ii. Hybrid chitosan nanoparticles (CS+FU+Fex) 
For combined hyperthermia treatment and drug release, 5-FU and ferrofluid 
loaded chitosan nanoparticles were prepared. First, three different concentrations of 
ferrofluid (with the same concentration as previous chapter, 1, 3.2 and 5.6% w/v) were 
dispersed in 5 mL of Milli-Q water. Each of this ferrofluid solution was mixed under 
mechanical stirring in a N2 atmosphere with chitosan solution (0.5% w/v) in a 
volumetric ratio chitosan:ferrofluid of 6:1. Separately, 6 mL of the aqueous TPP+5-FU 
solution prepared, as described in the previous section for the preparation of CS+FU 
nanoparticles. CS+FU+Fex nanoparticles were obtained by dropwise addition of 6 mL 
of TPP+5-FU solution into the solution containing the chitosan (30 mL) and ferrofluid 
(5 mL) under mechanical dispersion, followed by stirring for 10 min at room 
temperature. The nanoparticles dispersions were collected by centrifugation at 5000 rpm 
for 20 min. Finally, the supernatant was separated and then it was dried by 
lyophilization. 5-FU and ferrofluid loaded chitosan nanoparticles were named 
CS+FU+Fex, where x correspond to 1, 3.2 and 5.6% (w/v) of ferrofluid, respectively. 
 
6.2.3. Characterization of hybrid chitosan nanoparticles 
 
i. Morphological studies  
 
- Scanning Electron Microscopy with electron transmission (FESEM) 
For morphologic visualization of the samples by Scanning Electron Microscopy 
with electron transmission a Hitachi model SU8000 HRSEM was employed. It was used 
in the TE (electron transmission) detector bright field mode and SE operated at 0.5-30 
KV. The sample preparation was carried out with the same procedure described in 
chapter 5. 
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- Atomic Force Microscopy (AFM) 
AFM experiments were performed to analyze the morphology of the prepared 
nanoparticles following the same protocol as employed to characterized NP+Fex in 
previous chapter and using the same Multimode Scanning probe microscope. All of the 
images contained 256 × 256 data points. The nanoparticle diameter reported is the 
average of 100 nanoparticles and was analyzed using the ImageJ software. 
The coefficient of variance (CV) of size distribution was calculated as: 
CV (%) = (σ/D) x100  
where σ is the standard deviation (SD) of the particle size and D is their mean 
diameter. 
 
ii. Study of the chemical structure by Attenuated Total Reflection Fourier 
Transformed Infra-Red Spectroscopy (ATR-FTIR) 
Attenuated Total Reflection Fourier Transformed Infra Red Spectroscopy (ATR-
FTIR) was carried out on freeze-dried samples. Spectra were measured in a Spectrum 
One FT-IR Spectrometer of Perkin Elmer in the wave number range of 600-4000 cm−1 
and with 4 cm−1 resolution. 
 
6.2.4 Drug release from chitosan nanoparticles 
 
i. Evaluation of drug encapsulation efficiency and loading efficiency. 
For the determination of encapsulation efficiency (EE) of 5-FU in CS+FU and 
CS+FU+Fex, samples were centrifuged at 12000 rpm for 30 min, using centrifuge tubes 
IVSS Vivaspin 20, with a pore size of 3000 MWCO, to recover the residual fraction 
containing the 5-FU free. Then, this fraction was measured by ultraviolet spectroscopy 
(Perkin Elmer Instrument Lambda 35 UV/VIS spectrometer). 5-FU was measured at 
Equation 6.1  
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265 nm where an intense characteristic peak was displayed. The encapsulation 
efficiency was calculated according to the following equation[33]: 
              EE = total amount of 5-FU - amount of free 5-FU                          
                                          total amount of 5-FU 
 
The loading efficiency of 5-FU loaded into CS+FU and CS+FU+Fex samples 
was determined from the freeze dried samples as follows: a known amount of 
lyophilized samples was dissolved in acetic acid (1% v/v). Then the drug content was 
analyzed using UV/Vis spectrometry at 265 nm with the appropriate dilutions. The 
loading efficiency was calculated as follows: 
Loading efficiency (LC) = Amount of 5-FU incorporated in nanoparticles × 100 
                                      Amount lyophilized powder of sample                    
 
All measurements were performed in triplicate and the mean value calculated. 
 
ii. Evaluation of in vitro drug release. 
The release of 5-FU from CS+FU and CS+FU+Fex samples was studied at two 
different pHs, physiological pH (PBS at pH 7.4) and acidic pH (acetate buffer, pH 5.2) 
to simulate the tumoral environment[34]. Each of the samples under study was 
dispersed to a concentration of 0.01% (w/v). Then, each dispersion was placed into a 
dialysis tubing (MWCO 3500-5000 Da) that was immersed in 10 mL of the respective 
buffer at 37 ºC with moderate orbital stirring. An aliquot of 1 mL was withdrawn from 
the release medium at regular times and replaced with equivalent aliquots of fresh 
medium during 30 days. The kinetics of release of 5-FU from CS+FU and CS+FU+Fex 
samples was measured by UV/Vis spectroscopy (Perkin Elmer Instrument Lambda 35 
UV/VIS spectrometer, at 265 nm). All data reported are an average of three 
experiments.    
 
Equation 6.2  
Equation 6.3 
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6.2.5 Biological studies 
i. Cytotoxicity study by Alarmar Blue assay  
The cytotoxicity of the CS+FU and three CS+FU+Fex samples was measured 
through Alarmar Blue (AB) (provided by Serotec, Spain) assays for two cells lines, 
Fibroblast (FBH-INNOPROT SPAIN) and malignant human glioblastoma cells (A-172-
ECACC, UK). Both cells lines were seeded into 96 wells plates at a density of 10 × 
104cells/mL in complete medium and incubated to confluence. After being cultured for 
24 h, FBH and A-172 cells were treated for different aqueous dispersions of CS+FU and 
CS+FU+Fex samples and incubated at 37 ºC in humidified air with 5% CO2 for 24 h. 
After that, a solution of AB (10% v/v) prepared in a warm medium without phenol red 
was added to the plate and incubated at 37ºC for 4 h. Finally, fluorescence was 
measured with a Biotek Synergy HT detector using an emission wavelength of 590 nm 
and an excitation wavelength of 530 nm.  
Cell viability (CV) was calculated with the following equation:  
CV = 100 × (FDs – FDB/ FDC− FDB)  
 
where FDS, FDB, and FDC are the fluorescence density of the AB for the sample (S), 
blank (B) (culture medium without cells), and control (C), respectively. 
Samples were sterilized with a UV lamp (HNS OSRAM, 263 nm, 3.6UVC/W) at 
a power of 11 W for 2 h. 
 
ii. Cellular uptake of chitosan nanoparticles. 
The cellular uptake was determined by epifluorescent microscopy, which is a 
method that allows observing the nanoparticles carrying a fluorescent label (sodium 
fluorescein dye 20%) in different cells lines (FBH and A-172). The study was carried 
out for a selected group of chitosan nanoparticles (CS+TPP, NP+Fe5.6%, CS+FU and 
CS+FU+Fe5.6%) following the next procedure: a dispersion of fluorescent 
nanoparticles (0.06% (w/v) in medium without phenol red + fluorescein 0.01 % v/v) 
Equation 6.4 
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was added to the cells seeded onto a glass dish in semi confluence and incubates during 
24 h at 37 ºC and 5% of CO2. The cells were rinsed with phosphate buffered saline 
(PBS) and fixed with paraformaldehyde 3.7 % in PBS for 10 min at 37 ºC. After that, 
paraformaldehyde was removed and then rinsed with PBS. Finally, triton (Triton X-100, 
molecular biology grade, density 1.07 g/cm³) 0.05 % v/v in PBS was added for 20 min 
at 37 ºC for permeability in the cellular membrane. The samples were rinsed with PBS 
and the cell nuclei were stained with 10 µL/mL of Hoechst H33342 dye solution. In 
addition, phalloidin (1 µL/ 100 µL) was used for staining the actin cytoskeleton of the 
cells and left it for 30 min at room temperature in the darkness. Finally, fluorescence 
was observed with an epifluorescence microscope (Nikon eclipse TE2000-S) and three 
different filters. A DAPI filter set (excitation, 387-311 nm, emission bandpass 447-460 
nm) was used to detect cell nuclei, a FX RED filter set (excitation, 562-540 nm, 
emission bandpass 624-640 nm) was used for detect cytoskeleton of the cells and FITC 
filter set (excitation bandpass, 465–495 nm; emission bandpass, 515–555 nm) was used 
to detect fluorescent nanoparticles.   
 
6.2.6 In vitro magnetic hyperthermia experiments  
Two protocols were proposed in order to carry out the in vitro magnetic 
hyperthermia treatment over cancer and normal cells treated with hybrid chitosan 
nanoparticles. 
 
i. Protocols of study.  
- Protocol employing commercial equipment.  
The magnetic hyperthermia (MH) experiments were performed using a DM100 
equipment (nB nanoscale Biomagnetics, Spain) working at ƒ=580 kHz and 24 kA/m 
(≈300 Oe). Experiments were carried out within a thermally-insulated working space of 
about 1 cm3, using a closed vial of 1 mL volume. The study was carried out on 
malignant human glioblastoma (A-172) and fibroblast (FBH) loaded with chitosan 
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nanoparticles: CS+Fe5.6%, CS+FU and CS+FU+Fe5.6%. Sample CS+TPP was used as 
control. 
Both cells lines (FBH and A-172) were seeded onto discs of polystyrene (PS) (6 
mm of diameter), at a density of 10 × 104cells/mL in complete medium and incubated to 
confluence. First, PS discs were sterilized with ethanol and then with a UV lamp (HNS 
OSRAM, 263 nm, 3.6UVC/W) at a power of 11 W for 2 h. After being cultured for 24 
h, FBH and A-172 were treated with each of the corresponding dispersion of chitosan 
nanoparticles and incubated for 24 h. All nanoparticles dispersions employed were at 
non toxic concentrations, as determined by the cytotoxicity experiments (chapter 5). 
Then, both cells lines seeded onto disc of PS were taken and placed carefully into the 
vial, and after that it was filled with complete medium. In Figure 6.1 a scheme of the 
experiment is shown.  
Samples were exposed to the AC field during 20 min. Then, after the application 
of the magnetic field, the complete medium was removed and the samples were rinsed 
with PBS to remove dead cells and free chitosan nanoparticles. Samples were fixed with 
glutaraldehyde 2.5% (v/v) at 37 °C for 10 min immediately after the MH treatment 
(t=0). All the experiments were made by triplicate. 
 
 
Figure 6.1. Scheme for the in vitro magnetic hyperthermia treatment using PS discs. 
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- Protocol employing homemade equipment.  
The magnetic hyperthermia experiments were performed using a Power supply, 
(EASYHEAT 0224 BENCH) with an external heat station. We study the effect of an 
Alternative magnetic (AC) field working at 180 KHz and 35 KA/m (450 gauss) on the 
cell viability of two cells lines, malignant human glioblastoma (A-172) and fibroblast 
(FBH) loaded with chitosan nanoparticles: CS+Fe5.6%, CS+FU and CS+FU+Fe5.6%.   
Figure 6.2 shows the scheme of the experiment. Both cells lines (FBH and A-
172) were seeded onto an Ibidi dish (µ-Dish 35 mm, sterile, low wall) at a density of 15 
× 104 cells/mL in complete medium and incubated to confluence. After being cultured 
for 24 h, FBH and A-172 Ibidi dishes were treated with the corresponding dispersion of 
nanoparticles. Finally, after 24 h of incubation samples were exposed to the AC field 
during 20 min.  
 
 
Figure 6.2. Scheme for the in vitro magnetic hyperthermia treatment using Ibidi dishes. 
 
After that the samples were rinsed with PBS to remove dead cells and free 
chitosan nanoparticles. Samples were fixed with glutaraldehyde 2.5% (v/v) at 37 °C for 
10 min immediately after the MH treatment (t=0). Then, A-172 were treated again with 
chitosan nanoparticles and samples were fixed 4 h later (t=4) of the first MH treatment. 
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In order to study the cell death by several MH treatment, a second doses was 
applied 24 h latter of the first MH treatment. Samples were fixed 4 hours later (t=24) of 
the second doses. All the experiments were made for triplicate. During the experiment, 
the medium temperature was measured with an infrared camera (Jenoptik). 
 
ii. Determination of cell viability after of Magnetic Hyperthermia. 
Crystal violet (C.V) staining was used for determining cell viability after 
magnetic hyperthermia treatment. All the samples fixed, were treated with a 0.1% (w/v) 
of aqueous solution of crystal violet in PBS pH 7.2. After 10 min of incubation at room 
temperature under agitation, the staining solution was discarded; the samples were 
washed with Mili-Q water and then dried at 37 ºC. Finally, aqueous acetic acid (10% 
v/v) was added to the samples and an aliquot of 200 µL was taken and placed it into a 
well of plate to determinate the relative viability by a microplate reader at 620 nm-690 
nm.  
iii. Cell staining procedure. 
All the samples after the cell fixation were treated with acridine orange and 
propidium iodide (AO/PI), which were used to visualize living and dead cells 
simultaneously. Acridine orange (AO) is permeable to both live and dead cells and 
stains all nucleated cells to generate green fluorescence. On the other hand, propidium 
iodide (PI) enters dead cells with compromised membranes and stains all dead nucleated 
cells to generate red fluorescence.  
The procedure was as follows: All the samples fixed after magnetic 
hyperthermia treatment, were rinsed with PBS and then triton (Triton X-100, molecular 
biology grade, density 1.07 g/cm³) 0.05% v/v in PBS was added for 20 min at 37 ºC 
under low speed orbital shaking. After that, the samples were rinsed with PBS and 10 
µL/mL of AO/PI staining solution was added and left it for 30 min at room temperature 
in the darkness. Finally, the samples were rinsed twice with Tween 20 solution at 0.1% 
in PBS and left it with Mili-Q water. Samples were observed in an epifluorescence 
microscope (Nikon eclipse TE2000-S) equipped with a FX RED filter set to detect dead 
cells, and a FITC filter set to detect live cells. 
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6.3. RESULTS AND DISCUSSION  
 
6.3.1 Preparation of ferrofluid and 5-Florouracil loaded chitosan 
nanoparticles. 
Chitosan nanoparticles loaded with 5-Fluorouracil and ferrofluid at different 
concentrations were synthesized as described in experimental section. Chitosan 
nanoparticles have been prepared using a method based on electrostatic interaction 
between the positive amino groups of chitosan with the negatively charged phosphate 
groups of TPP explained in the chapter 5. In this way, these kinds of nanoparticles 
might act as dual functional material for drug release and magnetic hyperthermia 
treatment.  
 
6.3.2 Characterization of nanoparticles 
 
i. Morphological studies 
Figure 6.3 shows the FESEM micrograph corresponding to CS+FU+Fe3.2% 
nanoparticles. Bright field image allows corroborating the encapsulation of ferrofluid 
within a matrix of chitosan. The Figure 6.3, with the use of microscope software, 
permits obtained an estimation of nanoparticles sizes, which are in the order of 200 nm 
or less. However, this image suggests a high polydispersity, as will be confirmed by 
AFM analysis. From this morphological analysis, it is important to highlight that 5-FU 
and ferrofluid (as was proved in the previous chapter) does not affect the nanoparticles 
formation.  
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Figure 6.3. Micrograph corresponding CS+FU+Fe3.2% nanoparticles by field emission scanning 
electron microscopy. 
 
 The AFM analysis allows determining the morphological appearance and size 
for chitosan nanoparticles loaded with 5-FU and ferrofluid with different ferrofluid 
concentration (1, 3.2 and 5.6% w/v). Figure 6.4 shows the topography, the 
corresponding 3D image and histograms of the samples under study. The nanoparticle 
size provided by AFM corresponds to CS+FU+Fex nanoparticles spread and dried on a 
glass surface. As can be observe, all the samples presented a nearly spherical shape and 
a size in the range of 140-200 nm. The nanoparticles diameter is reported on the Figure 
6.4. Coefficient of variance (CV) was calculated according to the data obtained from the 
histogram and all the samples presented a CV in the range of 15-20%. This parameter 
describe the dispersion of samples, that can be related with the Gaussian curve (Figure 
6.4-c), it is observed that CS+FU+Fe1% and CS+FU+Fe5.6% presented a similar 
Gaussian curves, on the contrary CS+FU+Fe3.2%. The latter sample presented a 
slightly lower CV than rest of samples; consequently its Gaussian curve is narrower. 
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Figure 6.4. AFM images A) Topography (area 5 × 5 μm), B) 3D images and C) histogram, of 
CS+FU+Fex with different ferrofluid concentration (x= 1, 3.2 and 5.6% w/v). 
 
ii. Analysis of the chemical structure.  
ATR-FTIR analyses in the region of 600–2000 cm-1 was carried out to study the 
hypothesized interaction among the components of chitosan nanoparticles (chitosan, 5-
FU and ferrofluid). The 5-FU chemical structure is shown in Figure 6.5. Its spectrum 
(Fig 6.6-a) presented well define and sharp peaks at 1651 cm-1 attributed to C=O 
stretching, 1501 cm-1 assigned to N-H amine II band, N-H stretching of amide at 1429 
cm-1, 1245 cm-1 for C-F and 804 cm-1 due to C-H out of plane deformation[35].  
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Figure 6.5. 5-Fluorouracil  chemical structure. 
 
CS+TPP spectrum (Figure 6.6-b) as studied in the previous chapter, presents the 
band at 1570 cm-1 corresponding to N-H amine II band, 1218 cm-1 attributed to P=O 
stretching vibrations in phosphate ions of TPP and 1650 cm-1 that corresponds to C=O 
stretching.  
Spectra of CS+FU (Figure 6.6-c), CS+FU+Fe3.2% (Figure 6.6-d) and 
CS+FU+Fe5.6% (Figure 6.6-e) show a strong band at 1246 cm-1 and 813 cm-1 attributed 
to the presence of 5-FU (Figure 6.6-a). The band corresponding to the band attributed to 
N-H stretching of amide in 5-FU spectrum (Figure 6.6-a) which appeared at 1429 cm-1 
shift to 1407 cm-1 for all the samples loaded with 5-FU. Moreover, it was observed a 
shift corresponding to amino groups for CS+FU (Figure 6.6-c), CS+FU+Fe3.2% 
(Figure 6.6-d) and CS+FU+Fe5.6% (Figure 6.6-e) to respect at CS+TPP spectrum 
(Figure 6.6-b). This band in CS+TPP spectrum appeared at 1570 cm-1 and shifts to 1551 
cm-1 for CS+FU and CS+FU+Fe3.2%, while CS+FU+Fe5.6% presented a shift at 1557 
cm-1. These shifts could suggest the presence of hydrogen bonding between the polar 
functional groups in 5-fluorouracil and NH2 groups of chitosan. In addition, the band 
located at 804 cm-1 in 5-FU spectrum presented a shift to 808 cm-1 for CS+FU. With 
regard to CS+FU+Fe3.2% and CS+FU+Fe5.6% this band appeared at 813 cm-1. The 
higher shifts observed for samples loaded with ferrofluid, could suggest an interaction 
among 5-FU and ferrofluid.    
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Figure 6.6. ATR-FTIR spectra of a)5-FU, b)CS+TPP, c)CS+FU, d) CS+FU+Fe3.2% and e) 
CS+FU+Fe5.6%. 
 
To explain the above results, it is proposed the formation of a metal complex, 
based on a central atom or ion (in this case iron), bonded to a surrounding array of 
molecules or anions (ligands) which could interact with amine groups of the samples. 
Although, the bands corresponding to iron oxide nanoparticles were not observed by 
this technique. However, this kind of interaction among 5-FU and iron oxide 
nanoparticles (IONPs) has been recently reported in the literature[36]. This fact could 
explain as well, the slight shifts of the N-H amine band between samples loaded with 
ferrofluid in Figure 6.6. The N-H amine band appeared at 1551 cm-1 for 
CS+FU+Fe3.2% spectrum (Figure 6.6-d) and at 1557 cm-1 for CS+FU+Fe5.6% 
spectrum (Figure 6.6-e). Taking into account this hypothesis, of a metal complex, it 
could also affect other results, such as, the drug release and the loading efficiency of 
chitosan nanoparticles, as it will explain ahead.  
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6.3.3 Drug release from chitosan nanoparticles 
 
i. Drug encapsulation efficiency and loading efficiency. 
The encapsulation efficiency (EE) and loading efficiency (LC) of 5-FU in 
chitosan nanoparticles was determined through UV-spectroscopy, as described in 
experimental part. The results are summarized on Table 6.1.  
With regard to EE, all the samples presented very similar values on the range of 
80-82%. These results agree with other investigations which report EE on the range of 
80-85%[37]. On the other hand, LC values obtained for all the samples are on the range 
33-35% (Table 6.1), with the exception of CS+FU+Fe5.6%, which presented a 
significant increase in LC. This difference in the LC value obtained for CS+FU+Fe5.6% 
in comparison to the other ferrofluid loaded chitosan nanoparticles could be explained 
by the formation of a complex between iron and 5-FU, as was suggested by ATR-FTIR. 
This would explain why the same concentration of 5-FU (0.5% w/v), the sample with 
the highest amount of ferrofluid (CS+FU+Fe5.6%) presents the highest LC. 
 
Table 6.1. Loading efficiency (LC) and encapsulation efficiency (EE) of the samples 
under study. 
Sample EE(%) LC(%) 
CS+FU 81.9±0.6 33.8±7.2 
CS+FU+Fe1% 81.4±0.8 37.5±6.4 
CS+FU+Fe3.2% 80.8±0.7 34.7±4.0 
CS+FU+Fe5.6% 80.6±0.4 70.6±2.0 
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ii. In vitro drug release. 
Figure 6.7 shows the in vitro drug release of 5-FU from CS+FU and three 
CS+FU+Fex samples. As can be observed, all the samples presented a burst on the first 
day caused by diffusion of 5-FU located closer to the surface of chitosan nanoparticles 
at the two measured pH. Then, there was a controlled diffusion of 5-FU from chitosan 
nanoparticles during the next 30 days. 
From a general overview, there is a very clear dependence of the amount of 5-
FU released as a function of pH. For CS+FU, at the cumulative 5-FU release after three 
days was ~45% and at pH 5.2 was ~20%. However, for CS+FU+Fe1% and 
CS+FU+Fe3.2% at pH 5.2 the cumulative 5-FU release was similar ~18-23% but at pH 
7.4 decreases to ~35%.  These results might be explained by considering the major 
solubility of 5-FU in pH 7.4 than in pH 5.2 as previously reported [38].  
In contrast, for CS+FU+Fe5.6% is evident that amount of 5-FU released was 
independent from the pH, obtaining a percentage of the cumulative 5-FU release of ~10-
15%. It is observed the drug delivery is much lower for CS+FU+Fe5.6%. This fact, can 
be explained by the stabilization of 5-FU for the iron as we demonstrated thorough 
ATR-FTIR.  
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Figure 6.7. In vitro release of 5-FU from chitosan nanoparticles at pH=7.4 (empty symbols) and pH=5.2 
(full symbols) at 37 ºC: A) CS+FU, B) CS+FU+Fe1%, C) CS+FU+Fe3.2% and D) CS+FU+Fe5.6%. 
 
According to the results obtained, it is possible to modulate the drug release as a 
function of the ferrofluid concentration and pH for all the samples under study in order 
to provide a prolonged release of drug. 
 
6.3.4 Biological studies 
 
i. Cytotoxicity assays 
The cytotoxicity of samples under investigation CS+FU+Fex (x= 1,3.2 and 5.6% 
w/v) was evaluated with the Alamar Blue assay. The experiments were tested in two 
cell lines, Fibroblast and malignant human glioblastoma cells (A-172). Both cells lines 
were treated with chitosan nanoparticles dispersed at different concentrations in medium 
without phenol red. 
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Figure 6.8 shows Alamar Blue assay results, it is observed that all the samples 
presented a dose-dependent effect for both cells lines, that is, the higher the 
concentration of nanoparticles in the aqueous dispersions, the lower the cell viability. 
Specifically for CS+FU+Fe5.6%, at high concentration (5 mg/mL) presented a cell 
viability of ~10% for both cells lines, but at lower concentrations (0.6 mg/mL), cell 
viability achieved was almost 100% for FBH (FBH, Figure 6.8-a) and ~70% for A-172 
(Figure 6.8-b). This difference of the cell viability as a function of cell line can be 
attributed at two factors: firstly to the effect of drug action and secondly to intrinsic 
features of each cell line. Which means that cancer cell with regard to normal cells, loss 
important features as fast cell proliferation, loss of adhesion, invasion capacities and 
high resistant to die[39]. In this case, cancer cells (A-172) being sensitive to chitosan 
nanoparticles can be beneficial for the final application.   
 
 
Figure 6.8. Alamar Blue assay results, A) FBH and B) A-172 for chitosan nanoparticles loaded with 5-
FU at different concentrations, and for the negative control, cells without treatment. All the results are 
shown as mean n=4 ±S.D. 
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Based on the results found on AB assay, the concentration proposed for the next 
biological studies is 0.6 mg/mL, because at this concentration both cells lines showed 
high viabilities values. 
 
ii. Cellular uptake of chitosan nanoparticles  
The cellular uptakes of different chitosan nanoparticles in FBH and A-172 cells 
lines after 24 h of incubation have been measured through fluorescence technique using 
an epifluorescence microscope. The study was carried out for the following chitosan 
nanoparticles: CS+TPP, CS+Fe5.6%, CS+FU and CS+FU+Fe5.6%, at a concentration 
of 0.6 mg/mL. In Figure 6.9 is shown fluorescence images corresponding to cell lines, 
FBH and A-172 incubated with sample CS+FU+Fe5.6% for 24 h. To obtain a good 
observation for the fluorescence images different dyes were used, CS+FU+Fe5.6% were 
stained with sodium fluorescein dye (green), the cellular nuclei were stained using a 
Hoechst H33342 dye solution (blue) and the cytoskeleton of the cells were stained using 
phalloidin (red). The merged image (union of the three stains) shows that after 24 h of 
incubation, CS+FU+Fe5.6% were successfully internalized into both cells lines. Some 
agglomeration was observed around the cellular nuclei for both cases.  
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Figure 6.9. Uptake studies for CS+FU+Fe5.6% after 24 h of incubation, for FBH and A-172 cells lines.  
 
With regard to the rest of the samples, similar results have been obtained (see 
Annexed 1). Therefore, the physicochemical properties of chitosan nanoparticles 
prepared as example, positive surface charge, size, composition and encapsulation of 
different materials (ferrofluid and 5-FU) allow effective uptake into both cell lines. In 
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addition, it was observed that cellular uptake was independent of the nanoparticles size 
(range 140-200 nm) for our samples.   
 
6.3.5 In vitro Magnetic hyperthermia experiments  
 
Magnetic hyperthermia treatment was applied over two cells lines, A-172 and 
FBH treated with chitosan nanoparticles (CS+Fe5.6%, CS+FU and CS+FU+Fe5.6%). 
For this experiment, two protocols were proposed. Both protocols are based on to avoid 
the harvesting of such cells and to assure their cellular viability. The first protocol made 
use of commercial equipment and the second protocol of homemade equipment.  
 
i. Protocols of measurements. 
- Protocol employing at commercial equipment. 
 This experiment was carried out with commercial equipment, DM10. Therefore, 
it was necessary to select a support to seed the cells with the appropriate dimensions, 
because, it is introduced into a vial (see Figure 6.1). A small discs of polystyrene (PS) 
was employed to seed both cells lines (FBH and A-172).  
 
Figure 6.10. Photograph of crystal violet staining for FBH and A-172 cells lines seeded onto PS discs, 
after one magnetic hyperthermia treatment. 
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 Figure 6.10 shows, photographs of crystal violet staining for FBH and A-172 
after 20 min of MH treatment. Both cell lines presented an important change in their 
morphology, attributed to a cellular damage for the two cells lines. In particular, FBH 
cells treated with all the samples under investigations, mainly for CS+FU+Fe5.6%, 
samples look like “burn”. In the case of A-172 cells, there are some dark areas, which 
we attributed to cellular death.  
Despite of all the experiments were carried out by triplicate, the determination of 
cell viability by crystal violet was no reproducible and therefore we decided that this 
protocol is not accurate. Moreover, in some photographs it was observed some empty 
spaces on their surface (photographs not shown here). This negative result could 
indicate that PS discs are not the appropriate material for this kind of experiments, 
because it is not a commercial material for cell culture or need a special covering. So, 
taking into account these drawbacks, we discard this protocol. 
   
- Protocol employing homemade equipment.  
For this second protocol, we keep the same principle of avoiding the harvesting 
of the cells, as in the previous protocol. In addition, for this experiment Ibidi dishes 
were employed (see Figure 6.2), that are the material of choice for rest cell studies. 
Homemade equipment was employed for this experiment and it was possible to recorder 
the temperature of the samples with an infrared camera.  
 
ii. Determination of cell viability after of Magnetic Hyperthermia. 
Figure 6.11 shows photographs of crystal violet staining for FBH and A-172 
treated with different samples, after one doses of magnetic hyperthermia (MH) 
treatment and immediate fixation of cells with glutaraldehyde (t=0). Photographs were 
taking at 2X magnification (Figure 6.11-a) and 10X magnification (Figure 6.11-b). 
Figure 6.11-a shows for FBH and A-172 cells an evident cellular damage after the MH 
treatment, the small spots correspond to dead cells or in apoptosis process. As can be 
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observed in Figure 6.11-b, for both cell lines there are important changes over cells 
morphology after the hyperthermia treatment mainly for CS+FU+Fe5.6%. These 
changes on their morphology are due to cell shrinkage and as a result they presented 
smaller size, the cytoplasm is dense and the organelles are more tightly packed, thus 
suggesting that cells undergo on apoptosis process [40]. Therefore, this result 
demonstrates the ability of chitosan nanoparticles to produce cellular damage after MH 
treatment which results in a percentage of cell death, despite of low chitosan 
nanoparticles concentrations employed in these biological studies.  
 
 
Figure 6.11. Photograph of a) representative images with a magnification of 2x, of control and 
CS+FU+Fe5.6% for both cells lines and b) crystal violet staining for FBH and A-172 cells lines 
(magnification of 10X)  after one magnetic hyperthermia treatment and fixed immediately. 
 
Despite of the cellular damage observed in the photograph (Figure 6.11), it was 
impossible to observe an increasing of temperatures of the whole cell medium (44-46 
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°C) necessary to hyperthermia conditions[41]. This fact could be explained due to the 
low concentration of nanoparticles used for the experiment (0.6 mg/mL). In the 
experiment there was no increasing of temperature detectable with the infrared camera 
(Figure 6.12), although, temperature was homogeneous on the Ibidi dish, as can we 
observed in Figure 6.12.  
 
 
Figure 6.12. Photograph of infrared camera of FBH and A-172 cells lines in the moment of magnetic 
hyperthermia treatment was applied. 
 
Despite, that there was no increasing detectable of temperature during the MH 
experiments, Figure 6.11 shows a cellular damage of the samples under study. It has 
been reported some hypothesis that could explain this fact and to conclude that cellular 
death, after MH treatment, can be related to cluster formation of several cells fully 
loaded with magnetic nanoparticles and not to the temperature increase of a single 
cell[41]. 
In order to quantify the impact of MH over both cells lines, cell viability was 
determined through crystal violet staining for samples subjected to one MH treatment. 
As can be observed in Figure 6.13, after the first MH treatment, there is a significant 
reduction of the cell viability as a function of cell type being malignant human 
glioblastoma (A-172) more sensitive to MH treatment than normal cells (FBH). In fact, 
FBH treated with all the samples under study presented cell viability higher than ~94 %, 
which indicates than MH treatment does not have an important effect on these cells. On 
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the contrary, A-172 treated with chitosan nanoparticles presented an important decrease 
in the cell viability on the range of 67-75%. Therefore all chitosan nanoparticles were 
effective for A-172 after MH treatment achieving a reduction of cell viability. This 
difference could be related with loss of properties of cancer cells with regard to normal 
cells and it is a key issue for hyperthermia.  
 
 
Figure 6.13. Crystal Violet results, cell viability for FBH and A-172 cell lines after one MH treatment 
(t=0). 
 
In principle, no significant differences are observed between the cell viability 
calculated after the first MH treatment with crystal violet and the cell viability obtained 
by Alamar Blue assay (see Figure 6.8). This fact could be explained because crystal 
violet procedure stained all the cells including those that are in apoptosis process, which 
artificially increase the relative viability reported. This few selectivity in the stain 
process over different the states of the cells could mask, the effect of chitosan 
nanoparticles over both cells lines and hence the effect of the MH treatment over cell 
viability.  
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Taking into account this, as there is no literature study concerning the optimum 
time to fix the cells, the same MH experiment was applied to A-172 cell line but 
samples were fixed 4 h later of the first MH treatment, instead of being fixed 
immediately.     
In Figure 6.14 is shown crystal violet staining for A-172 cell lines photographs 
after the MH treatment and fixed 4 h later, taking at 2X magnification (Figure 6.14-a) 
and at 10X magnification (Figure 6.14-b). In Figure 6.14-a is observe a clear evidence 
of the cellular damage after the MH treatment. In Figure 6.14-b, it is possible to observe 
in detail how samples look. As can be observed, some of the cells in apoptosis process 
were removed after rinsing the samples before of their fixation. However, if we analyze 
the morphology of the cells that are still on the Ibidi dish, they look as healthy cells or 
in recuperation process. This fact is based on their long filopodia, which suggest that 
cells are growing and in recuperation process, however, it is still possible to observe 
some cell shrinkage. 
 
 
Figure 6.14. Photograph of crystal violet staining for A-172 cells lines after one magnetic hyperthermia 
treatment and fixed 4 h later, a) photograph taken at 2X, b) photograph with 10X of magnification. 
 
This hypothesis of the cell regeneration, 4 h later, of the MH treatment, was 
quantified trough crystal violet. The comparison of cell viability of samples fixed at t=0 
and t=4 is shown in Figure 6.15. On the one hand, it is very evident that cell viability 
decreased as a function of type of chitosan nanoparticles. In fact, cells treated with 
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CS+FU+Fe5.6% presented the lowest cell viability (~93%). On the other hand, cell 
viability of sample fixed at 4 h later of the MH treatment, increased to respect at 
samples fixed at t=0. This increase indicates cell regeneration during this 4 h. Therefore, 
this cell regeneration and their fast proliferation rate, mask the effect of chitosan 
nanoparticles over the A-172 cell line. 
 
 
Figure 6.15. Comparison of cell viability for A-172 cell line after one MH treatment fixed a different 
times. (t=0 and t=4). 
 
iii. Cell staining. 
AO/PI staining (Figure 6.16) allows recognizing easily dead cells (red 
fluorescence), lived cells (green fluorescence) and cells in the process of death (orange 
fluorescence) after MH treatment. In Figure 6.16 fluoresce images for FBH at t=0 and 
A-172 at t=0 and t=4 are show. It is observed for A-172 cell line dead cells, while for 
FBH was not abundant. This effect is also evident for A-172 cells fixed at t=4 where red 
fluorescence highly increases for cells treated with CS+FU+FE5.6%. This indicates a 
higher number of dead cells in this case. 
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Figure 6.16. Fluoresces images for FBH and A-172 cells lines treated with samples under study, 
obtained after AO/PI staining after one magnetic hyperthermia treatment and fixed at different times. 
 
iv. Effect of two Magnetic Hyperthermia treatments 
 
A second magnetic hyperthermia (MH) treatment was applied to A-172 cell line 
and samples were fixed 4 h  later (t=24). Cell viability was determined by crystal violet 
as in the previous MH treatment. Their corresponding photographs of crystal violet 
staining see Annexed 2.  
Figure 6.17 shows a comparison of the cell viability of cancer cells (A-172) with 
after one and two MH treatments and samples fixed 4 h latter of each treatment. As can 
be observed, the cell viability after a second MH treatment increases to respect at t=4 
for cells treated with NP+Fe5.6%. This fact can be explained, for the cell proliferation 
rate of A-172, which overcomes the cellular death. Also, these results suggest that some 
of the cells damaged during the MH treatment exposure appear as ‘healthy’ cells within 
few hours after (4h). In the case of cells treated with CS+FU the cell viability did not 
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present a significant change. Nevertheless, for samples treated with CS+FU+Fe5.6% 
cell viability decreased with regard to t=4 overcomes the cell proliferation.  
 
 
Figure 6.17. Comparison of cell viability for A-172 cell line determined by crystal violets at t= 4 and 
after a second MH treatment (t=24). 
 
AO/PI staining was made as well for this experiment, which it was possible to 
observed death cells (the results are show in Annexed 3). Figures 6.18 shows a 
representative images for A-172 cell line treated with CS+FU, obtained after AO/PI 
staining (Figure 6.18-a) and crystal violet staining (Figure 6.18-b) after a second MH 
treatment. In both images, it is observed a vacuolization process (circles) by the 
appearance of empty bags into cytoplasm, which indicated than cells are in process 
death. All this bags are enclosed within an intact plasma membrane, as can be observed 
in both images, which it is an important feature for apoptosis[40]. Also, typical nuclei 
separation and chromatin condensation related with apoptosis was observed (arrows). 
These results suggested that chitosan nanoparticles are capable of inducing apoptosis in 
A-172 cells. Same results were obtained for the other samples.  
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Figure 6.18. a) Fluoresce images obtained after AO/PI staining and b) crystal violet staining for A-172 
cell line treated with CS+FU, where is observed the vacuolization process (circles) and chromatin 
condensation (arrows).  
 
 Taking in account, all the biological studies performed after the magnetic 
hyperthermia applications, chitosan nanoparticles loaded with ferrofluid and 5-FU, arise 
as potential dual functional system against cancer. 
 
6.4 CONCLUSIONS  
 
In the study of preparation and characterization of 5-FU and ferrofluid loaded 
chitosan nanoparticles for in vitro Magnetic Hyperthermia, the following conclusions 
can be drawn: 
5-FU and ferrofluid loaded chitosan nanoparticles with dual properties for 
magnetic hyperthermia treatment and drug release were successful obtained by 
electrostatic interaction among chitosan and TPP. From the ATR-FTIR analysis, it was 
demonstrated on one hand, the electrostatic interaction between matrix (chitosan) and 
drug (5-FU) and on the other hand, drug with ferrofluid.  
The loading efficiency (LC) and encapsulation efficiency (EE) calculated for 
chitosan nanoparticles are comprised on the range of 30-36% and 80-85% respectively.  
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It was demonstrated that drug delivery profile of 5-FU from chitosan nanoparticles can 
be modulated as a function of ferrofluid concentration and pH. Moreover, drug delivery 
was faster at pH physiological than acid pH (pH 5.2). Therefore, these results evidence 
that chitosan nanoparticles and magnetic chitosan nanoparticles are an efficient nano-
carrier for drug release applications. 
Cytotoxicity assays by Alamar Blue showed that all the samples presented a 
dose-dependent effect for both cells lines and that as a function of cell line, cancer cells 
were more sensitive to chitosan nanoparticles loaded with 5-FU and ferrofluid than 
normal cells.  
Chitosan nanoparticles were successfully internalized over normal cells 
(Fibroblast) and malignant human glioblastoma (A-172). Physicochemical properties of 
all chitosan nanoparticles (size 140-200 nm) were optima for their uptake with both 
cells lines.  
Magnetic Hyperthermia (MH) treatment was applied over Fibroblast and 
malignant human glioblastoma cells (A-172) and treated with chitosan nanoparticles 
using two different protocols. A protocol was designed making use of commercial 
equipment. This protocol presented several drawbacks, as not reproducible results and 
PS disc used to seed the cells presented irregularities on its surface. Therefore, a second 
and definitive protocol was employed based on homemade equipment. A-172 cell line is 
more sensible to MH treatment than FBH. Cell viability for A-172 was on the range of 
67-75%. Samples fixed 4 h later of the first MH treatment, presented a cell regeneration 
which masked the effect of chitosan nanoparticles.   
The effect of a second MH treatment over A-172 was evaluated and it was 
evident the regeneration of some cells damaged after the treatment and therefore 
increased cell viability, however it was observed a reduction of ~20% with regard to 
control. Also, AO/PI staining and crystal violet staining leaded analysis morphologies 
changes over both cells lines after MH treatment and where was evident apoptosis 
process. 
In view of the entire characteristic, 5-Fluorouracil and ferrofluid loaded chitosan 
nanoparticles after an optimization process can be considered as potential nano-carrier 
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for hyperthermia application, achieving a reduction of cell viability and incite the 
apoptosis after MH treatment.  
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The present work has been focused on the Development of hybrid chitosan 
hydrogels for combined application in magnetic hyperthermia and drug delivery.  
Considering this objective, different chitosan hydrogels have been prepared: hydrogels 
with different size scale: macrogels, microgels and nanogels; composite 
chitosan/agarose hydrogels and ferrofluid loaded chitosan hydrogels. A systematic 
investigation on the preparation of each type of chitosan gel has been carried out and the 
effect of different experimental factors such as polymer concentration, crosslinking 
process, incorporation of the second polymer, addition of ferrofluid, flow rates, over 
their final properties has been analyzed. A deep characterization of the different 
chitosan systems by techniques such as Attenuated Total Reflection Fourier 
Transformed Infra-Red Spectroscopy (ATR-FTIR), thermogravimetric analysis (TGA), 
Scanning Electron Microscopy (SEM), X-ray diffraction measurements (XRD), and 
rheology was carried out. From the results obtained, the next general conclusions can be 
established: 
 
i. In the study of chitosan macrogels, the following general conclusions can be 
extracted: 
- In the synthesis of alkali chitosan macrogels obtained by precipitation in alkali 
media, hydrogen bonding and hydrophobic interactions are the responsible of 
their formation. From the viscoelastic study and fractal analysis, it can be 
concluded that all the samples present typical gel behaviour, in which the 
dynamic elastic modulus (G´) is relatively independent of the frequency of 
deformation, and that gels are constituted of flexible chains linked each other 
through the formation of cooperative hydrogen bonds.  
- In the synthesis of chitosan ferrogels prepared by in situ synthesis of iron 
oxide nanoparticles within chitosan matrix, chitosan concentration had a direct 
influence over the formation of iron oxide nanoparticles and chitosan ferrogels 
presented a higher thermal stability with regard to alkali chitosan macrogels. 
From the viscoelastic study, it is observed that elastic modulus of the chitosan 
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ferrogels depends on the concentration of chitosan and on the concentration of 
iron oxide nanoparticles.  
- Composite chitosan/agarose macrogels prepared by agarose gelification in the 
presence of a chitosan solution presented higher temporal stability (mass loss) 
than agarose macrogels. Temporal stability increased as a function of agarose 
concentration. Temperature and pH are two external parameters that also 
influence the temporal stability of composite chitosan/agarose macrogels. 
Samples were more stable at 37 ºC than at 45 ºC and with regard to pH, samples 
were more stable at physiological pH than in acid pH (pH=5.2). The melting 
point and elastic modulus increased as a function of agarose concentration; 
therefore chitosan addition improved the properties (mechanical properties and 
temporal stability) of the resulting composite gels.     
- Composite chitosan/agarose macrogels loaded with ferrofluid presented a 
porous microstructure. Their thermal stability increased with the ferrofluid 
content. Ferrofluid loaded chitosan/agarose macrogels presented lower melting 
point and elastic modulus with regard to composite chitosan/agarose macrogels, 
although no significant difference was observed with the ferrofluid content. 
Moreover, composite chitosan/agarose macrogels loaded with ferrofluid had the 
capacity to heat when submitted to an alternative magnetic field. With regard to 
their drug release profile, chitosan/agarose gels assured that 5-FU can be 
released along time (96 days) under the conditions employed in this work and 
the 5-FU release was higher at physiological pH than at acid pH (pH=5.2). 
 
ii. In the study of the preparation of chitosan microgels through microfluidics 
technique employing different microfluidic devices, it is possible to 
conclude that: 
- Microfluidics technique allowed both the emulsification of chitosan through T-
junction and flow-focusing droplet generator and the formation of chitosan 
microgels. 
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- In the study of flow-focusing droplet generator, two crosslinking processes in 
order to obtain chitosan microgels crosslinked with tripolyphosphate salts were 
assessed: off-chip and on-chip. The first process allowed the formation of 
chitosan droplets with diameters of 16 μm with a CV of 4.6%; however, a jetting 
regime was obtained accompanied of satellite droplets.  
- For on-chip crosslinking process of chitosan, two devices were proposed. A 
device with three inlets leads to fiber formation due to the fast crosslinking 
reaction among chitosan and sodium tripolyphosphate (TPP). A fourth inlet 
device, consisted in the incorporation of another dispersed phase, acetic acid, 
that favoured the chitosan microgels formation. In this case, the average 
diameter of the chitosan microgels decreased with the flow rate of the oil phase 
and the residence time of the chitosan microgels in the MF device affected the 
microgel size. 
- Composite chitosan/agarose microgels were successfully obtained by 
microfluidics technique using a flow-focusing device yielding transparent 
microgels with a well-defined round shape and polydispersity below 1.5%. 
Agarose concentration and the flow rate had a direct effect over their size, at 
higher agarose concentration the microgels size increased. The average diameter 
of microgels was smaller than the diameter of the corresponding precursor 
droplets, owing to microgel shrinkage upon gelation. Moreover, composite 
chitosan/agarose microgels loaded with ferrofluid can be also successfully 
obtained by microfluidics technique.  
- In general, for all the microfluidic devices designs studied, flow rate of the oil 
phase had a direct influence over the droplet size, the increase of the flow rate of 
the oil phase leads to a decrease of the droplets sizes. 
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iii. In the study of ionic crosslinking reaction of chitosan with sodium 
tripolyphosphate (TPP) to generate chitosan nanoparticles, it is possible to 
extract the next conclusions: 
- The crosslinking reaction between chitosan and TPP was influenced by three 
main experimental parameters: chitosan and TPP concentrations and volumetric 
ratios. The final state (clear, opalescent or precipitate solutions) allowed a first 
selection of the experimental conditions suitable to obtain chitosan particles of 
nanometric size. Then, size was corroborated by AFM or DLS techniques. 
- Chitosan nanoparticles loaded with ferrofluid were successfully obtained. 
These nanoparticles presented core-shell morphology and sizes in the range of 
192 to 259 nm. The encapsulation of ferrofluid within chitosan matrix was 
corroborated by field emission scanning electron microscopy and zeta-potencial. 
The zeta-potencial of all samples remained positive in the range of 57-63 mV. 
All samples presented a linear viscoelastic regime and from fractal analysis of 
the nanoparticles dispersions, a weak-like regime was obtained. Chitosan 
nanoparticles loaded with ferrofluid can act as hyperthermia agents due to their 
ability to heat when subjected to an alternative magnetic field.  
 
iv. In the study of chitosan nanoparticles for combined therapies against cancer, the 
following conclusions can be established: 
-  5-Fluorouracil was successfully encapsulated into chitosan nanoparticles 
loaded with ferrofluid. The sizes obtained are in the range of 140-200 nm, which 
proved to be suitable to be internalized in connective cells (Fibroblast) and 
malignant human glioblastoma cells (A-172) as demostrated through uptake 
studies.  
- The drug release profile of 5-Fluorouracil from chitosan nanoparticles loaded 
with ferrofluid was modulated as a function pH and ferrofluid content. For all 
the samples under study the drug release was higher at physiological pH than at 
pH 5.2. Moreover, the sample with the highest amount of ferrofluid presented 
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the lowest drug release. A controlled diffusion of 5-FU from chitosan 
nanoparticles was obtained during 30 days. 
- From cytotoxicity assays carried out on Fibroblast and cancer cells (A-172) it 
can be concluded that ferrofluid loaded chitosan nanoparticles presented a dose-
dependent effect. That is, the cell viability decreased with the concentration of 
the nanoparticles. Cancer cells (A-172) were more sensitive to chitosan 
nanoparticles than normal cells.  
- In situ magnetic hyperthermia (MH) experiments were carried out in a 
homemade equipment and the experimental protocol employed offered 
reproducibility on the results. The effect of the application of the magnetic 
hyperthermia treatment on cell viability was evaluated as a function of the 
number of doses of MH and the protocol employed for cell fixation. Cellular 
damage, changes over cells morphology and a reduction of cell viability was 
observed after the application of one MH treatment.  When cells were fixed 4 h 
after the first MH treatment, cell regeneration masked a possible effect of the 
chitosan nanoparticles over the A-172 cell line. A second magnetic hyperthermia 
treatment did not induce a significant change over cell viability. From the results 
obtained it was demonstrated that cancer cells (A-172) were more sensitive than 
Fibroblast cells to MH treatment. 
 
From this PhD work several fruitful national and international collaborations have 
been established with different groups as for example with E.Kumacheva (U. Toronto, 
CANADA), J. San Román (CSIC, SPAIN) and G. Goya (INA, SPAIN). 
Considering the results obtained in the present PhD work, new challenges arise for 
other PhD and Master projects. Future work is focused in the development of new 
biomaterials that can combine different cancer therapies with the objective to have a 
synergistic effect and reduce the side effects.   
 
 
Chapter 7 
214 
 
 
  
 
 
  
 
 
 
 
ABBREVIATIONS 
Abbreviations 
 
216 
 
Abbreviations 
 
 
217 
 
 
5-Fluorouracil 5-FU 
Phosphate buffer saline PBS 
Specific power absorption  SPA 
Temperature of the maximum weight loss rate Tp 
Linear Viscoelastic Regions LVR 
Elastic modulus  G´ 
Loss modulus  G´´ 
Elastic modulus plateau G0 
Critical deformation γ0 
Melting temperature Tm 
Temperature increase ΔT 
Time interval Δt 
Microfluidic MF 
Triple interpenetrating network  3XN 
oxidized dextran Odex 
N-carboxyethyl chitosan CEC 
Poly(dimethylsiloxane) PDMS 
Silicon Si 
Flow rate of the oil phase Qo 
Flow rate of the dispersed phase Qd 
Sodium tripolyphosphate TPP 
Coefficient of variance CV 
Mean diameter D 
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Generally recognized as safe GRAS 
Food and Drug administration FDA 
Alamar Blue AB 
Chitosan–sodium tripolyphosphate nanoparticles CS+TPP 
Ferrofluid loaded chitosan nanoparticles NP+Fe 
5-Fluorouracil loaded chitosan nanoparticles CS+FU 
Hybrid chitosan nanoparticles CS+FU+Fe 
Fibroblasts FBH 
Malignant human glioblastoma A-172 
Cell viability CV 
Lactate dehydrogenase LDH 
Acridine orange and propidium iodide (AO/PI)  
Polymeric nanoparticles NPs 
Blood−Brain Barrier BBB 
Standard deviation SD 
Encapsulation efficiency EE 
Loading efficiency LC 
Magnetic Hyperthermia MH 
Polystyrene PS 
Alternative magnetic AC 
Crystal violet C.V 
X-ray diffraction measurements XRD 
Differential thermogravimetric curves DTG 
Scanning Electron Microscopy SEM 
Dynamic light scattering DLS 
Abbreviations 
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Scanning Electron Microscopy with electron transmission FESEM 
Electron transmission TE 
Atomic Force Microscopy AFM 
Attenuated Total Reflection Fourier Transformed Infra-Red Spectroscopy ATR-FTIR 
Thermogravimetric analysis TGA 
Bright field BF 
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Annexe 6.1. Uptake studies 
 
 
Figure A-6.1. Uptake studies for different chitosan nanoparticles after 24 h of incubation, for FBH and 
A-172 cells lines.  
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Annexe 6.2. Determination of cell viability by crystal violet after a 
second magnetic hyperthermia treatment. 
 
Figure A-6.2 shows, photograph of crystal violet for A-172, after a second MH 
treatment and fixed 4 h later (t=24). As can be observe, it is evident the cellular damage 
by changes in its morphology, where A-172 cells look smaller than control cells and 
appear as a round or oval mass. To compare these photographs with the first MH 
treatment (Figure 6.15-b), these samples look more damaged. This is more evident for 
cells treated with CS+FU and CS+FU+Fe5.6%, On the other hand, for cells heated with 
NP+Fe5.6%, it is possible to observe cell regeneration at four hours after the MH 
treatment, for its long filopodia.  
 
 
 
Figure A-6.2. Photograph of crystal violet staining for A-172 cell line after a second magnetic 
hyperthermia treatment (t=24). 
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Annexed 6.3. AO/PI staining after a second magnetic hyperthermia 
treatment. 
 
 
In Figure A-6.3 is shown AO/PI staining, for A-172 cell treated with our 
chitosan nanoparticles after a second MH treatment (t=24), which suggest a significant 
evidence of cellular death and cells in process of death, recognized by the orange cells. 
These photographs indicate that cells treated with CS+FU and CS+FU+Fe5.6% have a 
more effect over A-172 cells. 
 
 
Figure A-6.3. Fluoresce images for A-172 cell line, obtained after AO/PI staining after a second 
magnetic hyperthermia treatment.  
 
 
 
 
 
 
 
 
Annexes 
 
226 
 
 
  
 
 
 
 
 
LIST OF PUBLICATIONS 
List of publications 
 
228 
 
 
List of publications 
   
229 
 
 
1. Hernández, R.; Zamora-Mora, V.; Sibaja-Ballestero, M.; Vega-Baudrit, J.; 
López, D.; Mijangos, C., Influence of iron oxide nanoparticles on the 
rheological properties of hybrid chitosan ferrogels. Journal of Colloid and 
Interface Science 2009, 339 (1), 53-59. 
 
2. Zamora-Mora V, Fernández-Gutiérrez M, Román JS, Goya G, Hernández R, 
Mijangos C., Magnetic core–shell chitosan nanoparticles: Rheological 
characterization and hyperthermia application. Carbohydrate Polymers. 2014, 
102:691-8. 
 
3. Zamora-Mora, V.; Velasco, D.; Hernández, R.; Mijangos, C.; Kumacheva, E., 
Chitosan/agarose hydrogels: Cooperative properties and microfluidic 
preparation. Carbohydrate Polymers 2014, 111 (0), 348-355. 
 
4. Zamora-Mora, V.; Velasco, D.; Hernández, R.; Mijangos, C., Chitosan 
microgels obtained by on-chip crosslinking reaction employing  a microfluidic 
device. Optofluidics Microfluidics and Nanofluidics Journal 2014. 
 
5. Zamora-Mora V, Fernández-Gutiérrez M, González Gómez A, Sanz B, Román 
JS, Goya G, Hernández R, Mijangos C. Chitosan nanoparticles for combined 
drug delivery and Magnetic Hyperthermia treatment. Biomacromolecules. In 
preparation.  
 
6. Zamora-Mora, V.; Echeverria, C.; Hernández, R.; Mijangos, C.; Ferrofluid 
loaded composite chitosan/agarose hydrogels. Performance in Magnetic 
Hyperthermia. To be sent 
 
7. Zamora-Mora, V.; Hernández, R.; Mijangos, C.; Uptake studies of chitosan 
nanoparticles through Raman spectroscopy. To be sent 
 
 
 
List of publications 
 
230 
 
 
 
 
 
